BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785. [PMID: 15692063 DOI: 10.1182/blood-2004-09-3502] [Cited by in Crossref: 2714] [Cited by in F6Publishing: 2844] [Article Influence: 150.8] [Reference Citation Analysis]
Number Citing Articles
1 Borcherding N, Severson KJ, Henderson N, Ortolan LS, Rosenthal AC, Bellizzi AM, Liu V, Link BK, Mangold AR, Jabbari A. Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment. Blood Adv 2023;7:321-35. [PMID: 35390145 DOI: 10.1182/bloodadvances.2021005991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chiang CT, Chuang SS, Lin HF, Li WH, Chiang YY, Chen BJ. Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype: Report of 2 Epstein-Barr Virus-Positive Cases. Am J Dermatopathol 2023;45:73-80. [PMID: 36669068 DOI: 10.1097/DAD.0000000000002254] [Reference Citation Analysis]
3 Rassek K, Iżykowska K, Żurawek M, Nowicka K, Joks M, Olek-Hrab K, Olszewska B, Sokołowska-Wojdyło M, Biernat W, Nowicki RJ, Przybylski GK. TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sézary Syndrome from Mycosis Fungoides and Benign Erythroderma. J Invest Dermatol 2023;143:344-347.e3. [PMID: 36087622 DOI: 10.1016/j.jid.2022.08.046] [Reference Citation Analysis]
4 Lin EC, Liao JB, Fang YH, Hong CH. The pathophysiology and current treatments for the subcutaneous panniculitis-like T cell lymphoma: An updated review. Asia Pac J Clin Oncol 2023;19:27-34. [PMID: 35509196 DOI: 10.1111/ajco.13787] [Reference Citation Analysis]
5 Alsomali DY, Bakshi N, Kharfan-Dabaja M, El Fakih R, Aljurf M. Diagnosis and Treatment of Subcutaneous Panniculitis-like T-cell Lymphoma: A Systematic Literature Review. Hematol Oncol Stem Cell Ther 2023;16:110-6. [PMID: 34015273 DOI: 10.1016/j.hemonc.2021.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Porkert S, Valencak J. Cutaneous lymphomas—fast facts about an orphan disease—a short review. memo 2023. [DOI: 10.1007/s12254-022-00863-0] [Reference Citation Analysis]
7 Shimshak S, Sokumbi O, Isaq N, Goyal A, Comfere N. A Practical Guide to the Diagnosis, Evaluation, and Treatment of Cutaneous T-Cell Lymphoma. Dermatologic Clinics 2023;41:209-229. [DOI: 10.1016/j.det.2022.07.019] [Reference Citation Analysis]
8 Hodak E, Geskin L, Guenova E, Ortiz-Romero PL, Willemze R, Zheng J, Cowan R, Foss F, Mangas C, Querfeld C. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion. Am J Clin Dermatol 2023;24:5-14. [PMID: 36399227 DOI: 10.1007/s40257-022-00732-w] [Reference Citation Analysis]
9 Hristov AC, Tejasvi T, Wilcox RA. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 2023;98:193-209. [PMID: 36226409 DOI: 10.1002/ajh.26760] [Reference Citation Analysis]
10 Goodlad JR, Cerroni L, Swerdlow SH. Recent advances in cutaneous lymphoma-implications for current and future classifications. Virchows Arch 2023;482:281-98. [PMID: 36278991 DOI: 10.1007/s00428-022-03421-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gru AA, Lim MS, Dogan A, Horwitz SM, Delabie J, Fu K, Peker D, Reddy VVB, Xu ML, Vij K, Slack GW, Miranda RN, Jagadeesh D, Lisano JM, Hsi ED, Torlakovic E. Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus. Arch Pathol Lab Med 2023;147:79-86. [PMID: 35472771 DOI: 10.5858/arpa.2021-0270-OA] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Karabulut YY, Dinç U, Köse EÇ, Türsen Ü. Deep learning as a new tool in the diagnosis of mycosis fungoides. Arch Dermatol Res 2022. [PMID: 36571610 DOI: 10.1007/s00403-022-02521-1] [Reference Citation Analysis]
13 Ottevanger R, van Beugen S, Evers AWM, Willemze R, Vermeer MH, Quint KD. Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider. Cancers (Basel) 2022;15. [PMID: 36612028 DOI: 10.3390/cancers15010032] [Reference Citation Analysis]
14 Duan Y, Gao H, Zhou C, Jin L, Yang J, Huang S, Zhang M, Zhang Y, Wang T. A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy? Orphanet J Rare Dis 2022;17:432. [PMID: 36503528 DOI: 10.1186/s13023-022-02575-4] [Reference Citation Analysis]
15 Plumptre IR, Said JT, Sun T, Larocca C, Virgen CA, Kupper TS, Fisher DC, Devlin PM, Elco CP, Song JS, LeBoeuf NR. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review. Leuk Lymphoma 2022;63:2832-46. [PMID: 35862569 DOI: 10.1080/10428194.2022.2098287] [Reference Citation Analysis]
16 Ram-wolff C. Linfomas cutáneos: clasificación. EMC - Dermatología 2022;56:1-6. [DOI: 10.1016/s1761-2896(22)47139-1] [Reference Citation Analysis]
17 Saksena A, Jain A, Pack SD, Kim J, Lee I, Tyagi M, Xi L, Pittaluga S, Raffeld M, Jaffe ES. Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT). American Journal of Surgical Pathology 2022;Publish Ahead of Print. [DOI: 10.1097/pas.0000000000002003] [Reference Citation Analysis]
18 Ward J, Prince HM, McCormack C, Lade S, Buelens O, van der Weyden C, Bhabha F, Campbell BA. Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder. Radiother Oncol 2022;178:109430. [PMID: 36455687 DOI: 10.1016/j.radonc.2022.11.019] [Reference Citation Analysis]
19 Chen S, Ji M, Xu P, Zhao W. Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis. Aging and Cancer 2022. [DOI: 10.1002/aac2.12058] [Reference Citation Analysis]
20 Luo Y, Vermeer MH, de Gruijl FR, Zoutman WH, Sluijter M, van Hall T, Tensen CP. In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1. Front Oncol 2022;12:1031052. [PMID: 36505769 DOI: 10.3389/fonc.2022.1031052] [Reference Citation Analysis]
21 Nowicka D, Mertowska P, Mertowski S, Hymos A, Forma A, Michalski A, Morawska I, Hrynkiewicz R, Niedźwiedzka-Rystwej P, Grywalska E. Etiopathogenesis, Diagnosis, and Treatment Strategies for Lymphomatoid Papulosis with Particular Emphasis on the Role of the Immune System. Cells 2022;11. [PMID: 36429125 DOI: 10.3390/cells11223697] [Reference Citation Analysis]
22 Kwesi-maliepaard EM, Malik M, van Welsem T, van Doorn R, Vermeer MH, Vlaming H, Jacobs H, van Leeuwen F. DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1032958] [Reference Citation Analysis]
23 Sorger H, Dey S, Vieyra-Garcia PA, Pölöske D, Teufelberger AR, de Araujo ED, Sedighi A, Graf R, Spiegl B, Lazzeri I, Braun T, Garces de Los Fayos Alonso I, Schlederer M, Timelthaler G, Kodajova P, Pirker C, Surbek M, Machtinger M, Graier T, Perchthaler I, Pan Y, Fink-Puches R, Cerroni L, Ober J, Otte M, Albrecht JD, Tin G, Abdeldayem A, Manaswiyoungkul P, Olaoye OO, Metzelder ML, Orlova A, Berger W, Wobser M, Nicolay JP, André F, Nguyen VA, Neubauer HA, Fleck R, Merkel O, Herling M, Heitzer E, Gunning PT, Kenner L, Moriggl R, Wolf P. Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma. EMBO Mol Med 2022;14:e15200. [PMID: 36341492 DOI: 10.15252/emmm.202115200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Kelly J, Mirkin G, Yim J, Hao X. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type on the Dorsal Foot in a Senior Woman: A Case Report. Journal of the American Podiatric Medical Association 2022;112. [DOI: 10.7547/21-143] [Reference Citation Analysis]
25 Rager T, Lake E. Mycosis Fungoides in Skin of Color. Journal of the Dermatology Nurses' Association 2022;14:261-264. [DOI: 10.1097/jdn.0000000000000708] [Reference Citation Analysis]
26 Fki A, Kotti N, Dhouib F, Kammoun N, Frikha M, Jmal Hammami K, Masmoudi M, Turki H, Hajjaji M. Les facteurs professionnels associés au mycosis fongoïde. Archives des Maladies Professionnelles et de l'Environnement 2022. [DOI: 10.1016/j.admp.2022.10.007] [Reference Citation Analysis]
27 Crimp C, Gangal A, Tarabadkar ES, Shinohara MM. Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations. CMAR 2022;Volume 14:3271-3279. [DOI: 10.2147/cmar.s351420] [Reference Citation Analysis]
28 Evans MG, Torres-cabala CA. Expanding the Molecular Landscape of Cutaneous T-Cell Lymphoma. Advances in Molecular Pathology 2022;5:29-40. [DOI: 10.1016/j.yamp.2022.05.001] [Reference Citation Analysis]
29 Patil K, Kuttikrishnan S, Khan AQ, Ahmad F, Alam M, Buddenkotte J, Ahmad A, Steinhoff M, Uddin S. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways. Semin Cancer Biol 2022;86:382-99. [PMID: 34906723 DOI: 10.1016/j.semcancer.2021.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Michonneau D, Bagot M, Beylot-barry M, de Masson A. Lymphome T sous-cutané à type de panniculite. Annales de Dermatologie et de Vénéréologie - FMC 2022. [DOI: 10.1016/j.fander.2021.10.009] [Reference Citation Analysis]
31 Verghese C, Li W, Gvazava N, Alimpertis E, Kahlon N, Sun H, Booth R. IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers. Clin Pathol 2022;15:2632010X221129242. [PMID: 36313587 DOI: 10.1177/2632010X221129242] [Reference Citation Analysis]
32 Hempel C, Aurich S, Dumann K, Ziemer M. [Disseminated recurrent papules and nodes]. Dermatologie (Heidelb) 2022;73:823-6. [PMID: 35267042 DOI: 10.1007/s00105-022-04969-8] [Reference Citation Analysis]
33 Kim R, Kwon BR, Byun JY, Choi YW, Choi HY, Park S, Lee MY. A Case of Vesicular Mycosis Fungoides. Ann Dermatol 2022;34:374-7. [PMID: 36198629 DOI: 10.5021/ad.20.100] [Reference Citation Analysis]
34 Goyal N, O’leary D, Carter JB, Comfere N, Sokumbi O, Goyal A. A Practical Review of the Presentation, Diagnosis, and Management of Cutaneous B-Cell Lymphomas. Dermatologic Clinics 2022. [DOI: 10.1016/j.det.2022.07.014] [Reference Citation Analysis]
35 Shin W, Lee SY, Jin H, Kim J, Kang S, Kim J, Jung S. Development and Evaluation of a Thimble-Like Head Bolus Shield for Hemi-Body Electron Beam Irradiation Technique. J Radiat Prot Res 2022;47:152-157. [DOI: 10.14407/jrpr.2022.00010] [Reference Citation Analysis]
36 Wojewoda K, Gillstedt M, Englund H, Ali S, Lewerin C, Osmancevic A. Diagnostic Outcomes and Treatment Modalities in Patients with Mycosis Fungoides in West Sweden—A Retrospective Register-Based Study. Cancers 2022;14:4661. [DOI: 10.3390/cancers14194661] [Reference Citation Analysis]
37 Roccuzzo G, Mastorino L, Gallo G, Fava P, Ribero S, Quaglino P. Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice. Clin Cosmet Investig Dermatol 2022;15:1899-907. [PMID: 36124283 DOI: 10.2147/CCID.S273063] [Reference Citation Analysis]
38 Kayishunge D, Ly S, Su J, Wong HK. Epidemiologic Trends of Cutaneous T-Cell Lymphoma in Arkansas Reveals Demographic Disparities. Cancers (Basel) 2022;14:4329. [PMID: 36077864 DOI: 10.3390/cancers14174329] [Reference Citation Analysis]
39 Temesgen Assefa A, Abel Tenaw T, Fisihatsion T. Recurrent primary cutaneous anaplastic large cell lymphoma in young female patient from Ethiopia: A Case Report. Arch Hematol Case Rep Rev 2022;7:019-022. [DOI: 10.17352/ahcrr.000040] [Reference Citation Analysis]
40 Satou A, Takahara T, Tsuzuki T. Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas. Diagnostics 2022;12:2001. [DOI: 10.3390/diagnostics12082001] [Reference Citation Analysis]
41 Guerrero-torija A, Vallejo-ruiz MDLS, Jaquero-valero MI, Baeza-hernández G, Echeverría-garcía B, Álvarez-garrido H. Linfomas T cutáneos primarios con afinidad por el panículo adiposo: buscando las diferencias. Piel 2022. [DOI: 10.1016/j.piel.2022.05.011] [Reference Citation Analysis]
42 Pérez H, Morales S, Enciso L, Carreño J, Rueda X. Análisis de supervivencia en pacientes con micosis fungoide foliculotropa de un centro latinoamericano. Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2022.07.018] [Reference Citation Analysis]
43 Kumar S, Dhamija B, Attrish D, Sawant V, Sengar M, Thorat J, Shet T, Jain H, Purwar R. Genetic alterations and oxidative stress in T cell lymphomas. Pharmacol Ther 2022;236:108109. [PMID: 35007658 DOI: 10.1016/j.pharmthera.2022.108109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Shreberk-Hassidim R, Geiger-Maor A, Eisenberg G, Merims S, Hajaj E, Cohen JE, Klein S, Frankenburg S, Moyal L, Hodak E, Zlotogorski A, Lotem M. The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma. Immunol Res 2022. [PMID: 35867216 DOI: 10.1007/s12026-022-09308-6] [Reference Citation Analysis]
45 Mizuno Y, Shibata S, Miyagaki T, Ito Y, Taira H, Omori I, Hisamoto T, Oka K, Matsuda KM, Boki H, Takahashi-Shishido N, Sugaya M, Sato S. Serum cell-free DNA as a new biomarker in cutaneous T-cell lymphoma. J Dermatol 2022. [PMID: 35821652 DOI: 10.1111/1346-8138.16520] [Reference Citation Analysis]
46 Jung JM, Lee MY, Won CH, Chang SE, Park C, Lee MW, Lee WJ. Clinicopathological Factors Associated with the Prognosis and Chronicity of Lymphomatoid Papulosis: A Retrospective Cohort Study. Clinical Lymphoma Myeloma and Leukemia 2022;22:e541-e548. [DOI: 10.1016/j.clml.2022.02.004] [Reference Citation Analysis]
47 Jung JM, Lee MY, Won CH, Chang SE, Lee MW, Lee WJ. Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides. Leuk Lymphoma 2022;63:1598-606. [PMID: 35201905 DOI: 10.1080/10428194.2022.2043303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Parsons MW, Wada DA, Halwani AS, Tao R, Gaffney DK. Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study. Leukemia & Lymphoma 2022. [DOI: 10.1080/10428194.2022.2081322] [Reference Citation Analysis]
49 Chen YW, Yang HZ, Zhao SS, Zhang Z, Chen ZM, Feng HH, An MH, Wang KK, Duan R, Chen BD. Ultrasound-guided microwave ablation as a palliative treatment for mycosis fungoides eyelid involvement: A case report. World J Clin Cases 2022; 10(17): 5825-5832 [DOI: 10.12998/wjcc.v10.i17.5825] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Lucioni M, Fraticelli S, Neri G, Feltri M, Ferrario G, Riboni R, Paulli M. Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features. Hemato 2022;3:318-340. [DOI: 10.3390/hemato3020023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Belousova IE, Gorenkova LG, Kravchenko SK, Kovrigina AM, Lepik EE, Shneyder TV. Efficacy of brentuximab vedotin in patients with CD30-positive lymphoproliferative skin diseases: results of the first prospective study in the Russian Federation. Vestnik dermatologii i venerologii 2022;98:53-62. [DOI: 10.25208/vdv1319] [Reference Citation Analysis]
52 Filonenko EV, Ivanova-radkevich VI. Photodynamic therapy in the treatment of patients with mycosis fungoides. Biomedical photonics 2022;11:27-36. [DOI: 10.24931/2413-9432-2022-11-1-27-36] [Reference Citation Analysis]
53 Filonenko EV, Ivanova-radkevich VI. Photodynamic therapy in the treatment of patients with mycosis fungoides. Biomedical photonics 2022;11:29-38. [DOI: 10.24931/2413-9432-2022-11-1-27-37] [Reference Citation Analysis]
54 Assaf C, Dobos G, Zech IM, Doess A, Hibbe T, Jadasz JJ. Versorgungsstruktur der Patienten mit Mycosis fungoides und Sézary-Syndrom in Deutschland - Versorgungsforschung auf Basis von GKV-Routinedaten. J Dtsch Dermatol Ges 2022;20:643-52. [PMID: 35578415 DOI: 10.1111/ddg.14725_g] [Reference Citation Analysis]
55 Assaf C, Booken N, Dippel E, Guenova E, Jonak C, Klemke CD, Nicolay JP, Schlaak M, Wobser M, Trautinger F. Chlormethin-Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH-Region) zum Therapiemanagement. J Dtsch Dermatol Ges 2022;20:579-88. [PMID: 35578416 DOI: 10.1111/ddg.14688_g] [Reference Citation Analysis]
56 Zein S, Bertram CA, Kiupel M, Klopfleisch R, Müller K. Auricular cutaneous T‐cell lymphoma, subtype mycosis fungoides and otitis externa/media in a domestic rat ( Rattus norvegicus forma domestica ). Vet Record Case Reports. [DOI: 10.1002/vrc2.377] [Reference Citation Analysis]
57 Assaf C, Dobos G, Zech IM, Doess A, Hibbe T, Jadasz JJ. Care structure of patients with mycosis fungoides and Sézary syndrome in Germany - Care research based on SHI claims data. J Dtsch Dermatol Ges 2022. [PMID: 35499207 DOI: 10.1111/ddg.14725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Picozza M, Cristofoletti C, Bresin A, Fioretti M, Sambucci M, Scala E, Monopoli A, Cantonetti M, Pilla MA, Accetturi MP, Borsellino G, D’atri S, Caprini E, Russo G, Narducci MG. Genetically driven CD39 expression affects Sezary cell viability, IL-2 production and detects two patient subsets with distinct prognosis. Journal of Investigative Dermatology 2022. [DOI: 10.1016/j.jid.2022.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Willemze R. Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification. La Presse Médicale 2022. [DOI: 10.1016/j.lpm.2022.104126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Lewis NE, Gao Q, Petrova‐drus K, Pulitzer M, Sigler A, Baik J, Moskowitz AJ, Horwitz SM, Dogan A, Roshal M. PD ‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome. Cytometry Part B Clinical 2022;102:189-198. [DOI: 10.1002/cyto.b.22070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Nenonen J, Winther AH, Leijonhufvud E, Belfrage E, Smedby KE, Brauner H. Overall survival and registration of cutaneous T-cell lymphoma patients in Sweden: a multi-center cohort and validation study. Acta Oncol 2022;61:597-601. [PMID: 35331072 DOI: 10.1080/0284186X.2022.2050296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hirata C, Nakai K, Kurasawa Y, Maekawa N, Kuniyuki S, Yamagami K, Ohsawa M, Tsuruta D. Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis. Dermatopathology 2022;9:143-7. [DOI: 10.3390/dermatopathology9020018] [Reference Citation Analysis]
63 Osto M, Afify O, Musa A, Ahmed U, Rehman R, Mehregan D. Woringer-Kolopp disease (localized pagetoid reticulosis): a systematic review. Int J Dermatol 2022. [PMID: 35485962 DOI: 10.1111/ijd.16224] [Reference Citation Analysis]
64 Scarisbrick JJ. The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas. Presse Med 2022;:104123. [PMID: 35490911 DOI: 10.1016/j.lpm.2022.104123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Gros A, Menguy S, Bobée V, Ducharme O, Cassaigne IC, Vergier B, Parrens M, Beylot-Barry M, Pham-Ledard A, Ruminy P, Jardin F, Merlio JP. Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling. PLoS One 2022;17:e0266978. [PMID: 35452489 DOI: 10.1371/journal.pone.0266978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Mizuno Y, Miyagaki T, Suga H, Kamijo H, Boki H, Kawana Y, Oka K, Hisamoto T, Oka T, Takahashi‐shishido N, Sugaya M, Sato S. Poor prognostic factors of Sézary syndrome: A retrospective single‐center study from Japan. J Cutaneous Imm & Allergy. [DOI: 10.1002/cia2.12241] [Reference Citation Analysis]
67 J. Alkhatib A. Lymphoma and the Microenvironmental Cross-Talk between Sex Hormone Receptors and Epstein-Barr Virus in Predicting Lymphoma Clinical Status. Lymphoma 2022. [DOI: 10.5772/intechopen.101055] [Reference Citation Analysis]
68 Assaf C, Booken N, Dippel E, Guenova E, Jonak C, Klemke C, Nicolay JP, Schlaak M, Wobser M, Trautinger F. The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region). J Deutsche Derma Gesell. [DOI: 10.1111/ddg.14688] [Reference Citation Analysis]
69 Wang H, Pi Y, Guo Y, Pei X, Xu XG. Influencing Factors of Total Skin Irradiation With Helical Tomotherapy. Front Oncol 2022;12:852345. [DOI: 10.3389/fonc.2022.852345] [Reference Citation Analysis]
70 Lenskaya V, de Moll EH, Hussein S, Phelps RG. Subtlety of Granulomatous Mycosis Fungoides: A Retrospective Case Series Study and Proposal of Helpful Multimodal Diagnostic Approach With Literature Review. Am J Dermatopathol 2022. [PMID: 35476045 DOI: 10.1097/DAD.0000000000002181] [Reference Citation Analysis]
71 Chen C, Liu Z, Liu J, Zhang W, Zhou D, Zhang Y. Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review. Front Oncol 2022;12:842123. [PMID: 35387123 DOI: 10.3389/fonc.2022.842123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Mahurin HM, Ware OR, Coolman DO TD, Stevenson PA, Pergam SA, Shinohara MM. Cannabis use among patients with cutaneous lymphoma: A cross-sectional survey. Complement Ther Med 2022;:102830. [PMID: 35395396 DOI: 10.1016/j.ctim.2022.102830] [Reference Citation Analysis]
73 Yang Z, Gong D, Huang F, Sun Y, Hu Q. Epidemiological Characteristics and the Development of Prognostic Nomograms of Patients With HIV-Associated Cutaneous T-Cell Lymphoma. Front Oncol 2022;12:847710. [PMID: 35372067 DOI: 10.3389/fonc.2022.847710] [Reference Citation Analysis]
74 Ohadi L, Hosseinzadeh F, Dadkhahfar S, Nasiri S. Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5682] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
75 Michali MC, Tsikou AT, Tsafaras CE, Kastanioudaki PI, Komnos ID. Primary Cutaneous Anaplastic Large Cell Lymphoma of the Nasal Dorsum and Nasal Tip. Cureus 2022. [DOI: 10.7759/cureus.23811] [Reference Citation Analysis]
76 Leary DO, Goyal N, Rubin N, Goyal A. Characterization of Primary and Secondary Cutaneous B-Cell Lymphomas: A Population-Based Study of 4758 Patients. Clinical Lymphoma Myeloma and Leukemia 2022;22:e269-e278. [DOI: 10.1016/j.clml.2021.10.009] [Reference Citation Analysis]
77 Goyal A, Nardi V. Gamma/Delta (γδ) T Cells: The Role of the T-Cell Receptor in Diagnosis and Prognosis of Hematologic Malignancies. Am J Dermatopathol 2022;44:237-48. [PMID: 35287137 DOI: 10.1097/DAD.0000000000002041] [Reference Citation Analysis]
78 Franceschi J, Ehret M, Visseaux L, Durlach A, Barbe C, Durot É, Grange F. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas. Acta Derm Venereol 2022;102:adv00676. [DOI: 10.2340/actadv.v102.1087] [Reference Citation Analysis]
79 Guo N, Jia L, Out-Luiting C, Miranda NFCC, Willemze R, Koning F, Vermeer M, Quint K. Mass Cytometric Analysis of Early-Stage Mycosis Fungoides. Cells 2022;11:1062. [PMID: 35406628 DOI: 10.3390/cells11071062] [Reference Citation Analysis]
80 van Santen S, Zoutman WH, de Masson A, Quint KD, Willemze R, Gerard N, Teague JE, Kupper TS, Clark RA, Tensen CP, Vermeer MH. Tumor clone frequency calculation using high throughput sequencing of the T-cell receptor β gene in folliculotropic mycosis fungoides patients. J Invest Dermatol 2022:S0022-202X(22)00197-X. [PMID: 35304252 DOI: 10.1016/j.jid.2021.11.044] [Reference Citation Analysis]
81 Jost M, Wehkamp U. The Skin Microbiome and Influencing Elements in Cutaneous T-Cell Lymphomas. Cancers 2022;14:1324. [DOI: 10.3390/cancers14051324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Liu X, Jin S, Hu S, Li R, Pan H, Liu Y, Lai P, Xu D, Sun J, Liu Z, Gao Y, Zhao Y, Liu F, Xiao Y, Li Y, Wen Y, Chen Z, Xu B, Lin Y, Ran M, Li Q, Yang S, Li H, Tu P, Haniffa M, Teichmann SA, Bai F, Wang Y. Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma. Nat Commun 2022;13:1158. [PMID: 35241665 DOI: 10.1038/s41467-022-28799-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
83 Cheng M, Zain J, Rosen ST, Querfeld C. Emerging drugs for the treatment of cutaneous T-cell lymphoma. Expert Opin Emerg Drugs 2022. [PMID: 35235473 DOI: 10.1080/14728214.2022.2049233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Karamova AE, Verbenko DA, Vorontsova AA, Zhilova MB, Nikonorov AA, Gatiatulina ER, Znamenskaya LF, Kubanov AA, Qian L. Effect of PUVA and NB-UVB Therapy on the Skin Cytokine Profile in Patients with Mycosis Fungoides. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/3149293] [Reference Citation Analysis]
85 Karagianni F, Piperi C, Casar B, de la Fuente-Vivas D, García-Gómez R, Lampadaki K, Pappa V, Papadavid E. Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma. Cancers (Basel) 2022;14:1070. [PMID: 35205818 DOI: 10.3390/cancers14041070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Gill RPK, Gantchev J, Martínez Villarreal A, Ramchatesingh B, Netchiporouk E, Akilov OE, Ødum N, Gniadecki R, Koralov SB, Litvinov IV. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma. Cells 2022;11:593. [PMID: 35203244 DOI: 10.3390/cells11040593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 He ZD, Yang HY, Zhou SS, Wang M, Mo QL, Huang FX, Peng ZG. Chidamide combined with traditional chemotherapy for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report. World J Clin Cases 2022; 10(4): 1341-1348 [DOI: 10.12998/wjcc.v10.i4.1341] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Ottevanger R, Melchers RC, Quint KD. Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab. JAAD Case Reports 2022. [DOI: 10.1016/j.jdcr.2022.02.003] [Reference Citation Analysis]
89 Khadzhieva MB, Zakharova ES, Kalinina EV, Abramov DS, Rumyantsev AG, Larin SS. Molecular genetic features of cutaneous T-cell lymphomas development on example of mycosis fungoides and Sezary syndrome. Onkogematologiâ 2022;17:65-74. [DOI: 10.17650/1818-8346-2022-17-1-65-74] [Reference Citation Analysis]
90 Morita A, Tateishi C, Ikumi K, Hayashi D, Nakada A, Nishihara H, Torii K, Nishida E, Tsuruta D. Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma. Dermatol Ther (Heidelb) 2022. [PMID: 35084694 DOI: 10.1007/s13555-021-00655-0] [Reference Citation Analysis]
91 Roccuzzo G, Giordano S, Avallone G, Rubatto M, Canonico S, Funaro A, Ortolan E, Senetta R, Fava P, Fierro MT, Ribero S, Quaglino P. Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System. Cells 2022;11:333. [DOI: 10.3390/cells11030333] [Reference Citation Analysis]
92 Miyashiro D, Souza BCE, Torrealba MP, Manfrere KCG, Sato MN, Sanches JA. The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome. Int J Mol Sci 2022;23:936. [PMID: 35055124 DOI: 10.3390/ijms23020936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, van Wezel T, van Eijk R, Ruano D, Tensen CP, Hauben E, Woei-A-Jin FJSH, Busschots AM, van den Berg A, Diepstra A, Vermeer MH, Vermaat JSP. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas. Virchows Arch 2022. [PMID: 35028710 DOI: 10.1007/s00428-021-03265-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
94 Dobos G, Miladi M, Michel L, Ram-Wolff C, Battistella M, Bagot M, de Masson A. Recent advances on cutaneous lymphoma epidemiology. Presse Med 2022;:104108. [PMID: 35026392 DOI: 10.1016/j.lpm.2022.104108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Fava P, Roccuzzo G, Alberti-Violetti S, Grandi V, Pileri A, Pimpinelli N, Berti E, Quaglino P. CUTANEOUS B-CELL LYMPHOMAS: UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT. Presse Med 2022;:104109. [PMID: 35026390 DOI: 10.1016/j.lpm.2022.104109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Bresin A, Caprini E, Russo G, Narducci MG. Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far. J Invest Dermatol 2022:S0022-202X(21)02615-4. [PMID: 35000751 DOI: 10.1016/j.jid.2021.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Chang YT, Ignatova D, Hoetzenecker W, Pascolo S, Fassnacht C, Guenova E. Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions. JID Innov 2022;2:100069. [PMID: 34977846 DOI: 10.1016/j.xjidi.2021.100069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
98 Kempf W, Stadler R. Cutaneous Lymphomas. Braun-Falco´s Dermatology 2022. [DOI: 10.1007/978-3-662-63709-8_109] [Reference Citation Analysis]
99 Margaritescu I, Chirita A, Addis K, Dinehart MS, Carlock S, Abate MS, Smoller B. Cutaneous Lymphomas and Lymphocytic Infiltrates. Atlas of Dermatology, Dermatopathology and Venereology 2022. [DOI: 10.1007/978-3-319-53805-1_83] [Reference Citation Analysis]
100 Olisova OY, Teplyuk NP, Grabovskaya OV, Grekova E. Sub-Erythroderma in a 52 Year Old Man. Clinical Cases in Exfoliative Dermatitis 2022. [DOI: 10.1007/978-3-031-08466-9_26] [Reference Citation Analysis]
101 Junkins-hopkins JM. Cutaneous Lymphomas. Handbook of Practical Immunohistochemistry 2022. [DOI: 10.1007/978-3-030-83328-2_33] [Reference Citation Analysis]
102 Crisan D, Crisan M. Dermatologic Concepts and Terminology. Textbook of Dermatologic Ultrasound 2022. [DOI: 10.1007/978-3-031-08736-3_3] [Reference Citation Analysis]
103 Al-tarawneh A. Mycosis fungoides in children and adolescents: A clinicopathological study in Jordan, Middle East. Turk J Dermatol 2022;16:7. [DOI: 10.4103/tjd.tjd_114_21] [Reference Citation Analysis]
104 Corail DR, Mondoloni M, Calvo AS, Quilhot P, Lescaille G, Baaroun V, Rochefort J. Oral manifestation of lymphomatoid papulosis: systematic review. J Oral Med Oral Surg 2022;28:30. [DOI: 10.1051/mbcb/2021043] [Reference Citation Analysis]
105 Mandava A. Ultrasound of Cutaneous Lymphomas. Textbook of Dermatologic Ultrasound 2022. [DOI: 10.1007/978-3-031-08736-3_11] [Reference Citation Analysis]
106 Assaf C, Waser N, Bagot M, He M, Li T, Dalal M, Gavini F, Trinchese F, Zomas A, Little M, Pimpinelli N, Ortiz-Romero PL, Illidge TM. Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries. Cancers (Basel) 2021;14:145. [PMID: 35008309 DOI: 10.3390/cancers14010145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Parida DK, Barik SK. Surviving With Mycosis Fungoides for Twenty Years: An Autobiographical Case Report. Cureus 2021. [DOI: 10.7759/cureus.20699] [Reference Citation Analysis]
108 Karamova AE, Vorontsova AA, Zhilova MB, Znamenskaya LF, Saytburkhanov RR, Aulova KM. Melanoma in patients with mycosis fungoides. Vestnik dermatologii i venerologii 2021;97:87-95. [DOI: 10.25208/vdv1288] [Reference Citation Analysis]
109 Ba W, Yang HH, Wang W, Li C. CD8+ mycosis fungoides with ichthyosiform clinical presentation and angiocentric feature. J Cutan Pathol 2021. [PMID: 34913182 DOI: 10.1111/cup.14188] [Reference Citation Analysis]
110 Kubanov AA, Karamova AE, Bogdanova EV, Znamenskaya LF, Vorontsova AA. Epidemiology and status of specialized medical care for patients with cutaneous T-cell lymphomas: A survey of 163 patients of Russian Federation. J Mod Onco 2021;23:628-634. [DOI: 10.26442/18151434.2021.4.201272] [Reference Citation Analysis]
111 Flanagan KE, Burns LJ, Pathoulas JT, Walker CJ, Pupo Wiss I, Cornejo KM, Senna MM. Primary Alopecia Neoplastica: A Novel Case Report and Literature Review. Skin Appendage Disord 2021;7:499-509. [PMID: 34901185 DOI: 10.1159/000516650] [Reference Citation Analysis]
112 Franke G, Dumann K, Jentzsch M, Monecke A, Doehring C, Nehring-vucinic C, Schwind S, Niederwieser D, Platzbecker U, Ziemer M, Vucinic V. Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome. Front Oncol 2021;11:749691. [DOI: 10.3389/fonc.2021.749691] [Reference Citation Analysis]
113 Podkonjak T, Cranmer H, Scarisbrick J, McCarthy G, Lilley C, Cheng LI. Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma. J Comp Eff Res 2021. [PMID: 34879742 DOI: 10.2217/cer-2021-0201] [Reference Citation Analysis]
114 Obayomi A, Abo Zaken G, Miteva M. SnapshotDx Quiz: December 2021. Journal of Investigative Dermatology 2021;141:e141-6. [DOI: 10.1016/j.jid.2021.10.013] [Reference Citation Analysis]
115 Jiang TT, Kruglov O, Lin GHY, Minic A, Jordan K, Uger RA, Wong M, Shou Y, Akilov OE. Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4+ BTLA+ T Cells in Tumor Microenvironment of Mycosis Fungoides. Cancers (Basel) 2021;13:5982. [PMID: 34885092 DOI: 10.3390/cancers13235982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Kawana Y, Suga H, Kamijo H, Miyagaki T, Sugaya M, Sato S. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome. Int J Mol Sci 2021;22:12576. [PMID: 34830466 DOI: 10.3390/ijms222212576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Haque WS, Alam S, Kabir H, Chowdhury A. Unilesional mycosis fungoides: a case report and review of literature. IMC Journal of Medical Science. [DOI: 10.55010/imcjms.16.009] [Reference Citation Analysis]
118 Minokawa Y, Sawada Y, Nakamura M. The Influences of Omega-3 Polyunsaturated Fatty Acids on the Development of Skin Cancers. Diagnostics (Basel) 2021;11:2149. [PMID: 34829495 DOI: 10.3390/diagnostics11112149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Stahly S, Manway M, Lin CC, Sukpraprut-Braaten S. Pagetoid Reticulosis: A Rare Dermatologic Malignancy Presenting in a Middle-Aged Female. Cureus 2021;13:e18524. [PMID: 34754679 DOI: 10.7759/cureus.18524] [Reference Citation Analysis]
120 Sato S, Sawada Y, Nakamura M. STING Signaling and Skin Cancers. Cancers (Basel) 2021;13:5603. [PMID: 34830754 DOI: 10.3390/cancers13225603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
121 Deb PQ, Hurley HJ, Cai D, Bhate C. Incidence and Outcomes of Primary Cutaneous Anaplastic Large Cell Lymphoma: a SEER Population Based Study (Preprint).. [DOI: 10.2196/preprints.34759] [Reference Citation Analysis]
122 Lee SY, Kim WH, Choi JH, Kim KS, Hwang JH. Early diagnosis and surgical treatment of primary cutaneous marginal zone B-cell lymphomas of the face in an Asian patient. Arch Craniofac Surg 2021;22:280-4. [PMID: 34732041 DOI: 10.7181/acfs.2021.00472] [Reference Citation Analysis]
123 Yoshie O. CCR4 as a Therapeutic Target for Cancer Immunotherapy. Cancers (Basel) 2021;13:5542. [PMID: 34771703 DOI: 10.3390/cancers13215542] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
124 Leupin N, Zinzani PL, Morschhauser F, Dalle S, Maerevoet M, Michot JM, Ribrag V, Offner F, Beylot-Barry M, Moins-Teisserenc H, Zwaenepoel K, de Winne K, Battistella M, Hultberg A, Gandini D, Moshir M, Jacobs J, Delahaye T, Khan A, Zabrocki P, Silence K, van Rompaey L, Borg C, Motta G, Melle F, Calleri A, Pauwels P, de Haard H, Pileri S, Bagot M. Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma. Cancer 2021. [PMID: 34726773 DOI: 10.1002/cncr.34005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Kostecki HD. What is the cause of this patient's solitary facial nodule? JAAPA 2021;34:53-5. [PMID: 34699453 DOI: 10.1097/01.JAA.0000795028.84164.0f] [Reference Citation Analysis]
126 Zhu S, Liu Z, Jia X. Primary cutaneous NK/T cell lymphoma. Medicine: Case Reports and Study Protocols 2021;2:e0152. [DOI: 10.1097/md9.0000000000000152] [Reference Citation Analysis]
127 Nguyen T, Yaghsezian A, Lin YL, Klokkevold P. An unusual case of cluster of differentiation 30-positive T-cell lymphoproliferative disorder manifesting as mandibular gingival ulceration: A case report. J Am Dent Assoc 2021:S0002-8177(21)00442-6. [PMID: 34756592 DOI: 10.1016/j.adaj.2021.07.015] [Reference Citation Analysis]
128 Lee J, Jiang H, Gru AA. Primary cutaneous anaplastic large-cell lymphoma with aberrant cytokeratin expression: An unusual mimicker of poorly differentiated carcinomas. J Cutan Pathol 2021. [PMID: 34705295 DOI: 10.1111/cup.14157] [Reference Citation Analysis]
129 Nguyen CN, Iyer SP, Miranda RN, Torres-Cabala CA, Curry JL, Fang P, Thomas VD, Huen AO. Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse. JAAD Case Rep 2021;17:34-7. [PMID: 34692965 DOI: 10.1016/j.jdcr.2021.09.005] [Reference Citation Analysis]
130 Farabi B, Seminario-Vidal L, Jamgochian M, Akay BN, Atak MF, Rao BK, Karagaiah P, Grabbe S, Goldust M. Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials. J Cosmet Dermatol 2021. [PMID: 34687485 DOI: 10.1111/jocd.14528] [Reference Citation Analysis]
131 Flora A, Gibson M, Toon C, Rawson R, Lowe P. Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosum. IJDVL 2021;88:90-2. [DOI: 10.25259/ijdvl_296_2021] [Reference Citation Analysis]
132 Bin Waqar SH, Zaman U, Salahi N, Gupta R, McFarlane IM. A Perplexing Case of Recurrent Abscess-Like Lesions: Insights Into Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Cureus 2021;13:e17766. [PMID: 34659977 DOI: 10.7759/cureus.17766] [Reference Citation Analysis]
133 Hamada T, Morita A, Suga H, Boki H, Fujimura T, Hirai Y, Shimauchi T, Tateishi C, Kiyohara E, Muto I, Nakajima H, Abe R, Fujii K, Nishigori C, Nakano E, Yonekura K, Funakoshi T, Amano M, Miyagaki T, Makita N, Manaka K, Shimoyama Y, Sugaya M. Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance. J Dermatol 2021. [PMID: 34658060 DOI: 10.1111/1346-8138.16201] [Reference Citation Analysis]
134 Hristov AC, Tejasvi T, A Wilcox R. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 2021;96:1313-28. [PMID: 34297414 DOI: 10.1002/ajh.26299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
135 Rindler K, Jonak C, Alkon N, Thaler FM, Kurz H, Shaw LE, Stingl G, Weninger W, Halbritter F, Bauer WM, Farlik M, Brunner PM. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma. Mol Cancer 2021;20:124. [PMID: 34583709 DOI: 10.1186/s12943-021-01419-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
136 Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides und Sézary-Syndrom. J Dtsch Dermatol Ges 2021;19:1307-35. [PMID: 34541808 DOI: 10.1111/ddg.14610_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
137 Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides and Sézary syndrome. J Dtsch Dermatol Ges 2021;19:1307-34. [PMID: 34541796 DOI: 10.1111/ddg.14610] [Reference Citation Analysis]
138 Kasinathan G, Sathar J. Disseminated mature T-cell phenotype CD4/CD8 double-negative mycosis fungoides with pleural involvement. Hematol Transfus Cell Ther 2021:S2531-1379(21)00132-2. [PMID: 34593365 DOI: 10.1016/j.htct.2021.07.004] [Reference Citation Analysis]
139 Miyagaki T. Diagnosis of Early Mycosis Fungoides. Diagnostics (Basel) 2021;11:1721. [PMID: 34574062 DOI: 10.3390/diagnostics11091721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Roccuzzo G, Giordano S, Fava P, Pileri A, Guglielmo A, Tonella L, Sanlorenzo M, Ribero S, Fierro MT, Quaglino P. Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives. Front Oncol 2021;11:733770. [PMID: 34485162 DOI: 10.3389/fonc.2021.733770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
141 Jung JM, Lim DJ, Won CH, Chang SE, Lee MW, Lee WJ. Mycosis Fungoides in Children and Adolescents: A Systematic Review. JAMA Dermatol 2021;157:431-8. [PMID: 33656521 DOI: 10.1001/jamadermatol.2021.0083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
142 Xing LX, Zhang J, Shen H, Tang XL, He L, Wu JZ, Li JY, Miao Y. Association of marital status with stage and survival in patients with mycosis fungoides: A population-based study. Cancer Med 2021;10:7320-9. [PMID: 34480528 DOI: 10.1002/cam4.4232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Ilter N, Keskin N, Adisen E, Erdem O, Ogut B. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma mimicking pyoderma gangrenosum. Australas J Dermatol 2021;62:e605-7. [PMID: 34477215 DOI: 10.1111/ajd.13708] [Reference Citation Analysis]
144 Hematopoietic and Lymphoid Tumors. Nonmelanocytic Tumors of the Skin 2021. [DOI: 10.55418/9781933477121-3] [Reference Citation Analysis]
145 Shinohara M, Mahurin H, Tarabadkar E, Hippe D, Lachance K, Kim E, Loggers E. Health‐related quality of life in cutaneous T‐cell lymphoma: A cross‐sectional survey study. Skin Health and Disease 2021;1. [DOI: 10.1002/ski2.45] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Miyashiro D, Sanches JA. Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort. Int J Dermatol 2021. [PMID: 34435672 DOI: 10.1111/ijd.15865] [Reference Citation Analysis]
147 Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Cutaneous T cell lymphoma. Nat Rev Dis Primers 2021;7:61. [PMID: 34446710 DOI: 10.1038/s41572-021-00296-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
148 Prag Naveh H, Amitay-Laish I, Zidan O, Leshem YA, Sherman S, Noyman Y, Taieb J, Didkovsky E, Hodak E. Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects. J Dermatolog Treat 2021;:1-7. [PMID: 34427536 DOI: 10.1080/09546634.2021.1967266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
149 Merlio JP, Kadin ME. Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas. Cancers (Basel) 2021;13:4256. [PMID: 34503066 DOI: 10.3390/cancers13174256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
150 Wennberg E, Richards PQ, Bain PA, Huang V, Sullivan SD, Maverakis EM, Molina GE, Wu PA. Topical treatments for early-stage mycosis fungoides using Grading Recommendations Assessment, Development and Evaluation (GRADE) criteria: A systematic review. JAAD Int 2021;3:26-41. [PMID: 34409369 DOI: 10.1016/j.jdin.2021.01.002] [Reference Citation Analysis]
151 Wohlmuth-Wieser I. Primary cutaneous T-cell lymphomas in childhood and adolescence. J Dtsch Dermatol Ges 2021;19:563-81. [PMID: 33861015 DOI: 10.1111/ddg.14509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Miyagaki T. Diagnosis and prognostic stratification of cutaneous lymphoma. J Dermatol 2021. [PMID: 34346516 DOI: 10.1111/1346-8138.16099] [Reference Citation Analysis]
153 Ottevanger R, van Beugen S, Evers AWM, Willemze R, Vermeer MH, Quint KD. Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature. J Eur Acad Dermatol Venereol 2021. [PMID: 34331819 DOI: 10.1111/jdv.17570] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
154 Goyal A, O'Leary D, Foreman RK, Duncan LM. Assessing the diagnosis of "primary cutaneous mantle cell lymphoma": A systematic review and population-based analysis. J Am Acad Dermatol 2021:S0190-9622(21)02201-5. [PMID: 34343606 DOI: 10.1016/j.jaad.2021.07.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Xu S, Foss F. New nonchemotherapy treatment options for cutaneous T-cell lymphomas. Expert Rev Anticancer Ther 2021;21:1017-28. [PMID: 33554707 DOI: 10.1080/14737140.2021.1882859] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Horwitz S, Zinzani PL, Bagot M, Kim YH, Moskowitz AJ, Porcu P, Dwyer K, Sun W, Herr FM, Scarisbrick J. Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial. Leuk Lymphoma 2021;:1-10. [PMID: 34304674 DOI: 10.1080/10428194.2021.1953007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Bomze D, Sprecher E, Goldberg I, Samuelov L, Geller S. Primary Cutaneous B-Cell Lymphomas in Children and Adolescents: A SEER Population-Based Study. Clin Lymphoma Myeloma Leuk 2021:S2152-2650(21)00304-9. [PMID: 34417159 DOI: 10.1016/j.clml.2021.07.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Lee YP, Yoon SE, Song Y, Kim SJ, Yoon DH, Chen TY, Koh YI, Kang KW, Lee HS, Wei KTK, Lim ST, Poon M, Irawan C, Zhao W, Do YR, Lee MH, Ng SC, Lee WS, Guo Y, Zhang H, Kang HJ, Yun HJ, Kim HJ, Lung DTC, Kwak JY, Han JJ, Mun YC, Oh SY, Shim H, Kwon JH, Sohn BS, Park SK, Jo JC, Ko YH, Jun Z, Kim WS. Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia. Int J Hematol 2021;114:355-62. [PMID: 34302593 DOI: 10.1007/s12185-021-03179-7] [Reference Citation Analysis]
159 Sakamoto M, Miyagaki T, Kamijo H, Oka T, Boki H, Takahashi-Shishido N, Suga H, Sugaya M, Sato S. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma. Int J Mol Sci 2021;22:7889. [PMID: 34360654 DOI: 10.3390/ijms22157889] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
160 Sasapu A, Dunn ALJ, Gardner J, Wong HK. Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin. BMJ Case Rep 2021;14:e242896. [PMID: 34290015 DOI: 10.1136/bcr-2021-242896] [Reference Citation Analysis]
161 Mahurin HM, Tarabadkar E, Hippe DS, Lachance K, Kim EJ, Loggers ET, Shinohara MM. Integrative medicine use in patients with cutaneous T-Cell lymphoma: A cross-sectional survey study. Complement Ther Med 2021;61:102762. [PMID: 34302983 DOI: 10.1016/j.ctim.2021.102762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
162 Abreu M, Miranda M, Castro M, Fernandes I, Cabral R, Santos AH, Fonseca S, Rodrigues J, Leander M, Lau C, Freitas I, Coimbra S, Santos-Silva A, Lima M. IL-31 and IL-8 in Cutaneous T-Cell Lymphoma: Looking for Their Role in Itch. Adv Hematol 2021;2021:5582581. [PMID: 34335777 DOI: 10.1155/2021/5582581] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
163 Azuma K, Ohmi A, Goto-Koshino Y, Tomiyasu H, Ohno K, Chambers JK, Uchida K, Namba H, Nagata M, Nagamine E, Nibe K, Irie M, Tsujimoto H. Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T-cell lymphomas. Vet Comp Oncol 2021. [PMID: 34250731 DOI: 10.1111/vco.12752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Lin M, Kowolik CM, Xie J, Yadav S, Overman LE, Horne DA. Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma. Cancers (Basel) 2021;13:3367. [PMID: 34282785 DOI: 10.3390/cancers13133367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Sarriugarte Aldecoa-otalora J, Mitxelena Eceiza J, Córdoba Iturriagagoitia A, Viguria Alegría M. Pápulas rojizas centrofaciales. Actas Dermo-Sifiliográficas 2021;112:668-670. [DOI: 10.1016/j.ad.2019.11.011] [Reference Citation Analysis]
166 Jiang M, Zhao L, Zheng J, Zhang J, Chen P, Zhou W. Report of Eleven Patients of Subcutaneous Panniculitis-Like T-Cell Lymphoma: Clinicopathologic Features, 18F-FDG PET/CT Findings and Outcome. Front Oncol 2021;11:650822. [PMID: 34277404 DOI: 10.3389/fonc.2021.650822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 López de Cáceres CVB, Rodrigues-Fernandes CI, Rendón Henao J, Morais TML, Soares CD, de Almeida OP, Fonseca FP, Delgado-Azañero W. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population. J Oral Pathol Med 2021;50:530-9. [PMID: 34097774 DOI: 10.1111/jop.13203] [Reference Citation Analysis]
168 Suh KS, Jang MS, Jung JH, Kwon DI, Seong SH, Lee KH, Park JB. Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review. J Am Acad Dermatol 2021:S0190-9622(21)02005-3. [PMID: 34197872 DOI: 10.1016/j.jaad.2021.06.860] [Reference Citation Analysis]
169 Vallecorsa P, Di Venosa G, Gola G, Sáenz D, Mamone L, MacRobert AJ, Ramírez J, Casas A. Photodynamic therapy of cutaneous T-cell lymphoma cell lines mediated by 5-aminolevulinic acid and derivatives. J Photochem Photobiol B 2021;221:112244. [PMID: 34174487 DOI: 10.1016/j.jphotobiol.2021.112244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
170 Otagiri H, Kondo E, Morioka M, Sakai H, Yamada S, Kurita H. A case of primary cutaneous γδ T-cell lymphoma with initial symptoms in the tongue. Jpn J Oral Maxillofac Surg 2021;67:335-339. [DOI: 10.5794/jjoms.67.335] [Reference Citation Analysis]
171 Henry KA, Wiese D, Maiti A, Harris G, Vucetic S, Stroup AM. Geographic clustering of cutaneous T-cell lymphoma in New Jersey: an exploratory analysis using residential histories. Cancer Causes Control 2021;32:989-99. [PMID: 34117957 DOI: 10.1007/s10552-021-01452-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Pruksaeakanan C, Teyateeti P, Patthamalai P, Thumrongtharadol J, Chairatchaneeboon M. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study. Biomed Res Int 2021;2021:4057661. [PMID: 34235215 DOI: 10.1155/2021/4057661] [Reference Citation Analysis]
173 Tomasini D, Croci GA, Hotz A, Cione S, Cecchetti C, Ciambelli F, Crivelli F. Gamma/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to "T-cell-receptor-silent" aggressive lymphoma: Description of one case. J Cutan Pathol 2021;48:1197-203. [PMID: 34002416 DOI: 10.1111/cup.14063] [Reference Citation Analysis]
174 Cortes JR, Patrone CC, Quinn SA, Gu Y, Sanchez-Martin M, Mackey A, Cooke AJ, Shih BB, Laurent AP, Trager MH, Ferrando AA, Geskin LJ, Palomero T. Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma. J Invest Dermatol 2021:S0022-202X(21)01308-7. [PMID: 34089720 DOI: 10.1016/j.jid.2021.04.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
175 Gisriel SD, Hung KW, Braddock DT, Seropian S, Foss FM, Robert ME, Xu ML. Simultaneous colonic T-cell lymphoma and graft-versus-host disease: A rare diagnosis. Human Pathology: Case Reports 2021;24:200507. [DOI: 10.1016/j.ehpc.2021.200507] [Reference Citation Analysis]
176 Stürmer S, Schlaak M. Primär kutane Lymphome*. InFo Hämatol Onkol 2021;24:42-55. [DOI: 10.1007/s15004-021-8688-5] [Reference Citation Analysis]
177 Truong K, Janz-Robinson E, Khan T, Curtin P, Wells J. Lymphomatoid papulosis presenting on a finger. Australas J Dermatol 2021;62:e414-6. [PMID: 34021584 DOI: 10.1111/ajd.13599] [Reference Citation Analysis]
178 Chang FC, Coomarasamy C, Jarrett P. The epidemiology of mycosis fungoides in New Zealand. Australas J Dermatol 2021;62:414-6. [PMID: 34009650 DOI: 10.1111/ajd.13616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
179 Sarriugarte Aldecoa-Otalora J, Mitxelena Eceiza J, Córdoba Iturriagagoitia A, Viguria Alegría MC. Reddish Papules in the Center of the Face. Actas Dermosifiliogr (Engl Ed) 2021:S1578-2190(21)00175-X. [PMID: 34059452 DOI: 10.1016/j.adengl.2021.05.015] [Reference Citation Analysis]
180 Moon IJ, Lee KH, Choi JW, Lee WJ, Won CH, Chang S, Choi JH, Lee MW. Clinical characteristics and long-term outcomes of 97 Korean patients with mycosis fungoides. Int J Dermatol 2021. [PMID: 33991105 DOI: 10.1111/ijd.15561] [Reference Citation Analysis]
181 Weng WK, Arai S, Rezvani A, Johnston L, Lowsky R, Miklos D, Shizuru J, Muffly L, Meyer E, Negrin RS, Wang E, Almazan T, Million L, Khodadoust M, Li S, Hoppe RT, Kim YH. Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma. Blood Adv 2020;4:4474-82. [PMID: 32941647 DOI: 10.1182/bloodadvances.2020001627] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
182 Pavlidis A, Piperi C, Papadavid E. Novel therapeutic approaches for cutaneous T cell lymphomas. Expert Rev Clin Immunol 2021;17:629-41. [PMID: 33890833 DOI: 10.1080/1744666X.2021.1919085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
183 Gu X, Wang Y, Zhang C, Liu Y. GFI-1 overexpression promotes cell proliferation and apoptosis resistance in mycosis fungoides by repressing Bax and P21. Oncol Lett 2021;22:521. [PMID: 34025788 DOI: 10.3892/ol.2021.12782] [Reference Citation Analysis]
184 de Leval L, Jaffe ES. Lymphoma Classification. Cancer J 2020;26:176-85. [PMID: 32496451 DOI: 10.1097/PPO.0000000000000451] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 12.5] [Reference Citation Analysis]
185 Lyu WT, Song QB, Qiong W, Liu J, Yong R, Yi FT, Han DL. A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma. Medicine (Baltimore) 2021;100:e25770. [PMID: 33950967 DOI: 10.1097/MD.0000000000025770] [Reference Citation Analysis]
186 Ottevanger R, de Bruin DT, Willemze R, Jansen PM, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Vermeer MH, Quint KD. Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020. Br J Dermatol 2021;185:434-5. [PMID: 33690948 DOI: 10.1111/bjd.20048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
187 Kim EJ, Guitart J, Querfeld C, Girardi M, Musiek A, Akilov OE, Angello JT, Bailey WL, Geskin LJ. The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma. Am J Clin Dermatol 2021;22:407-14. [PMID: 33656660 DOI: 10.1007/s40257-021-00591-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
188 Morse DC, Park KE, Chitsazzadeh V, Li S, Young K, Gunther JR, Dabaja BS, Duvic M. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. Int J Gynecol Pathol 2021;40:229-33. [PMID: 33741766 DOI: 10.1097/PGP.0000000000000648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Ruiz-villaverde R, Rueda-villafranca B, Ruiz-carrascosa J. Bruise-like Spots Appearing Progressively on the Face and Back. Actas Dermo-Sifiliográficas (English Edition) 2021;112:447-448. [DOI: 10.1016/j.adengl.2021.02.015] [Reference Citation Analysis]
190 Sławińska M, Sokołowska-Wojdyło M, Olszewska B, Nowicki RJ, Sobjanek M, Zalaudek I. Dermoscopic and trichoscopic features of primary cutaneous lymphomas - systematic review. J Eur Acad Dermatol Venereol 2021;35:1470-84. [PMID: 33710688 DOI: 10.1111/jdv.17219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
191 Gru AA, Rooke B, Molloy K, Scarisbrick J. Cutaneous T‐cell Lymphoma. The Peripheral T‐Cell Lymphomas 2021. [DOI: 10.1002/9781119671336.ch18] [Reference Citation Analysis]
192 Herek TA, Iqbal J. Molecular Classification of the Peripheral T‐cell Lymphomas. The Peripheral T‐Cell Lymphomas 2021. [DOI: 10.1002/9781119671336.ch7] [Reference Citation Analysis]
193 Kelley JT, Brown NA, Hristov AC, Bresler SC. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components. J Cutan Pathol 2021;48:969-74. [PMID: 33786907 DOI: 10.1111/cup.14020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Wohlmuth-Wieser I. Primär kutane T-Zell-Lymphome im Kindes- und Jugendalter. J Dtsch Dermatol Ges 2021;19:563-83. [PMID: 33861014 DOI: 10.1111/ddg.14509_g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
195 García-Díaz N, Piris MÁ, Ortiz-Romero PL, Vaqué JP. Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy. Cancers (Basel) 2021;13:1931. [PMID: 33923722 DOI: 10.3390/cancers13081931] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
196 Li L, Wu C, Chai Y, Dong C, Zhao L. Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review. Int J Immunopathol Pharmacol 2021;35:20587384211009342. [PMID: 33845613 DOI: 10.1177/20587384211009342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
197 References. Flow Cytometry of Hematological Malignancies 2021. [DOI: 10.1002/9781119611288.refs] [Reference Citation Analysis]
198 Pastor M, Mazzei ME, Magliano J. Lesión nodular de rápido crecimiento en el párpado. Diagnóstico y comentario. Piel 2021;36:250-251. [DOI: 10.1016/j.piel.2020.10.003] [Reference Citation Analysis]
199 Alnasser MA, AlKhawajah NM, AlQadri NG, Shadid AM, Alsaif FM. Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report. Case Rep Oncol 2021;14:256-61. [PMID: 33776713 DOI: 10.1159/000512822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
200 Kume M, Kiyohara E, Matsumura Y, Koguchi-Yoshioka H, Tanemura A, Hanaoka Y, Taminato M, Tashima H, Tomita K, Kubo T, Watanabe R, Fujimoto M. Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma. Front Immunol 2021;12:651048. [PMID: 33859643 DOI: 10.3389/fimmu.2021.651048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
201 Tambe SA, Zambare US, Nayak CS. Folliculotropic Mycosis Fungoides. Indian Dermatol Online J 2021;12:178-80. [PMID: 33768049 DOI: 10.4103/idoj.IDOJ_289_20] [Reference Citation Analysis]
202 Tomasini C, Michelerio A, Quaglino P. Spiky/keratosis-pilaris-like early follicular mycosis fungoides: A clinicopathologic study of 20 cases with extended follow-up. J Cutan Pathol 2021;48:1124-32. [PMID: 33675561 DOI: 10.1111/cup.14002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
203 Jung JM, Yoo H, Lim DJ, Won CH, Chang SE, Lee MW, Lee WJ. Clinicoprognostic implications of head and neck involvement by mycosis fungoides: A retrospective cohort study. J Am Acad Dermatol 2021:S0190-9622(21)00609-5. [PMID: 33771590 DOI: 10.1016/j.jaad.2021.03.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Rucińska A. Aktualny stan wiedzy w zakresie leczenia interdyscyplinarnego chłoniaków w oparciu o informacje pozyskane na konferencji ASTR0’S 56-th Annual Meeting. LOS 2021;18:20-23. [DOI: 10.21641/los.2021.18.1.51] [Reference Citation Analysis]
205 Scheu A, Schnabl SM, Steiner DP, Fend F, Berneburg M, Yazdi AS. Stellenwert diagnostischer Verfahren und Risiko von Zweittumoren bei primär kutanen Lymphomen. J Dtsch Dermatol Ges 2021;19:373-82. [PMID: 33709586 DOI: 10.1111/ddg.14400_g] [Reference Citation Analysis]
206 Cardwell LA, Majerowski J, Chiu YE, Harrington AM, Sokumbi O. Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient. J Cutan Pathol 2021;48:706-12. [PMID: 33476057 DOI: 10.1111/cup.13967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
207 Fréchet L, Woronoff AS, Gérazime A, Puzenat E, Dupond AS, Nardin C, Popescu D, Aubin F. Primary cutaneous lymphoma: a population-based cancer registry descriptive study of 155 consecutive cases diagnosed between 1979 and 2016. Leuk Lymphoma 2021;62:2010-3. [PMID: 33682600 DOI: 10.1080/10428194.2021.1891232] [Reference Citation Analysis]
208 Vermeer M. Epidemiology of cutaneous lymphoma. Br J Dermatol 2021;184:993-4. [PMID: 33656170 DOI: 10.1111/bjd.19829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
209 Stürmer S, Schlaak M. Primär kutane Lymphome. hautnah dermatologie 2021;37:51-63. [DOI: 10.1007/s15012-021-6619-7] [Reference Citation Analysis]
210 Shingleton J, Wang J, Baloh C, Dave T, Davis N, Happ L, Jadi O, Kositsky R, Li X, Love C, Panea R, Qin Q, Reddy A, Singhi N, Smith E, Thakkar D, Dave SS. Non-Hodgkin Lymphomas: Malignancies Arising from Mature B Cells. Cold Spring Harb Perspect Med 2021;11:a034843. [PMID: 32152246 DOI: 10.1101/cshperspect.a034843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Lim EJ, Leong N, McAdory LE, Ho CL. Multimodality imaging and treatment strategy for malignant scalp neoplasms in adults. Clin Imaging 2021;77:48-57. [PMID: 33640791 DOI: 10.1016/j.clinimag.2021.02.036] [Reference Citation Analysis]
212 Rajashekara Swamy M, Pollock S, J Goldberg L, Shen L. A case of lymphomatoid papulosis type E in a young adult: An uncommon entity. J Cutan Pathol 2021;48:694-700. [PMID: 33533041 DOI: 10.1111/cup.13974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
213 Scheu A, Schnabl SM, Steiner DP, Fend F, Berneburg M, Yazdi AS. Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas. J Dtsch Dermatol Ges 2021;19:373-81. [PMID: 33576187 DOI: 10.1111/ddg.14400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
214 Nishikawa Y, Kanemaru S, Mori A, Nagano M, Mochida K, Amano M. Adult T-cell leukemia/lymphoma with pagetoid reticulosis-like skin lesions. Int J Dermatol 2021;60:e342-4. [PMID: 33559154 DOI: 10.1111/ijd.15446] [Reference Citation Analysis]
215 Misra M, Raghuvanshi S, Goel MM, Verma SP. ALK-negative primary cutaneous T-cell anaplastic large cell lymphoma, myxoid variant; masquerading as sarcoma: unveiling the diagnostic dilemma. BMJ Case Rep 2021;14:e239350. [PMID: 33547131 DOI: 10.1136/bcr-2020-239350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Jia X, Jin G, Ma Y, Cen W, Wen X, Zhang W. The prognostic role of age in primary cutaneous B-cell lymphoma: a proposal derived from a population-based registry. Aging Clin Exp Res 2021;33:429-36. [PMID: 32385755 DOI: 10.1007/s40520-020-01544-w] [Reference Citation Analysis]
217 Vermeer MH, Nicolay JP, Scarisbrick JJ, Zinzani PL. The importance of assessing blood tumour burden in cutaneous T-cell lymphoma. Br J Dermatol 2021;185:19-25. [PMID: 33155285 DOI: 10.1111/bjd.19669] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
218 Symes E, Dominiak N. Primary Cutaneous B-Cell Lymphoma Complicated by Clonal T-Cell Populations: A Diagnostic Dilemma. Am J Dermatopathol 2021;43:454-8. [PMID: 33481377 DOI: 10.1097/DAD.0000000000001906] [Reference Citation Analysis]
219 Wilhelm R, Eckes T, Imre G, Kippenberger S, Meissner M, Thomas D, Trautmann S, Merlio JP, Chevret E, Kaufmann R, Pfeilschifter J, Koch A, Jäger M. C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers (Basel) 2021;13:E270. [PMID: 33450826 DOI: 10.3390/cancers13020270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
220 Mateeva V, Patsatsi A. Management of primary cutaneous lymphomas during the COVID-19 pandemic. Clin Dermatol 2021;39:64-75. [PMID: 33972055 DOI: 10.1016/j.clindermatol.2020.12.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
221 Kamijo H, Miyagaki T. Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy. Curr Treat Options Oncol 2021;22:10. [PMID: 33415447 DOI: 10.1007/s11864-020-00809-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
222 Baykal C, Kılıç Sayar S, Yazganoğlu KD, Büyükbabani N. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey. Turk J Haematol 2021;38:49-56. [PMID: 33389922 DOI: 10.4274/tjh.galenos.2020.2020.0685] [Reference Citation Analysis]
223 Domínguez-gómez MA, Estrada-ramírez KP, Morales-sánchez MA, Jurado-santa Cruz F, Navarrete-franco G, Ramos-garibay JA, González-gonzález M, Peralta-pedrero ML. Micosis fungoide hiperpigmentada de cara y pliegues en adultos: estudio prospectivo de una nueva variedad clínica. Revista del Centro Dermatológico Pascua 2021;30:131-138. [DOI: 10.35366/103826] [Reference Citation Analysis]
224 Pandey SN. Skin Cancer: Molecular Biomarker for Diagnosis, Prognosis, Prevention, and Targeted Therapy. Skin Cancer: Pathogenesis and Diagnosis 2021. [DOI: 10.1007/978-981-16-0364-8_7] [Reference Citation Analysis]
225 Willemze R, Theurich S, Schlaak M. Indolent Cutaneous T-Cell Lymphomas. Hematologic Malignancies 2021. [DOI: 10.1007/978-3-030-55989-2_14] [Reference Citation Analysis]
226 Pattamadilok B, Poomputsar T. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB‐UVB) with a twice‐weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years. Photodermatol Photoimmunol Photomed 2021;37:49-55. [DOI: 10.1111/phpp.12611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
227 Hadi R, Miller TI, May C, Lehman JS, Bennett DD, Piliang M, Chang O, Shinohara MM. Impact of clinical photographs on the accuracy and confidence in the histopathological diagnosis of mycosis fungoides. J Cutan Pathol 2021;48:842-6. [PMID: 33326119 DOI: 10.1111/cup.13938] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
228 Bhabha FK, McCormack C, Wells J, Campbell BA, Newland K, Lade S, Buelens O, Joske D, Shortt J, Mapp S, Radeski D, Hertzberg M, Khot A, Van Der Weyden C, Khoo C, Hawkes E, Prince HM. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement. Australas J Dermatol 2021;62:e8-e18. [PMID: 33368169 DOI: 10.1111/ajd.13467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
229 Wohlmuth-Wieser I, Ramjist JM, Shear N, Alhusayen R. Morphologic Features of Cutaneous T-Cell Lymphomas Using Dermoscopy and High Frequency Ultrasound. J Clin Med 2020;10:E17. [PMID: 33374774 DOI: 10.3390/jcm10010017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Kempf W, Mitteldorf C, Battistella M, Willemze R, Cerroni L, Santucci M, Geissinger E, Jansen P, Vermeer MH, Marschalko M, Papadavid E, Piris MA, Ortiz-Romero PL, Novelli M, Paulli M, Quaglino P, Ranki A, Rodríguez Peralto JL, Wobser M, Auschra B, Robson A. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features. J Eur Acad Dermatol Venereol 2021;35:658-68. [PMID: 32997839 DOI: 10.1111/jdv.16969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
231 Sawada Y, Mashima E, Saito-Sasaki N, Nakamura M. The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies. Int J Mol Sci 2020;21:E9732. [PMID: 33419290 DOI: 10.3390/ijms21249732] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
232 Ruiz-Villaverde R, Rueda-Villafranca B, Ruiz-Carrascosa JC. Bruise-like Spots Appearing Progressively on the Face and Back. Actas Dermosifiliogr (Engl Ed) 2021;112:447-8. [PMID: 33307012 DOI: 10.1016/j.ad.2019.05.024] [Reference Citation Analysis]
233 Immunophenotyping in the Diagnosis and Monitoring of Haematological Neoplasms and Related Conditions with Tables and Figures for Quick Reference. Immunophenotyping for Haematologists 2020. [DOI: 10.1002/9781119606161.ch3] [Reference Citation Analysis]
234 Contreras-Chavez P, Sanchez-Nadales A, Babets I, Sajjad-Hassan R, Lansigan F. Primary cutaneous B-cell lymphoma-leg type in a young adult with HIV: a case report. Oxf Med Case Reports 2020;2020:omaa110. [PMID: 33269089 DOI: 10.1093/omcr/omaa110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
235 Dobos G, de Masson A, Ram-Wolff C, Beylot-Barry M, Pham-Ledard A, Ortonne N, Ingen-Housz-Oro S, Battistella M, d'Incan M, Rouanet J, Franck F, Vignon-Pennamen MD, Franck N, Carlotti A, Boulinguez S, Lamant L, Petrella T, Dalac S, Joly P, Courville P, Rivet J, Dereure O, Amatore F, Taix S, Grange F, Durlach A, Quéreux G, Josselin N, Moulonguet I, Mortier L, Dubois R, Maubec E, Laroche L, Michel L, Templier I, Barete S, Nardin C, Augereau O, Vergier B, Bagot M; French Study Group on Cutaneous Lymphomas (GFELC). Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry. Br J Dermatol 2021;184:1059-67. [PMID: 33131055 DOI: 10.1111/bjd.19644] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
236 Sun D, Zheng S, Hong YX, Chen HD, Gao XH. Subcutaneous panniculitis-like T cell lymphoma presented as erythema nodosum: A case report. Dermatol Ther 2021;34:e14572. [PMID: 33219732 DOI: 10.1111/dth.14572] [Reference Citation Analysis]
237 Ohtsuka M, Hamada T, Miyagaki T, Shimauchi T, Yonekura K, Kiyohara E, Fujita H, Izutsu K, Okuma K, Kawai K, Koga H, Sugaya M. Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020. J Dermatol 2021;48:e49-71. [PMID: 33245165 DOI: 10.1111/1346-8138.15707] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
238 Kampa F, Mitteldorf C. A review of CD30 expression in cutaneous neoplasms. J Cutan Pathol 2021;48:495-510. [PMID: 33047376 DOI: 10.1111/cup.13894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
239 Ding X, Chen J, Kuai L, Xing M, Ru Y, Luo Y, Luo Y, Zhou M, Li B, Li X. CD4/CD8 dual-positive mycosis fungoides: A case report and literature review. Medicine (Baltimore) 2020;99:e22786. [PMID: 33080750 DOI: 10.1097/MD.0000000000022786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
240 Kim S, Kim A, Hah JO. Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Syndrome in a Child: A Successful Treatment with the BFM-NHL-90 Protocol. Clin Pediatr Hematol Oncol 2020;27:129-33. [DOI: 10.15264/cpho.2020.27.2.129] [Reference Citation Analysis]
241 Shen XZ, Yu SL, Liu F, Luo ZY. Familial aggregation of subcutaneous panniculitis-like T cell lymphoma: A case report of monozygotic twin brothers. Medicine (Baltimore) 2020;99:e22629. [PMID: 33080699 DOI: 10.1097/MD.0000000000022629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
242 Manole I, Butacu AI, Negulet IE, Valcoci MC, Tiplica GS. Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma: A Rare Association With Large Plaque Parapsoriasis. Cureus 2020;12:e11228. [PMID: 33269156 DOI: 10.7759/cureus.11228] [Reference Citation Analysis]
243 Mascolo M, Travaglino A, Varricchio S, Russo D, Sabattini E, Agostinelli C, Bertuzzi C, Baldo A, Pileri A, Picardi M, Pane F, Staibano S. Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides. Virchows Arch 2021;478:961-8. [PMID: 33098490 DOI: 10.1007/s00428-020-02952-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
244 Trochopoulos AGX, Zaharieva MM, Marinova MH, Yoncheva K, Tibi IP, Berger MR, Konstantinov SM. Antineoplastic effect of a novel nanosized curcumin on cutaneous T cell lymphoma. Oncol Lett 2020;20:304. [PMID: 33093913 DOI: 10.3892/ol.2020.12167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
245 Shekhar A, Sinha CP, Sinha DK, Yadav SK, Baxla T. Intragluteal Cleft Ulcer: a Rare Presentation of Primary Cutaneous Non-Hodgkin's Lymphoma. Indian J Surg Oncol 2020;11:24-6. [PMID: 33088123 DOI: 10.1007/s13193-019-01012-6] [Reference Citation Analysis]
246 Scarisbrick JJ, Bagot M, Ortiz-Romero PL. The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma. Br J Haematol 2021;192:683-96. [PMID: 33095448 DOI: 10.1111/bjh.17117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
247 Beltzung F, Ortonne N, Pelletier L, Beylot-Barry M, Ingen-Housz-Oro S, Franck F, Pereira B, Godfraind C, Delfau MH, D'Incan M, Vergier B. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group. Am J Surg Pathol 2020;44:862-72. [PMID: 32271188 DOI: 10.1097/PAS.0000000000001470] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
248 Pileri A, Agostinelli C, Bertuzzi C, Grandi V, Maio V, Lastrucci I, Santucci M, Pimpinelli N. Prognostic significance of Bcl-2 expression in primary cutaneous B-cell lymphoma: a reappraisal. Ital J Dermatol Venerol 2021;156:642-9. [PMID: 33070565 DOI: 10.23736/S0392-0488.20.06622-5] [Reference Citation Analysis]
249 Verheyden MJ, Venning VL, Khurana S, Cheung K. Follicular lymphomatoid papulosis - not a simple folliculitis. Australas J Dermatol 2021;62:235-7. [PMID: 33070325 DOI: 10.1111/ajd.13493] [Reference Citation Analysis]
250 Melchers RC, Willemze R, van de Loo M, van Doorn R, Jansen PM, Cleven AHG, Solleveld N, Bekkenk MW, van Kester MS, Diercks GFH, Vermeer MH, Quint KD. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma. Am J Surg Pathol 2020;44:776-81. [PMID: 32412717 DOI: 10.1097/PAS.0000000000001449] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
251 Russo I, Fagotto L, Sernicola A, Alaibac M. Primary Cutaneous B-Cell Lymphomas in Patients With Impaired Immunity. Front Oncol 2020;10:1296. [PMID: 33042785 DOI: 10.3389/fonc.2020.01296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
252 Dobos G, Pohrt A, Ram-Wolff C, Lebbé C, Bouaziz JD, Battistella M, Bagot M, de Masson A. Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients. Cancers (Basel) 2020;12:E2921. [PMID: 33050643 DOI: 10.3390/cancers12102921] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
253 Barasch NJK, Liu YC, Ho J, Bailey N, Aggarwal N, Cook JR, Swerdlow SH. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. Hum Pathol 2020;106:93-105. [PMID: 33045225 DOI: 10.1016/j.humpath.2020.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
254 Iuliano A, Fossataro F, Laezza MP, Lanni V, Mascolo M, Varricchio S, Uccello G, Tranfa F, Strianese D. Primary cutaneous anaplastic large-cell lymphoma of the eyelid: report of two cases and review of the literature. Orbit 2020;:1-7. [PMID: 32998605 DOI: 10.1080/01676830.2020.1826543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
255 Melchers RC, Willemze R, Vermaat JSP, Jansen PM, Daniëls LA, Putter H, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Vermeer MH, Quint KD. Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease. Blood 2020;135:769-73. [PMID: 31977038 DOI: 10.1182/blood.2019002799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
256 Gibson SE, Swerdlow SH. How I Diagnose Primary Cutaneous Marginal Zone Lymphoma. Am J Clin Pathol 2020;154:428-49. [PMID: 32808967 DOI: 10.1093/ajcp/aqaa116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
257 Yoshida N, Miyoshi H, Arakawa F, Nakashima K, Kawamoto K, Seto M, Ohshima K. Cytokine-related genes play critical roles in extrafollicular growth of follicular lymphoma cells. Hematol Oncol 2020;38:673-9. [PMID: 32835439 DOI: 10.1002/hon.2795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
258 Lee C, Peddi S, Anderson C, Su H, Cui H, Epstein AL, MacKay JA. Adaptable antibody Nanoworms designed for non-Hodgkin lymphoma. Biomaterials 2020;262:120338. [PMID: 32916604 DOI: 10.1016/j.biomaterials.2020.120338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
259 Cutaneous B‐cell lymphomas. Skin Lymphoma 2020. [DOI: 10.1002/9781119485933.part2] [Reference Citation Analysis]
260 Krishnan M, Lunning M. Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial? J Oncol Pract 2019;15:307-12. [PMID: 31185190 DOI: 10.1200/JOP.18.00594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
261 Dejust S, Morland D, Durot E, Grange F, Papathanassiou D. 18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type. Clin Nucl Med 2020;45:403-4. [PMID: 32209875 DOI: 10.1097/RLU.0000000000002995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
262 Kreutzer KM, Effendy I. Cicatricial Alopecia Related to Folliculotropic Mycosis Fungoides. Dermatol Ther (Heidelb) 2020;10:1175-80. [PMID: 32833161 DOI: 10.1007/s13555-020-00429-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
263 Hristov AC, Tejasvi T, Wilcox RA. Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 2020. [PMID: 32815650 DOI: 10.1002/ajh.25970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
264 Olisova OY, Grekova EV, Zaletaev DV, Alekseeva EA. Overexpression of STAT4 at early stages of mycosis fungoides: Coincidence or not? Australas J Dermatol 2021;62:e119-20. [PMID: 32808277 DOI: 10.1111/ajd.13420] [Reference Citation Analysis]
265 Iżykowska K, Rassek K, Żurawek M, Nowicka K, Paczkowska J, Ziółkowska-Suchanek I, Podralska M, Dzikiewicz-Krawczyk A, Joks M, Olek-Hrab K, Giefing M, Przybylski GK. Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells. J Cell Mol Med 2020;24:10970-7. [PMID: 32794659 DOI: 10.1111/jcmm.15729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
266 Gao Y, Liu F, Sun J, Wen Y, Tu P, Kadin ME, Wang Y. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma. J Invest Dermatol 2021;141:607-618.e6. [PMID: 32771472 DOI: 10.1016/j.jid.2020.05.120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
267 Zhu L, Han X, Liu Z, Leng S, Shan N, Lv X, Lu K, Hun S, Wu Y, Liu X. Survival prediction model for patients with mycosis fungoides/Sezary syndrome. Future Oncol 2020;16:2487-98. [PMID: 32746631 DOI: 10.2217/fon-2020-0502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
268 Bhat TS, Herbosa CM, Rosenberg AR, Sogade O, Jeffe DB, Mehta-Shah N, Semenov YR, Musiek AC. Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma. Br J Dermatol 2021;184:310-8. [PMID: 32510571 DOI: 10.1111/bjd.19298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
269 Dimitriou F, Schanz U, Nair G, Kimeswenger S, Brüggen MC, Hoetzenecker W, French LE, Dummer R, Cozzio A, Guenova E. Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis. Front Med (Lausanne) 2020;7:290. [PMID: 32714935 DOI: 10.3389/fmed.2020.00290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
270 Liu Y, Ma Y, Zhou H, Zhou X, Shao J. Analysis of clinicopathological features and prognostic factors of non-Hodgkin's intravascular large B-cell lymphoma. Oncol Lett 2020;20:43. [PMID: 32802165 DOI: 10.3892/ol.2020.11908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
271 Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Salopek T, Wong GK, Gniadecki R. Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing. Blood Adv 2019;3:1175-84. [PMID: 30967393 DOI: 10.1182/bloodadvances.2018027482] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
272 Johnson LDS, Banerjee S, Kruglov O, Viller NN, Horwitz SM, Lesokhin A, Zain J, Querfeld C, Chen R, Okada C, Sawas A, O'Connor OA, Sievers EL, Shou Y, Uger RA, Wong M, Akilov OE. Targeting CD47 in Sézary syndrome with SIRPαFc. Blood Adv 2019;3:1145-53. [PMID: 30962222 DOI: 10.1182/bloodadvances.2018030577] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 17.0] [Reference Citation Analysis]
273 Chyrek AJ, Bielȩda GM, Burchardt WM, Chicheł A. High-dose-rate brachytherapy of primary cutaneous B-cell lymphoma: the first reported case series. J Contemp Brachytherapy 2020;12:241-7. [PMID: 32695195 DOI: 10.5114/jcb.2020.96864] [Reference Citation Analysis]
274 Olszewska B, Sokołowska-Wojdyło M, Lakomy J, Nowicki RJ. The ambiguous pruritogenic role of interleukin-31 in cutaneous T-cell lymphomas in comparison to atopic dermatitis: a review. Postepy Dermatol Alergol 2020;37:319-25. [PMID: 32792870 DOI: 10.5114/ada.2020.96260] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
275 Olszewska B, Żawrocki A, Lakomy J, Karczewska J, Gleń J, Zabłotna M, Malek M, Jankau J, Lange M, Biernat W, Nowicki RJ, Sokołowska-Wojdyło M. Mapping signal transducer and activator of transcription (STAT) activity in different stages of mycosis fungoides and Sezary syndrome. Int J Dermatol 2020;59:1106-12. [PMID: 32643174 DOI: 10.1111/ijd.15036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
276 Valipour A, Jäger M, Wu P, Schmitt J, Bunch C, Weberschock T. Interventions for mycosis fungoides. Cochrane Database Syst Rev 2020;7:CD008946. [PMID: 32632956 DOI: 10.1002/14651858.CD008946.pub3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
277 Wang B, Li K, Wang H, Shen X, Zheng J. Systemic chemotherapy promotes HIF-1α-mediated glycolysis and IL-17F pathways in cutaneous T-cell lymphoma. Exp Dermatol 2020;29:987-92. [PMID: 32573814 DOI: 10.1111/exd.14133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
278 Miyashiro D, Sanches JA. Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center. Sci Rep 2020;10:9774. [PMID: 32555205 DOI: 10.1038/s41598-020-66040-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
279 Shamim H, Riemer C, Weenig R, Sokumbi O, Sciallis G, McEvoy M, Mischke D, Comfere N. Acneiform Presentations of Folliculotropic Mycosis Fungoides. Am J Dermatopathol 2021;43:85-92. [PMID: 33492839 DOI: 10.1097/DAD.0000000000001698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
280 Schachter O, Tabibian-Keissar H, Debby A, Segal O, Baum S, Barzilai A. Evaluation of the polymerase chain reaction-based T-cell receptor β clonality test in the diagnosis of early mycosis fungoides. J Am Acad Dermatol 2020;83:1400-5. [PMID: 32526320 DOI: 10.1016/j.jaad.2020.05.110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
281 Pulitzer MP, Horna P, Almeida J. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping. Cytometry B Clin Cytom 2021;100:132-8. [PMID: 32516521 DOI: 10.1002/cyto.b.21888] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
282 Dimassi AB, Howlett C, Phua CW. Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report. Cureus 2020;12:e8534. [PMID: 32665881 DOI: 10.7759/cureus.8534] [Reference Citation Analysis]
283 Dumont M, Battistella M, Ram-Wolff C, Bagot M, de Masson A. Diagnosis and Treatment of Primary Cutaneous B-Cell Lymphomas: State of the Art and Perspectives. Cancers (Basel) 2020;12:E1497. [PMID: 32521744 DOI: 10.3390/cancers12061497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
284 Georgakopoulos I, Papadavid E, Platoni K, Kougioumtzopoulou A, Patatoukas G, Kypraiou E, Nikolaou V, Efstathopoulos E, Kelekis N, Kouloulias V. Low dose total skin electron beam therapy for the management of T cell cutaneous lymphomas. Dermatol Ther 2020;33:e13478. [PMID: 32391976 DOI: 10.1111/dth.13478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
285 Alsayyah A. Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann Diagn Pathol 2020;47:151546. [PMID: 32554312 DOI: 10.1016/j.anndiagpath.2020.151546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
286 Flores-Balcázar C, Urías-Arce DM, Charli-Joseph Y, De León-Alfaro MA, Pérez-Álvarez SI, Ramos-Prudencio R. Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center. Rep Pract Oncol Radiother 2020;25:562-7. [PMID: 32494229 DOI: 10.1016/j.rpor.2020.03.020] [Reference Citation Analysis]
287 Kalay Yildizhan I, Sanli H, Akay BN, Uzundere C, Okcu Heper A. Folliculotropic mycosis fungoides: Clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital. Dermatol Ther 2020;33:e13585. [PMID: 32410323 DOI: 10.1111/dth.13585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
288 Vitiello P, Sica A, Ronchi A, Caccavale S, Franco R, Argenziano G. Primary Cutaneous B-Cell Lymphomas: An Update. Front Oncol 2020;10:651. [PMID: 32528871 DOI: 10.3389/fonc.2020.00651] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
289 Larocca C, Kupper T. Mycosis Fungoides and Sézary Syndrome: An Update. Hematol Oncol Clin North Am 2019;33:103-20. [PMID: 30497668 DOI: 10.1016/j.hoc.2018.09.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
290 Pileri A, Agostinelli C, Bertuzzi C, Grandi V, Maio V, Lastrucci I, Santucci M, Pimpinelli N. BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role. Front Oncol 2020;10:662. [PMID: 32411611 DOI: 10.3389/fonc.2020.00662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
291 Willerslev-Olsen A, Buus TB, Nastasi C, Blümel E, Gluud M, Bonefeld CM, Geisler C, Lindahl LM, Vermeer M, Wasik MA, Iversen L, Becker JC, Andersen MH, Gjerdrum LMR, Litvinov IV, Litman T, Krejsgaard T, Woetmann A, Ødum N. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome. Blood Cancer J 2020;10:57. [PMID: 32409671 DOI: 10.1038/s41408-020-0324-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
292 Xu ML, Gabali A, Hsi ED, Fedoriw Y, Vij K, Salama ME, Ramchandren R, O'Malley D, Wick MR, Battistella M, Gru AA. Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis. Am J Surg Pathol 2020;44:e1-e14. [PMID: 31567279 DOI: 10.1097/PAS.0000000000001368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
293 Quan Q, Wang J, Liu L. An Effective Convolutional Neural Network for Classifying Red Blood Cells in Malaria Diseases. Interdiscip Sci 2020;12:217-25. [PMID: 32394271 DOI: 10.1007/s12539-020-00367-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
294 Brunner PM, Jonak C, Knobler R. Recent advances in understanding and managing cutaneous T-cell lymphomas. F1000Res 2020;9:F1000 Faculty Rev-331. [PMID: 32419924 DOI: 10.12688/f1000research.21922.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
295 Chung E, Schneider SL, Hurst EA. Cells to Surgery Quiz: May 2020. Journal of Investigative Dermatology 2020;140:e55-e60. [DOI: 10.1016/j.jid.2020.02.016] [Reference Citation Analysis]
296 Pérez González YC, Llamas Velasco MDM, Díaz Recuero JL, Machan S, Núñez Hipolito L, Piris Pinilla MA, Rodríguez Pinilla SM. Adnexotropism as a Histopathological Clue for the Diagnosis of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder. The American Journal of Dermatopathology 2020;42:383-4. [DOI: 10.1097/dad.0000000000001490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
297 Bresin A, Cristofoletti C, Caprini E, Cantonetti M, Monopoli A, Russo G, Narducci MG. Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology 2020;140:1045-1053.e6. [DOI: 10.1016/j.jid.2019.08.454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
298 Khan S, Malhomme de la Roche H, Whittaker S, Rickaby W, Calonje E. Violaceous facial nodules. Clin Exp Dermatol 2020;45:642-5. [PMID: 32343859 DOI: 10.1111/ced.14178] [Reference Citation Analysis]
299 Zheng XD, Zhang YL, Xie JL, Zhou XG. Primary cutaneous mantle cell lymphoma: Report of a rare case. World J Clin Cases 2020; 8(8): 1507-1514 [PMID: 32368544 DOI: 10.12998/wjcc.v8.i8.1507] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
300 Jothishankar B, Di Raimondo C, Mueller L, Zain J, Parekh V, Abdulla F. Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient. Pediatr Dermatol 2020;37:759-61. [PMID: 32323885 DOI: 10.1111/pde.14165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
301 Gao C, McCormack CJ, van der Weyden C, Twigger R, Buelens O, Lade S, Khoo C, Campbell BA, Goh M, McKelvie P, Prince HM. The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol 2021;84:185-7. [PMID: 32334059 DOI: 10.1016/j.jaad.2020.04.073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
302 Fiore D, Cappelli LV, Broccoli A, Zinzani PL, Chan WC, Inghirami G. Peripheral T cell lymphomas: from the bench to the clinic. Nat Rev Cancer 2020;20:323-42. [PMID: 32249838 DOI: 10.1038/s41568-020-0247-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
303 Arellano J, Salinas MP, Araya MI. Epidemiological analysis of the Chilean national registry of cutaneous T-cell lymphomas, years 2006-2012. Med Clin (Barc) 2020;154:236-7. [PMID: 30591280 DOI: 10.1016/j.medcli.2018.11.011] [Reference Citation Analysis]
304 Stainthorpe A, Fleeman N, Houten R, Chaplin M, Boland A, Beale S, Dundar Y, McEntee J, Syndikus I. Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoecon Open 2020;4:563-74. [PMID: 32207075 DOI: 10.1007/s41669-020-00203-0] [Reference Citation Analysis]
305 Sica A, Vitiello P, Caccavale S, Sagnelli C, Calogero A, Doraro CA, Pastore F, Ciardiello F, Argenziano G, Reginelli A, Cappabianca S, Franco R, Ronchi A. Primary Cutaneous DLBCL Non-GCB Type: Challenges of a Rare Case. Open Med (Wars) 2020;15:119-25. [PMID: 32258414 DOI: 10.1515/med-2020-0018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
306 Morita A, Tateishi C, Muramatsu S, Kubo R, Yonezawa E, Kato H, Nishida E, Tsuruta D. Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T-cell lymphoma. J Dermatol 2020;47:443-51. [PMID: 32189402 DOI: 10.1111/1346-8138.15310] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
307 Arellano J, Salinas MP, Araya MI. Epidemiological analysis of the Chilean national registry of cutaneous T-cell lymphomas, years 2006–2012. Medicina Clínica (English Edition) 2020;154:236-237. [DOI: 10.1016/j.medcle.2018.11.036] [Reference Citation Analysis]
308 Neagu M, Constantin C, Cretoiu SM, Zurac S. miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front Cell Dev Biol 2020;8:71. [PMID: 32185171 DOI: 10.3389/fcell.2020.00071] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 14.3] [Reference Citation Analysis]
309 Trager MH, Chen C, Husain S, Geskin LJ. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides. J Dermatol 2020;47:546-50. [PMID: 32100361 DOI: 10.1111/1346-8138.15276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
310 Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Wong GK, Gniadecki R. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma. Blood 2019;134:1517-27. [PMID: 31515249 DOI: 10.1182/blood.2019002516] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
311 von Dücker L, Fleischer M, Stutz N, Thieme M, Witte M, Zillikens D, Sadik CD, Terheyden P. Primary Cutaneous Gamma-Delta T-Cell Lymphoma With Long-Term Indolent Clinical Course Initially Mimicking Lupus Erythematosus Profundus. Front Oncol 2020;10:133. [PMID: 32140447 DOI: 10.3389/fonc.2020.00133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
312 Murphy WS, Yeh JE, Nazarian RM, Sohani AR, Kvedar J, Kroshinsky D. A Case of Fever and Erythema Nodosum-Like Lesions Leading to a New Diagnosis of Gamma-Delta T-Cell Lymphoma Complicated by Hemophagocytic Lymphohistiocytosis. Dermatopathology (Basel) 2019;6:266-70. [PMID: 32232033 DOI: 10.1159/000505471] [Reference Citation Analysis]
313 Xerfan EMS, Andersen ML, Tomimori J, Tufik S, Facina AS. Cutaneous T-cell lymphomas and sleep quality: a bidirectional relationship? Int J Dermatol 2020;59:e150-1. [PMID: 32043570 DOI: 10.1111/ijd.14806] [Reference Citation Analysis]
314 Ortiz-Romero PL, Servitje O, Estrach MT, Izu-Belloso RM, Fernández-de-Misa R, Gallardo F, López-Martínez N, Pérez-Mitru A. Cost of early-stage mycosis fungoides treatments in Spain. Clinicoecon Outcomes Res 2020;12:91-105. [PMID: 32104021 DOI: 10.2147/CEOR.S233376] [Reference Citation Analysis]
315 Peterson E, Weed J, Lo Sicco K, Latkowski JA. Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified. Dermatol Clin 2019;37:455-69. [PMID: 31466586 DOI: 10.1016/j.det.2019.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
316 Vieyra-Garcia P, Fink-Puches R, Porkert S, Lang R, Pöchlauer S, Ratzinger G, Tanew A, Selhofer S, Paul-Gunther S, Hofer A, Gruber-Wackernagel A, Legat F, Patra V, Quehenberger F, Cerroni L, Clark R, Wolf P. Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial. JAMA Dermatol 2019;155:538-47. [PMID: 30892603 DOI: 10.1001/jamadermatol.2018.5905] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
317 Scarisbrick JJ. Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome? Journal of Investigative Dermatology 2020;140:281-3. [DOI: 10.1016/j.jid.2019.08.440] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
318 Fujii K, Hamada T, Shimauchi T, Asai J, Fujisawa Y, Ihn H, Katoh N. Cutaneous lymphoma in Japan, 2012-2017: A nationwide study. J Dermatol Sci 2020;97:187-93. [PMID: 32033869 DOI: 10.1016/j.jdermsci.2020.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
319 Liu KL, Tsai WC, Lee CH. Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review. PLoS One 2020;15:e0228046. [PMID: 31978091 DOI: 10.1371/journal.pone.0228046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
320 Walia R, Yeung CCS. An Update on Molecular Biology of Cutaneous T Cell Lymphoma. Front Oncol 2019;9:1558. [PMID: 32039026 DOI: 10.3389/fonc.2019.01558] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
321 Bikkina P, Reddy K, Ali Z, Kumar N. Positron emission tomography-computed tomography in subcutaneous panniculitis-like T-cell lymphoma. World J Nucl Med 2019;18:428-30. [PMID: 31933563 DOI: 10.4103/wjnm.WJNM_64_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
322 Griffin DB, Hajar T, Simpson E, White KP, Shinohara MM. Management of Cutaneous T-Cell Lymphoma/Mycosis Fungoides Occurring in the Setting of Solid Organ Transplantation: Report of 2 Cases. Clin Lymphoma Myeloma Leuk 2020;20:e39-42. [PMID: 31924574 DOI: 10.1016/j.clml.2019.12.010] [Reference Citation Analysis]
323 Piccinno R, Damiani G, Rossi LC, Berti E. Radiotherapy of primary cutaneous anaplastic large cell lymphoma: our experience in 30 cases. Int J Dermatol 2020;59:469-73. [PMID: 31916593 DOI: 10.1111/ijd.14754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
324 Escanilla C, Guavita Falla PM, Cevallos C, Ávalos Jobet N, Bobadilla Bruneau F. Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder: The first-reported Latin-American case with response to doxycycline. Clin Case Rep 2019;7:2405-9. [PMID: 31893069 DOI: 10.1002/ccr3.2454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
325 Grijsen ML. Malignant Cutaneous Neoplasms. Skin Disorders in Migrants 2020. [DOI: 10.1007/978-3-030-37476-1_17] [Reference Citation Analysis]
326 Voorhees TJ, Bowers EV, Kelsey CR, Park Y, Beaven AW. Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sézary Syndrome. Novel Therapeutics for Rare Lymphomas 2020. [DOI: 10.1007/978-3-030-25610-4_14] [Reference Citation Analysis]
327 Abramson JS. Non-Hodgkin Lymphomas. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00103-1] [Reference Citation Analysis]
328 Liu Z, Pan H, Gong C, Fan Z, Wen Y, Jiang T, Xiong R, Li H, Wang Y. Multi-class Skin Lesion Segmentation for Cutaneous T-cell Lymphomas on High-Resolution Clinical Images. Medical Image Computing and Computer Assisted Intervention – MICCAI 2020 2020. [DOI: 10.1007/978-3-030-59725-2_34] [Reference Citation Analysis]
329 Torres-cabala CA, Tetzlaff MT, Nagarajan P, Ivan D, Curry JL, Aung PP, Prieto VG. Skin. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_1] [Reference Citation Analysis]
330 Margaritescu I, Chirita A, Addis K, Dinehart MS, Carlock S, Abate MS, Smoller BR. Cutaneous Lymphomas and Lymphocytic Infiltrates. Atlas of Dermatology, Dermatopathology and Venereology 2020. [DOI: 10.1007/978-3-319-45134-3_83-1] [Reference Citation Analysis]
331 Mochel MC, Marques MEA, Hoang MP. Panniculitis. Hospital-Based Dermatopathology 2020. [DOI: 10.1007/978-3-030-35820-4_12] [Reference Citation Analysis]
332 Jiang L, Li P, Quan Q, Chen P, Qiu H, Zhang B. Cutaneous extranodal natural killer (NK) / T - cell lymphoma: A comprehensive clinical features and outcomes analysis of 71 cases. Leukemia Research 2020;88:106284. [DOI: 10.1016/j.leukres.2019.106284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
333 Patel S, Patel KB, Patel A, Katara B, Vora NS. High grade cutaneous B-cell lymphoma presenting as lethal midline granuloma - case report of an unusual presentation. Int J Dermatol 2020;59:115-9. [PMID: 30938452 DOI: 10.1111/ijd.14445] [Reference Citation Analysis]
334 Querfeld C, Rosen ST, Duvic M. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00104-3] [Reference Citation Analysis]
335 Kempf W, Stadler R. Cutaneous Lymphomas. Braun-Falco´s Dermatology 2020. [DOI: 10.1007/978-3-662-58713-3_109-1] [Reference Citation Analysis]
336 Tsang M, Gantchev J, Lefrançois P, Xie P, Ghazawi FM, Netchiporouk E, Moreau L, Sasseville D, Litvinov IV. Transcriptional Profiling Use to Improve Personalized Diagnosis and Management of Cutaneous T-Cell Lymphoma (CTCL). Cutaneous Biometrics 2020. [DOI: 10.1007/978-3-319-56591-0_29-1] [Reference Citation Analysis]
337 Wang L. Primary Extranodal Lymphomas of the GI Tract, Lung, CNS, and Skin with Common Mimics. Practical Lymph Node and Bone Marrow Pathology 2020. [DOI: 10.1007/978-3-030-32189-5_12] [Reference Citation Analysis]
338 Bastidas Torres AN, Cats D, Mei H, Fanoni D, Gliozzo J, Corti L, Paulli M, Vermeer MH, Willemze R, Berti E, Tensen CP. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm. Genes Chromosomes Cancer 2020;59:295-308. [PMID: 31846142 DOI: 10.1002/gcc.22831] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
339 Luo Y, Liu Z, Liu J, Liu Y, Zhang W, Zhang Y. Mycosis Fungoides and Variants of Mycosis Fungoides: A Retrospective Study of 93 Patients in a Chinese Population at a Single Center. Ann Dermatol 2020;32:14-20. [PMID: 33911704 DOI: 10.5021/ad.2020.32.1.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
340 Kim Y, Coomarasamy C, Jarrett P. The epidemiology of subcutaneous panniculitis-like alpha-beta T-cell lymphoma in New Zealand. Australas J Dermatol 2020;61:e196-9. [PMID: 31868922 DOI: 10.1111/ajd.13226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
341 Ibrahim MA, Mohamed A, Soltan MY. Thymocyte selection-associated high-mobility group box as a potential diagnostic marker differentiating hypopigmented mycosis fungoides from early vitiligo: A pilot study. Indian J Dermatol Venereol Leprol 2021;87:819-25. [PMID: 31857520 DOI: 10.4103/ijdvl.IJDVL_1011_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
342 Garcia-Arpa M, Flores-Terry MA, Franco-Muñoz M, de Lara-Simón IM. Spiky follicular mycosis fungoides and hidradenitis suppurativa-like lesions in a patient - complete remission with interferon alpha. An Bras Dermatol 2020;95:121-3. [PMID: 31899065 DOI: 10.1016/j.abd.2019.04.011] [Reference Citation Analysis]
343 Ahmed AA, Almohanna H, Griggs J, Tosti A. Unusual Clinical Presentation of a Primary Cutaneous Follicle Center Lymphoma on the Scalp of a Middle-Aged Female: Case Report and Review of the Literature. Skin Appendage Disord 2019;5:379-85. [PMID: 31799268 DOI: 10.1159/000501174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
344 Melchers RC, Willemze R, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Putter H, Jansen PM, Vermeer MH, Quint KD. Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis. J Eur Acad Dermatol Venereol 2020;34:260-6. [PMID: 31715046 DOI: 10.1111/jdv.16065] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
345 Jothishankar B, Venkataraman G, Goldberg RC, Abdulla F. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS). Annals of Diagnostic Pathology 2019;43:151404. [DOI: 10.1016/j.anndiagpath.2019.151404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
346 Walter HS, Trethewey CS, Ahearne MJ, Jackson R, Jayne S, Wagner SD, Saldanha G, Dyer MJ. Successful Treatment of Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type With Single-Agent Venetoclax. JCO Precision Oncology 2019. [DOI: 10.1200/po.19.00002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
347 Sidiropoulou P, Nikolaou V, Marinos L, Voudouri D, Komini E, Economidi A, Rigopoulos D, Stratigos A. The different faces of mycosis fungoides: results of a single‐center study. Int J Dermatol 2019;59:314-20. [DOI: 10.1111/ijd.14735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
348 Li L, Majerowski J, Sokumbi O. Cutaneous spindled follicle center cell lymphoma with abundant mucin: A diagnostic pitfall. J Cutan Pathol 2019;47:394-7. [DOI: 10.1111/cup.13609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
349 Bodemer C. Panniculitis in Children. Harper's Textbook of Pediatric Dermatology 2019. [DOI: 10.1002/9781119142812.ch102] [Reference Citation Analysis]
350 Levy R, Pope E. Primary Cutaneous Lymphoma. In: Hoeger P, Kinsler V, Yan A, Harper J, Oranje A, Bodemer C, Larralde M, Luk D, Mendiratta V, Purvis D, editors. Harper's Textbook of Pediatric Dermatology. Wiley; 2019. pp. 1044-62. [DOI: 10.1002/9781119142812.ch88] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
351 Häyrinen M, Uotila P, Sahi H, Haapasaari K, Teppo H, Soini Y, Lapela M, Vasala K, Turpeenniemi‐hujanen T, Ranki A, Kuusisto M, Kuittinen O. Twist and Zeb1 expression identify mycosis fungoides patients with low risk of disease progression. J Eur Acad Dermatol Venereol 2020;34. [DOI: 10.1111/jdv.16009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
352 Kamijo H, Miyagaki T, Takahashi-Shishido N, Nakajima R, Oka T, Suga H, Sugaya M, Sato S. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47. Leukemia 2020;34:845-56. [PMID: 31712778 DOI: 10.1038/s41375-019-0622-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
353 Melhoranse Gouveia B, Wells J, Kim J, Consuegra G, Longo C, Fernandez-Penas P. Systematic review and proposal of an in vivo reflectance confocal microscopy assessment tool for cutaneous lymphoma. J Cutan Pathol 2020;47:295-304. [PMID: 31618473 DOI: 10.1111/cup.13598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
354 Xu J, Huang H, Wang S, Chen Y, Yin X, Zhang X, Zhang Y. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma. Arch Dermatol Res 2020;312:513-25. [PMID: 31676945 DOI: 10.1007/s00403-019-02000-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
355 Iyer A, Hennessey D, O’keefe S, Patterson J, Wang W, Wong GK, Gniadecki R. Independent evolution of cutaneous lymphoma subclones in different microenvironments of the skin.. [DOI: 10.1101/829671] [Reference Citation Analysis]
356 Cieza-díaz DE, Prieto-torres L, Rodríguez-pinilla SM, Córdoba Mascuñano R, Manso Alonso R, Machan S, Piris Pinilla MÁ, Requena Caballero L. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas? The American Journal of Dermatopathology 2019;41:846-50. [DOI: 10.1097/dad.0000000000001423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
357 Stephens MR, Haun PL, Micheletti RG. Numerous Pink-Purple Papules in a Middle-aged Man. JAMA Dermatol 2019;155:1308-9. [PMID: 31553405 DOI: 10.1001/jamadermatol.2019.2949] [Reference Citation Analysis]
358 Skaljic M, Cotton CH, Reilly AF, Pillai V, Perman MJ. Complete resolution of primary cutaneous marginal zone B‐cell lymphoma on the cheek of a 7‐year‐old boy with intralesional triamcinolone and tincture of time. Pediatr Dermatol 2019;37:228-9. [DOI: 10.1111/pde.14028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
359 Duffy R, Sahu J. Retinoids in Lymphoma. Retinoids in Dermatology 2019. [DOI: 10.1201/9780429456732-27] [Reference Citation Analysis]
360 Ferranti M, Tadiotto Cicogna G, Russo I, Alaibac M. Immunomodulation in Cutaneous T Cell Lymphoma. Front Oncol 2019;9:1025. [PMID: 31649883 DOI: 10.3389/fonc.2019.01025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
361 Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M; ESMO Guidelines Committee. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018;29:iv30-40. [PMID: 29878045 DOI: 10.1093/annonc/mdy133] [Cited by in Crossref: 105] [Cited by in F6Publishing: 111] [Article Influence: 26.3] [Reference Citation Analysis]
362 Jaffe ES. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals. Mod Pathol 2020;33:96-106. [DOI: 10.1038/s41379-019-0385-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
363 Talaat IM, Abdelmaksoud RE, Guimei M, Agamia NF, Nugud A, El-Serafi AT. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients. PLoS One 2019;14:e0224305. [PMID: 31648231 DOI: 10.1371/journal.pone.0224305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
364 Rodriguez O, Sowash M, Mosojane KI, Ralefala T, Grover S, Haun P, Kovarik C, Williams VL. A retrospective review of cutaneous lymphoma in Botswana. Int J Dermatol 2020;59:352-8. [PMID: 31647120 DOI: 10.1111/ijd.14690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
365 Joly E, Rimond O, Salaun V, Comoz F, Morice C, Dompmartin A, Verneuil L. [Localized urticarial rituximab-induced reaction in primary cutaneous marginal zone B-cell lymphoma]. Ann Dermatol Venereol 2020;147:50-2. [PMID: 31635943 DOI: 10.1016/j.annder.2019.09.002] [Reference Citation Analysis]
366 Roelens M, Masson A, Ram‐wolff C, Maki G, Cayuela J, Marie‐cardine A, Bensussan A, Toubert A, Bagot M, Moins‐teisserenc H. Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR 3 DL 2 marker. Br J Dermatol 2020;182:1415-22. [DOI: 10.1111/bjd.18481] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
367 Ferreira CR, Zhao S, Sanches JA, Miyashiro D, Cury-Martins J, Azevedo RS, Zerbini MCN, Natkunam Y, Gratzinger D. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil. Diagn Pathol 2019;14:115. [PMID: 31640798 DOI: 10.1186/s13000-019-0900-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
368 O'Malley JT, de Masson A, Lowry EL, Giobbie-Hurder A, LeBoeuf NR, Larocca C, Gehad A, Seger E, Teague JE, Fisher DC, Kupper TS, Devlin PM, Clark RA. Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clin Cancer Res 2020;26:408-18. [PMID: 31636100 DOI: 10.1158/1078-0432.CCR-18-4147] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
369 Kamijo H, Sugaya M. Two distinct variants of mycosis fungoides (MF): Folliculotropic MF and erythrodermic MF. J Dermatol 2019;46:1136-40. [PMID: 31625194 DOI: 10.1111/1346-8138.15114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
370 Van Kouwenberg E, Lee DC, Dalvi S, Hoehn J, Adetayo OA. Primary Cutaneous Peripheral T-Cell Lymphoma of the Hand: Case Report of a Rare Diagnosis and Review of the Literature. J Hand Microsurg 2019;11:S31-5. [PMID: 31616124 DOI: 10.1055/s-0038-1661422] [Reference Citation Analysis]
371 Clemens MW, DeCoster RC, Fairchild B, Bessonov AA, Santanelli di Pompeo F. Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Semin Plast Surg 2019;33:270-8. [PMID: 31632211 DOI: 10.1055/s-0039-1696998] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
372 Suzuki H, Boki H, Kamijo H, Nakajima R, Oka T, Shishido-Takahashi N, Suga H, Sugaya M, Sato S, Miyagaki T. YKL-40 Promotes Proliferation of Cutaneous T-Cell Lymphoma Tumor Cells through Extracellular Signal-Regulated Kinase Pathways. J Invest Dermatol 2020;140:860-868.e3. [PMID: 31622598 DOI: 10.1016/j.jid.2019.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
373 Martinez-Cabriales SA, Walsh S, Sade S, Shear NH. Lymphomatoid papulosis: an update and review. J Eur Acad Dermatol Venereol 2020;34:59-73. [PMID: 31494989 DOI: 10.1111/jdv.15931] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
374 Fernández-de-Misa R, Hernández-Machín B, Combalía A, García Muret MP, Servitje O, Muniesa C, Gallardo F, Pujol RM, Martí RM, Ortiz-Brugués A, Maroñas-Jiménez L, Ortiz-Romero PL, Blanch Rius L, Izu R, Román C, Cañueto J, Blanes M, Morillo M, Bastida J, Peñate Y, Pérez Gala S, Espinosa Lara P, Pérez Gil A, Estrach T. Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma. J Eur Acad Dermatol Venereol 2020;34:762-8. [PMID: 31591786 DOI: 10.1111/jdv.16006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
375 Martinez XU, Di Raimondo C, Abdulla FR, Zain J, Rosen ST, Querfeld C. Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome. Best Pract Res Clin Haematol 2019;32:239-52. [PMID: 31585624 DOI: 10.1016/j.beha.2019.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
376 Dubyk F, Gru A, Flowers R. Refractory Hand Dermatitis With Massive Thumb Enlargement: Answer. Am J Dermatopathol 2019;41:775-6. [PMID: 31567298 DOI: 10.1097/DAD.0000000000001192] [Reference Citation Analysis]
377 Bobrowicz M, Zagozdzon R, Domagala J, Vasconcelos-Berg R, Guenova E, Winiarska M. Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives. Cancers (Basel) 2019;11:E1420. [PMID: 31554169 DOI: 10.3390/cancers11101420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
378 de Masson A, O'Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, Tawa M, Fisher DC, Devlin PM, Teague JE, Leboeuf NR, Kirsch IR, Robins H, Clark RA, Kupper TS. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med 2018;10:eaar5894. [PMID: 29743350 DOI: 10.1126/scitranslmed.aar5894] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 17.3] [Reference Citation Analysis]
379 Tanita K, Fujimura T, Sato Y, Lyu C, Kambayashi Y, Ogata D, Fukushima S, Miyashita A, Nakajima H, Nakamura M, Morita A, Aiba S. Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma. Front Oncol 2019;9:907. [PMID: 31616630 DOI: 10.3389/fonc.2019.00907] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
380 El Sayed H, Shalaby S, Abdel-Halim MRE, Aboelfadl DM, Samir N. Efficacy of doxycycline in the treatment of early stages of mycosis fungoides: a randomized controlled trial. J Dermatolog Treat 2021;32:424-31. [PMID: 31526286 DOI: 10.1080/09546634.2019.1667474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
381 Meconi F, Secchi R, Palmieri R, Vaccarini S, Rapisarda VM, Giannì L, Esposito F, Provenzano I, Nasso D, Pupo L, Cantonetti M. Primary Cutaneous Anaplastic Large Cell Lymphoma of the Oral Cavity Successfully Treated with Brentuximab Vedotin. Case Rep Hematol 2019;2019:9651207. [PMID: 31637066 DOI: 10.1155/2019/9651207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
382 Nakajima R, Miyagaki T, Kamijo H, Oka T, Shishido-Takahashi N, Suga H, Sugaya M, Sato S. Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma. J Dermatol Sci 2019;96:134-42. [PMID: 31787505 DOI: 10.1016/j.jdermsci.2019.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
383 Erraji H, Hali F, Baline K, Marnissi F, Chiheb S. [Epidemiological and clinical profile and outcome in 166 mycosis fungoides patients in Casablanca]. Ann Dermatol Venereol 2019;146:825-8. [PMID: 31519349 DOI: 10.1016/j.annder.2019.08.006] [Reference Citation Analysis]
384 Chen B, Zheng Y, Zhu J, Liang Y. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides. Exp Dermatol 2019;28:1279-88. [PMID: 31461795 DOI: 10.1111/exd.14026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
385 Geller S, Lebowitz E, Pulitzer MP, Horwitz SM, Moskowitz AJ, Dusza S, Myskowski PL. Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol 2020;83:430-9. [PMID: 31499157 DOI: 10.1016/j.jaad.2019.08.073] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
386 Schrader AMR, Jansen PM, Vermeer MH, Kleiverda JK, Vermaat JSP, Willemze R. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Am J Surg Pathol 2018;42:1488-94. [PMID: 30113335 DOI: 10.1097/PAS.0000000000001132] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
387 Cocks M, Porcu P, Wick MR, Gru AA. Recent Advances in Cutaneous T-cell Lymphoma. Surgical Pathology Clinics 2019;12:783-803. [DOI: 10.1016/j.path.2019.03.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
388 Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 2019;94:1027-41. [PMID: 31313347 DOI: 10.1002/ajh.25577] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
389 Liaw TY, Hu SC. Intravascular Large B-Cell Lymphoma with Initial Presentation in Skin: A Rare Mimicker of Cellulitis. Am J Med 2019;132:e709-10. [PMID: 30998920 DOI: 10.1016/j.amjmed.2019.03.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
390 Bontoux C, Bruneau J, Molina TJ. [Histopathological classification of chronic B-lymphoproliferative disorders]. Presse Med 2019;48:792-806. [PMID: 31447335 DOI: 10.1016/j.lpm.2019.07.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
391 Moerman-Herzog AM, Acheampong DA, Brooks AG, Blair SM, Hsu PC, Wong HK. Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes. Oncotarget 2019;10:5052-69. [PMID: 31489115 DOI: 10.18632/oncotarget.27120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
392 Ramelyte E, Dummer R, Guenova E. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update. Expert Opin Investig Drugs 2019;28:799-809. [PMID: 31398295 DOI: 10.1080/13543784.2019.1654995] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
393 Specht L, Skov L. Cutaneous Lymphomas. Clin Oncol (R Coll Radiol) 2019;31:797-807. [PMID: 31405542 DOI: 10.1016/j.clon.2019.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
394 Shalabi D, Vadalia N, Nikbakht N. Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature. Dermatol Ther (Heidelb) 2019;9:807-14. [PMID: 31407190 DOI: 10.1007/s13555-019-00317-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
395 Fujii K, Kanekura T. Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma. Front Med (Lausanne) 2019;6:181. [PMID: 31457014 DOI: 10.3389/fmed.2019.00181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
396 Shinohara MM, Shustov A. How I treat primary cutaneous CD30+ lymphoproliferative disorders. Blood 2019;134:515-24. [DOI: 10.1182/blood.2019000785] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
397 Hu T, Buus TB, Krejsgaard T, Nansen A, Lundholt BK, Spee P, Fredholm S, Petersen DL, Blümel E, Gluud M, Monteiro MN, Willerslev-Olsen A, Andersen MH, Straten PT, Met Ö, Stolearenco V, Fogh H, Gniadecki R, Nastasi C, Litman T, Woetmann A, Gjerdrum LMR, Ødum N. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome. Oncotarget 2019;10:4894-906. [PMID: 31448055 DOI: 10.18632/oncotarget.27122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
398 Ashizawa S, Matsuo Y, Shiraishi Y, Sueoka M, Morita C, Shizukawa H, Takahagi S, Hiragun T, Hide M. A Case of Secondary Sézary Syndrome Successfully Treated with Mogamulizumab. Nishinihon J Dermatol 2019;81:306-310. [DOI: 10.2336/nishinihonhifu.81.306] [Reference Citation Analysis]
399 Klemke C. Klinisch-pathologische Korrelation weist den Weg. Dtsch Dermatolog 2019;67:604-615. [DOI: 10.1007/s15011-019-2572-8] [Reference Citation Analysis]
400 Geller S, Hollmann TJ, Horwitz SM, Myskowski PL, Pulitzer M. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment. Histopathology 2020;76:222-32. [PMID: 31355940 DOI: 10.1111/his.13960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
401 Malachowski SJ, Sun J, Chen PL, Seminario-Vidal L. Diagnosis and Management of Cutaneous B-Cell Lymphomas. Dermatol Clin 2019;37:443-54. [PMID: 31466585 DOI: 10.1016/j.det.2019.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
402 Sivanand A, Surmanowicz P, Alhusayen R, Hull P, Litvinov IV, Zhou Y, Gniadecki R. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments. J Cutan Med Surg 2019;23:537-44. [PMID: 31353944 DOI: 10.1177/1203475419867610] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
403 Molloy K, Jonak C, Woei‐a‐jin F, Guenova E, Busschots A, Bervoets A, Hauben E, Knobler R, Porkert S, Fassnacht C, Cowan R, Papadavid E, Beylot‐barry M, Berti E, Alberti Violetti S, Estrach T, Matin R, Akilov O, Vakeva L, Prince M, Bates A, Bayne M, Wachsmuch R, Wehkamp U, Marschalko M, Servitje O, Turner D, Weatherhead S, Wobser M, Sanches J, Mckay P, Klemke D, Peng C, Howles A, Yoo J, Evison F, Scarisbrick J. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study. Br J Dermatol 2020;182:770-9. [DOI: 10.1111/bjd.18089] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
404 Navarrete‐dechent C, Puerto C, Abarzúa‐araya Á, Molgó M, Geller S, Andreani S, Cury‐martins J, Sanches JA, Montoya J, González S, Uribe P. Dermoscopy of primary cutaneous B‐ and T‐cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case‐control study with histopathologic correlation. Int J Dermatol 2019;58:1270-6. [DOI: 10.1111/ijd.14590] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
405 Lindahl LM, Willerslev-Olsen A, Gjerdrum LMR, Nielsen PR, Blümel E, Rittig AH, Celis P, Herpers B, Becker JC, Stausbøl-Grøn B, Wasik MA, Gluud M, Fredholm S, Buus TB, Johansen C, Nastasi C, Peiffer L, Kubat L, Bzorek M, Eriksen JO, Krejsgaard T, Bonefeld CM, Geisler C, Mustelin T, Langhoff E, Givskov M, Woetmann A, Kilian M, Litman T, Iversen L, Odum N. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma. Blood 2019;134:1072-83. [PMID: 31331920 DOI: 10.1182/blood.2018888107] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 15.3] [Reference Citation Analysis]
406 Gorenkova LG, Kravchenko SK, Belousova IE. Potentials of brentuximab vedotin in the treatment of relapse/refractory cutaneous T-cell lymphomas: literature review and authors’ observation. Vestnik dermatologii i venerologii 2019;95:42-9. [DOI: 10.25208/0042-4609-2019-95-2-42-49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
407 Blümel E, Willerslev-Olsen A, Gluud M, Lindahl LM, Fredholm S, Nastasi C, Krejsgaard T, Surewaard BGJ, Koralov SB, Hu T, Persson JL, Bonefeld CM, Geisler C, Iversen L, Becker JC, Andersen MH, Woetmann A, Buus TB, Ødum N. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma. Oncoimmunology 2019;8:e1641387. [PMID: 31646088 DOI: 10.1080/2162402X.2019.1641387] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
408 Hrudka J, Eis V, Heřman J, Prouzová Z, Rosenwald A, Duška F. Panniculitis-like T-cell-lymphoma in the mesentery associated with hemophagocytic syndrome: autopsy case report. Diagn Pathol 2019;14. [DOI: 10.1186/s13000-019-0854-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
409 Iyer A, Hennessey D, O’keefe S, Patterson J, Wang W, Ka-shu Wong G, Gniadecki R. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma.. [DOI: 10.1101/703876] [Reference Citation Analysis]
410 Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, DiCaudo DJ, Shinohara M, Hong EK, Horton B, Kim YH. The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study. Am J Surg Pathol 2018;42:726-34. [PMID: 29543675 DOI: 10.1097/PAS.0000000000001041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
411 Maradana S, Akella P, Nalluru SS, Jindal V, Siddiqui AD. Hypertriglyceridemia Induced Pancreatitis Due to Brentuximab Therapy: First Case Report. Cureus 2019;11:e5138. [PMID: 31523567 DOI: 10.7759/cureus.5138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
412 Walsh NM, Kutzner H, Requena L, Cerroni L. Plasmacytic cutaneous pathology: A review. J Cutan Pathol 2019;46:698-708. [DOI: 10.1111/cup.13499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
413 Baik BS, Lee WS, Ji SY, Park KS, Yang WS, Kim SY. Treatment of primary cutaneous anaplastic large cell lymphoma. Arch Craniofac Surg 2019;20:207-11. [PMID: 31256561 DOI: 10.7181/acfs.2018.02201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
414 Sunil G, Chirukandath R, Pratap P, Krishnan S, M. V. UNUSUAL CASE OF SUBCUTANEOUS NODULES WITH ENDOBRONCHIAL LESIONS IN A PATIENT WITH RETROVIRAL INFECTION: DISSEMINATED CUTANEOUS LYMPHOMA: CASE REPORT. jebmh 2019;6:1819-1821. [DOI: 10.18410/jebmh/2019/370] [Reference Citation Analysis]
415 Senthil R, Gangadharan VP, Visakh RA, Mahadevan P, Pratap T, Jayasree MG. 18F-FDG PET/CT in Lymphomatoid Papulosis Mimicking Primary Cutaneous Anaplastic Large Cell Lymphoma. Clin Nucl Med 2019;44:e609-11. [DOI: 10.1097/rlu.0000000000002674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
416 Larocca CA, LeBoeuf NR. Overview of Cutaneous T-Cell Lymphomas. Hematol Oncol Clin North Am 2019;33:669-86. [PMID: 31229162 DOI: 10.1016/j.hoc.2019.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
417 Xia L, Wu L, Xia H, Bao J, Li Q, Chen X, Xia R. miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway. Cell Cycle 2019;18:1635-45. [PMID: 31213131 DOI: 10.1080/15384101.2019.1629789] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
418 Gorenkova LG, Kravchenko SK, Belousova IE, Babicheva LG, Kalashnikova DD, Poddubnaya IV. Successful experience of combined immunochemotherapy at refractory course of primary cutaneous peripheral T-cell lymphoma, unspecified. J Mod Onco 2019;21:25-28. [DOI: 10.26442/18151434.2019.2.190399] [Reference Citation Analysis]
419 Sherry AD, Ding GX, Kirschner AN. Diffuse Primary Cutaneous Anaplastic Large Cell Lymphoma Treated by Rotational Total Skin Electron Beam Radiotherapy with Custom Shielding: Case Report. J Med Imaging Radiat Sci 2019;50:454-9. [PMID: 31213358 DOI: 10.1016/j.jmir.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
420 Park M, Kim MH, Kwon JE, Lee YM. Self-healing eschar-like erythematous nodules. JAAD Case Rep 2019;5:468-70. [PMID: 31192997 DOI: 10.1016/j.jdcr.2019.02.020] [Reference Citation Analysis]
421 Miraflor AP, Pulitzer MP, Myskowski PL, Geller S. Scleromyxedematous Changes in a Patient With Long-Standing Mycosis Fungoides Who Progressed to Sézary Syndrome. Am J Dermatopathol 2019;41:e139-43. [PMID: 31169525 DOI: 10.1097/DAD.0000000000001464] [Reference Citation Analysis]
422 Neves Cavada M, Silveira Martha A, Sgarabotto Pezzin L, Mazzaferro Krebs J, Mazzini Steffen L, Schultz Maahs G. Extranodal NK/T-Cell Lymphoma, Nasal Type-Case Report of 2 Cases. Ear Nose Throat J 2020;99:NP91-3. [PMID: 31170821 DOI: 10.1177/0145561319856016] [Reference Citation Analysis]
423 Moosic KB, Paila U, Olson KC, Dziewulska K, Wang TT, Xing JC, Ratan A, Feith DJ, Loughran TP Jr, Olson TL. Genomics of LGL leukemia and select other rare leukemia/lymphomas. Best Pract Res Clin Haematol 2019;32:196-206. [PMID: 31585620 DOI: 10.1016/j.beha.2019.06.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
424 Garzón E, Dávila Rodríguez JJ, Aguilar Benavides K, Loaiza A. Micosis fungoide hipopigmentada: la gran simuladora. Piel 2019;34:378-380. [DOI: 10.1016/j.piel.2018.07.012] [Reference Citation Analysis]
425 Uribe-bojanini E, Santa-vélez C, Rueda-cadena X, Morales S. Severe and Lethal Presentation of Folliculotropic Mycosis Fungoides. Actas Dermo-Sifiliográficas (English Edition) 2019;110:412-414. [DOI: 10.1016/j.adengl.2019.04.015] [Reference Citation Analysis]
426 Goodlad JR. Cutaneous lymphoma and important differential diagnoses: emphasis on cases with a cytotoxic phenotype. Diagnostic Histopathology 2019;25:240-248. [DOI: 10.1016/j.mpdhp.2019.04.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
427 Mazaro R, Luz F, Lorensetti D, Hartmann G, Fighera R. Reticulose pagetoide em um cão: relato de caso. Arq Bras Med Vet Zootec 2019;71:883-888. [DOI: 10.1590/1678-4162-10638] [Reference Citation Analysis]
428 Riswold K, Johnson J, Weenig R. Diffuse follicular plugging. Int J Dermatol 2019;58:e189-90. [PMID: 31140589 DOI: 10.1111/ijd.14474] [Reference Citation Analysis]
429 Ducharme O, Beylot-Barry M, Pham-Ledard A, Bohers E, Viailly PJ, Bandres T, Faur N, Frison E, Vergier B, Jardin F, Merlio JP, Gros A. Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type. J Invest Dermatol 2019;139:2334-2342.e8. [PMID: 31150604 DOI: 10.1016/j.jid.2019.05.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
430 Hamada T, Tokura Y, Sugaya M, Ohtsuka M, Tsuboi R, Nagatani T, Kiyohara E, Tani M, Setoyama M, Matsushita S, Kawai K, Yonekura K, Saida T, Iwatsuki K. Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201). J Dermatol 2019;46:557-63. [PMID: 31090237 DOI: 10.1111/1346-8138.14923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
431 Shamim H, Johnson EF, Gibson LE, Comfere N. Mycosis fungoides with spongiosis: A potential diagnostic pitfall. J Cutan Pathol 2019;46:645-52. [DOI: 10.1111/cup.13477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
432 Dulmage BO, Akilov O, Vu JR, Falo LD, Geskin LJ. Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma. Oncotarget 2019;10:3104-13. [PMID: 31139323 DOI: 10.18632/oncotarget.5742] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
433 Maitre E, Le‐page A, Comoz F, Truquet F, Damaj G, Cornet E, Verneuil L, Salaün V, Troussard X. Usefulness of Flow Cytometry for the Detection of Cutaneous Localization in Malignant Hematologic Disorders. Cytometry 2019;96:283-93. [DOI: 10.1002/cyto.b.21784] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
434 Kaplan MH, Kaminski M, Estes JM, Gitlin SD, Zahn J, Elder JT, Tejasvi T, Gensterblum E, Sawalha AH, McGowan JP, Dosik MH, Direskeneli H, Direskeneli GS, Adebamowo SN, Adebamowo CA, Sajadi M, Contreras-Galindo R. Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection. BMC Med Genomics 2019;12:58. [PMID: 31046767 DOI: 10.1186/s12920-019-0505-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
435 Hodak E, Amitay-laish I. Mycosis fungoides: A great imitator. Clinics in Dermatology 2019;37:255-67. [DOI: 10.1016/j.clindermatol.2019.01.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
436 Querfeld C. The emerging role of micro RNA s in the molecular diagnosis of mycosis fungoides. Br J Dermatol 2019;180:984-5. [DOI: 10.1111/bjd.17768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
437 Menguy S, Beylot‐barry M, Parrens M, Ledard A, Frison E, Comoz F, Battistella M, Szablewski V, Balme B, Croue A, Franck F, Ortonne N, Tournier E, Lamant L, Carlotti A, De Muret A, Le Gall F, Lorton M, Merlio J, Vergier B. Primary cutaneous large B‐cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases. Histopathology 2019;74:1067-80. [DOI: 10.1111/his.13832] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
438 Hbibi M, Benmiloud S, Rahmouni S, Tadmouri I, Abourazzak S, Chaouki S, Souilmi FZ, Idrissi ML, Hida M. [Macrophage activation syndrome revealing subcutaneous T-cell lymphoma in a 16-year old adolescent]. Pan Afr Med J 2018;31:74. [PMID: 31007821 DOI: 10.11604/pamj.2018.31.74.14686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
439 Suga H, Sato S. IL ‐10–producing regulatory B cells in skin diseases. J Cutan Immunol Allergy 2019;2:68-74. [DOI: 10.1002/cia2.12059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
440 Ghazawi FM, Alghazawi N, Le M, Netchiporouk E, Glassman SJ, Sasseville D, Litvinov IV. Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL). Front Oncol 2019;9:300. [PMID: 31106143 DOI: 10.3389/fonc.2019.00300] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
441 Scarfò I, Frigault MJ, Maus MV. CAR-Based Approaches to Cutaneous T-Cell Lymphoma. Front Oncol 2019;9:259. [PMID: 31058076 DOI: 10.3389/fonc.2019.00259] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
442 Werner AC, Laver NV, Landmann DS. Primary Cutaneous Follicle Center Lymphoma of the Eyelid: A Case Report and Review of the Literature in Light of Recent Changes to the WHO Classification of Lymphoid Neoplasms. Ocul Oncol Pathol 2019;5:147-52. [PMID: 30976595 DOI: 10.1159/000491381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
443 Canterbury CR, Walton DM, Shackelford AJ, Bergen MS, Peters SM. 84-year-old woman with a right cheek mass. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130:130-5. [PMID: 32173386 DOI: 10.1016/j.oooo.2019.04.002] [Reference Citation Analysis]
444 Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, Christensen JP, Krejsgaard T, Litman T, Woetmann A, Ødum N. Single-cell heterogeneity in Sézary syndrome. Blood Adv 2018;2:2115-26. [PMID: 30139925 DOI: 10.1182/bloodadvances.2018022608] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 15.3] [Reference Citation Analysis]
445 Van-de-velde V, Zhou Y. Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma. J Cutan Med Surg 2019;23:319-27. [DOI: 10.1177/1203475419840629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
446 Carias E, DeLorenzo M, Owston M, Gonzalez O, Kumar S, Dick EJ Jr. Cutaneous epitheliotropic lymphoma in a baboon (Papio spp.): A case report and a brief literature review. J Med Primatol 2019;48:192-6. [PMID: 30941777 DOI: 10.1111/jmp.12410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
447 Herrscher H, Blind A, Freysz M, Cribier B, Mahé A. Lymphome intravasculaire simulant une récidive de cancer du sein : une présentation clinique originale. Annales de Dermatologie et de Vénéréologie 2019;146:292-6. [DOI: 10.1016/j.annder.2019.01.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
448 Vázquez-Armenta G, Gómez-Garnica MF, Mondragón-Cervantes MI, González-Lucano LR. Angiocentric Centrofacial Lymphoma as a Challenging Diagnosis in an Elderly Man. Am J Case Rep 2019;20:412-8. [PMID: 30926768 DOI: 10.12659/AJCR.913856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
449 Felcht M, Klemke CD, Nicolay JP, Weiss C, Assaf C, Wobser M, Schlaak M, Hillen U, Moritz R, Tantcheva-Poor I, Nashan D, Beyer M, Dippel E, Müller CSL, Sachse MM, Meiss F, Géraud C, Marx A, Goerdt S, Geissinger E, Kempf W. Primär kutanes diffus-großzelliges B-Zell-Lymphom, NOS oder leg type: klinische, morphologische und prognostische Unterschiede. J Dtsch Dermatol Ges 2019;17:275-86. [PMID: 30920753 DOI: 10.1111/ddg.13773_g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
450 Ito A, Sugita K, Ikeda A, Yamamoto O. CD4/CD8 Double-negative Mycosis Fungoides: A Case Report and Literature Review. Yonago Acta Med 2019;62:153-8. [PMID: 30962758 [PMID: 30962758 DOI: 10.33160/yam.2019.03.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
451 Ling YL, Huang X, Mitri G, Lovelace B, Pham A, Knobler R, Li X, Gao X. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015. J Dermatolog Treat 2020;31:91-8. [PMID: 30892982 DOI: 10.1080/09546634.2019.1587144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
452 Damasco FM, Geskin LJ, Akilov OE. Nail Changes in Sézary Syndrome: A Single-Center Study and Review of the Literature. J Cutan Med Surg 2019;23:380-7. [DOI: 10.1177/1203475419839937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
453 Lim HLJ, Tan EST, Tee SI, Ho ZY, Boey JJJ, Tan WP, Tang MBY, Shen L, Chan YH, Tan SH. Epidemiology and prognostic factors for mycosis fungoides and Sézary syndrome in a multi-ethnic Asian cohort: a 12-year review. J Eur Acad Dermatol Venereol 2019;33:1513-21. [PMID: 30801779 DOI: 10.1111/jdv.15526] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
454 Denis D, Beneton N, Laribi K, Maillard H. Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel. Cancer Manag Res 2019;11:2241-51. [PMID: 30962713 DOI: 10.2147/CMAR.S138661] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
455 Xu L, Che Y, Ding X, Song J, Zhang X, Sun X. Successful treatment of a rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review. Dermatol Ther 2019;32:e12878. [PMID: 30884048 DOI: 10.1111/dth.12878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
456 Tratzmiller S, Schneider U, Dunsche A, Klemke CD. [Whitish-reddish circumscribed ulcerated nodule on the tongue of a younger woman]. Hautarzt 2019;70:459-61. [PMID: 30874840 DOI: 10.1007/s00105-019-4382-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
457 Gug G, Huang Q, Chiticariu E, Solovan C, Baudis M. DNA copy number imbalances in primary cutaneous lymphomas. J Eur Acad Dermatol Venereol 2019;33:1062-75. [PMID: 30659659 DOI: 10.1111/jdv.15442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
458 Felcht M, Klemke CD, Nicolay JP, Weiss C, Assaf C, Wobser M, Schlaak M, Hillen U, Moritz R, Tantcheva-Poor I, Nashan D, Beyer M, Dippel E, Müller CSL, Sachse MM, Meiss F, Géraud C, Marx A, Goerdt S, Geissinger E, Kempf W. Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences. J Dtsch Dermatol Ges 2019;17:275-85. [PMID: 30851152 DOI: 10.1111/ddg.13773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
459 Maemoto H, Ariga T, Kusada T, Heianna J, Manabe Y, Miyakawa A, Nakachi S, Morishima S, Iraha S, Ganaha F, Masuzaki H, Murayama S. Radiation-induced dermatitis after administration of mogamulizumab for adult T-cell leukaemia/lymphoma: a multi-institutional retrospective study. Jpn J Clin Oncol 2019;49:153-9. [PMID: 30452692 DOI: 10.1093/jjco/hyy172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
460 Soltan MY, Sumarni U, Assaf C, Langer P, Reidel U, Eberle J. Key Role of Reactive Oxygen Species (ROS) in Indirubin Derivative-Induced Cell Death in Cutaneous T-Cell Lymphoma Cells. Int J Mol Sci 2019;20:E1158. [PMID: 30866411 DOI: 10.3390/ijms20051158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
461 Yonan YA, Cumsky HJL, Costello CM, Maly CJ, Rosenthal AC, Reeder CB, Rule WG, Pittelkow MR, Craig FE, DiCaudo DJ, Mangold AR. Syringotropic and folliculotropic mycosis fungoides with mycosis fungoides-associated vasculopathic ulcers. JAAD Case Rep 2019;5:231-3. [PMID: 30834284 DOI: 10.1016/j.jdcr.2019.01.020] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
462 Darjani A, Zeinab Azimi S, Alireza Mesbah S, Rafiei R, Gharaei Nejad K, Rafiee B. Lymphomatoid papulosis mimicking cutaneous histiocytosis. Gazz Med Ital - Arch Sci Med 2019;178. [DOI: 10.23736/s0393-3660.18.03760-9] [Reference Citation Analysis]
463 Halec G, Waterboer T, Brenner N, Butt J, Hardy WD, DʼSouza G, Wolinsky S, Macatangay BJ, Pawlita M, Detels R, Martínez-Maza O, Hussain SK. Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma. J Acquir Immune Defic Syndr 2019;80:e53-63. [PMID: 30531297 DOI: 10.1097/QAI.0000000000001916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
464 Papoudou-Bai A, Marinos L, Vassou A, Kapsali E, Kanavaros P. CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type. Case Rep Dermatol Med 2019;2019:3730915. [PMID: 30792929 DOI: 10.1155/2019/3730915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
465 Wang RF, Sokumbi O, Chiu YE. Folliculotropic mycosis fungoides in a pediatric patient mimicking black dot tinea capitis. Pediatr Dermatol 2019;36:386-7. [DOI: 10.1111/pde.13768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
466 Jaque A, Mereniuk A, Walsh S, Shear NH, Sade S, Zagorski B, Alhusayen R. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients. Int J Dermatol 2019;58:933-9. [DOI: 10.1111/ijd.14391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
467 Sneha LM, Ramaswamy S, Shalini S, Scott J. Cutaneous Abscess: An Isolated Manifestation of Disseminated Anaplastic Large-cell Lymphoma in a Child. Indian J Dermatol 2019;64:83-4. [PMID: 30745646 DOI: 10.4103/ijd.IJD_514_16] [Reference Citation Analysis]
468 DeStefano CB, Desale S, Fernandez SJ, Shenoy AG. The impact of environmental ultraviolet exposure on the clinical course of mycosis fungoides. J Am Acad Dermatol 2019;81:1074-7. [PMID: 30763649 DOI: 10.1016/j.jaad.2019.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
469 Ollila TA, Sahin I, Olszewski AJ. Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma. Onco Targets Ther 2019;12:1085-94. [PMID: 30799938 DOI: 10.2147/OTT.S165615] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
470 Cairo MS, Beishuizen A. Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol 2019;185:1021-42. [PMID: 30729513 DOI: 10.1111/bjh.15764] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
471 Borcherding N, Voigt AP, Liu V, Link BK, Zhang W, Jabbari A. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. Clin Cancer Res 2019;25:2996-3005. [PMID: 30718356 DOI: 10.1158/1078-0432.CCR-18-3309] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
472 Geller S, Gomez CJ, Myskowski PL, Pulitzer M. Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study. J Am Acad Dermatol 2019;80:1704-11. [PMID: 30716405 DOI: 10.1016/j.jaad.2019.01.062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
473 Chen C, Gu YD, Geskin LJ. A Review of Primary Cutaneous CD30+ Lymphoproliferative Disorders. Hematology/Oncology Clinics of North America 2019;33:121-34. [DOI: 10.1016/j.hoc.2018.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
474 Damasco F, Akilov OE. Rare Cutaneous T-Cell Lymphomas. Hematology/Oncology Clinics of North America 2019;33:135-48. [DOI: 10.1016/j.hoc.2018.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
475 Goggins CA, Gocke MT, Jang S, DeSimone JA. Oral mycosis fungoides with CD30+ large cell transformation successfully treated with brentuximab vedotin. JAAD Case Rep 2019;5:180-3. [PMID: 30733988 DOI: 10.1016/j.jdcr.2018.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
476 Kheterpal MK, Dai J, Geller S, Pulitzer M, Ni A, Myskowski PL, Moskowitz A, Kim J, Hong EK, Fong S, Hoppe RT, Kim YH, Horwitz SM. Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin. J Am Acad Dermatol 2019;81:970-6. [PMID: 30703460 DOI: 10.1016/j.jaad.2019.01.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
477 Moyal L, Gorovitz‐haris B, Yehezkel S, Jacob‐hirsch J, Bershtein V, Barzilai A, Rotem C, Sherman S, Amitay‐laish I, Feinmesser M, Hodak E. Unilesional mycosis fungoides is associated with increased expression of micro RNA ‐17~92 and T helper 1 skewing. Br J Dermatol 2019;180:1123-34. [DOI: 10.1111/bjd.17425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
478 Uribe-Bojanini E, Santa-Vélez C, Rueda-Cadena X, Morales SD. Severe and Lethal Presentation of Folliculotropic Mycosis Fungoides. Actas Dermosifiliogr (Engl Ed) 2019;110:412-4. [PMID: 30642565 DOI: 10.1016/j.ad.2018.02.027] [Reference Citation Analysis]
479 Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019;133:1703-14. [PMID: 30635287 DOI: 10.1182/blood-2018-11-881268] [Cited by in Crossref: 512] [Cited by in F6Publishing: 545] [Article Influence: 128.0] [Reference Citation Analysis]
480 Vieyra-Garcia P, Crouch JD, O'Malley JT, Seger EW, Yang CH, Teague JE, Vromans AM, Gehad A, Win TS, Yu Z, Lowry EL, Na JI, Rook AH, Wolf P, Clark RA. Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma. JCI Insight 2019;4:124233. [PMID: 30626755 DOI: 10.1172/jci.insight.124233] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
481 Mandava A, Koppula V, Wortsman X, Catalano O, Alfageme F. The clinical value of imaging in primary cutaneous lymphomas: Role of high resolution ultrasound and PET-CT. Br J Radiol 2019;92:20180904. [PMID: 30608186 DOI: 10.1259/bjr.20180904] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
482 Subtil A. Extranodal NK/T-Cell Lymphoma, Nasal Type. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_33] [Reference Citation Analysis]
483 Bretsztajn S, Leturc T, Euvrard E, Bodard A. Lymphomatoid papulosis localized to the oral mucosa: case report and literature review. J Oral Med Oral Surg 2019;25:30. [DOI: 10.1051/mbcb/2019021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
484 Nogami K, Mochida K, Takarabe A, Ushiroda Y, Eto H, Narita Y, Hayashi M, Horikawa N, Ishii Y, Amano M. Subcutaneous panniculitis-like T-cell lymphoma : Clinical features, therapeutic approaches, and outcomes in a case series of five patients. Skin Cancer 2019;34:28-34. [DOI: 10.5227/skincancer.34.28] [Reference Citation Analysis]
485 Subtil A. Subcutaneous Panniculitis-Like T-Cell Lymphoma (Alpha-Beta). Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_30] [Reference Citation Analysis]
486 Subtil A. Differential Diagnosis of Pannicular-Based Infiltrate. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_13] [Reference Citation Analysis]
487 Nikolaenko L, Zain J, Rosen ST, Querfeld C. CD30-Positive Lymphoproliferative Disorders. Cancer Treatment and Research 2019. [DOI: 10.1007/978-3-319-99716-2_12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
488 van der Weyden C, Mccormack C, Lade S, Johnstone RW, Prince HM. Rare T-Cell Subtypes. Cancer Treatment and Research 2019. [DOI: 10.1007/978-3-319-99716-2_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
489 Subtil A. Sézary Syndrome. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_26] [Reference Citation Analysis]
490 Subtil A. Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-cell Lymphoproliferative Disorder. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_29] [Reference Citation Analysis]
491 Leuchte K, Schlaak M, Stadler R, Theurich S, von Bergwelt-baildon M. Innovative Behandlungskonzepte mit Modulation der Mikroumgebung beim kutanen T-Zell-Lymphom. Kompass Dermatol 2019;7:111-119. [DOI: 10.1159/000500890] [Reference Citation Analysis]
492 Subtil A. Adult T-Cell Leukemia/Lymphoma (ATLL). Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_35] [Reference Citation Analysis]
493 Subtil A. Differential Diagnosis of CD30 Expression. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_17] [Reference Citation Analysis]
494 Gujral S. Pathology of Lymphoreticular Tissues. Hematopathology 2019. [DOI: 10.1007/978-981-13-7713-6_16] [Reference Citation Analysis]
495 Subtil A. Primary Cutaneous CD30+ Lymphoproliferative Disorders, Lymphomatoid Papulosis. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_28] [Reference Citation Analysis]
496 Willemze R. Cutaneous T-Cell Lymphomas in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence 2019. [DOI: 10.1007/978-3-030-11769-6_23] [Reference Citation Analysis]
497 Subtil A. Differential Diagnosis of Ulceration. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_8] [Reference Citation Analysis]
498 Subtil A. Granulomatous Slack Skin. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_25] [Reference Citation Analysis]
499 Querfeld C, Zain J, Rosen ST. Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary Syndrome. Cancer Treatment and Research 2019. [DOI: 10.1007/978-3-319-99716-2_11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
500 Subtil A. Pagetoid Reticulosis. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_24] [Reference Citation Analysis]
501 Subtil A. Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_32] [Reference Citation Analysis]
502 Subtil A. Classic Mycosis Fungoides. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_22] [Reference Citation Analysis]
503 Kelsey A, Parikh SA, Finch J, Grant-kels JM. Skin Health and Healthy Aging: Skin Disease. Healthy Aging 2019. [DOI: 10.1007/978-3-030-06200-2_11] [Reference Citation Analysis]
504 Subtil A. Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified (NOS). Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_37] [Reference Citation Analysis]
505 Heinzerling L, Hartmann A, Hund M. Kutane Lymphome. Medikamentöse Tumortherapie in der Dermato-Onkologie 2019. [DOI: 10.1007/978-3-662-58012-7_3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
506 Subtil A. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_38] [Reference Citation Analysis]
507 Subtil A. Lymphocyte Morphology. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_3] [Reference Citation Analysis]
508 Subtil A. Primary Cutaneous CD30+ Lymphoproliferative Disorders: Cutaneous Anaplastic Large Cell Lymphoma. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_27] [Reference Citation Analysis]
509 Kempf W, Geissinger E. Kutane lymphoproliferative und hämatopoietische Erkrankungen. Pathologie 2019. [DOI: 10.1007/978-3-540-85184-4_38] [Reference Citation Analysis]
510 Subtil A. Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma (Indolent CD8-Positive Lymphoid Proliferation of the Ear). Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_36] [Reference Citation Analysis]
511 Siaghani PJ, Wong JT, Chan J, Weisenburger DD, Song JY. Epidemiology and Pathology of T- and NK-Cell Lymphomas. Cancer Treatment and Research 2019. [DOI: 10.1007/978-3-319-99716-2_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
512 Zain J. Transplantation. Cancer Treatment and Research 2019. [DOI: 10.1007/978-3-319-99716-2_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
513 Subtil A. Lymphomatoid Granulomatosis (LYG). Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_42] [Reference Citation Analysis]
514 Subtil A. Hydroa Vacciniforme-Like Lymphoproliferative Disorder. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_34] [Reference Citation Analysis]
515 Subtil A. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_39] [Reference Citation Analysis]
516 Subtil A. Differential Diagnosis of Large Cell Infiltrate. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_14] [Reference Citation Analysis]
517 Iqbal J, de Leval L. Pathology and Molecular Pathogenesis of T-Cell Lymphoma. Springer Reference Medizin 2019. [DOI: 10.1007/978-3-030-00362-3_4] [Reference Citation Analysis]
518 Subtil A. Primary Cutaneous Marginal Zone B-Cell Lymphoma. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_41] [Reference Citation Analysis]
519 Subtil A. Primary Cutaneous Follicle Center Lymphoma. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_40] [Reference Citation Analysis]
520 Maemoto H, Ariga T, Nakachi S, Toita T, Hashimoto S, Heianna J, Shiina H, Kusada T, Makino W, Kakinohana Y, Miyagi T, Yamamoto Y, Morishima S, Masuzaki H, Murayama S. Appropriate radiation dose for symptomatic relief and local control in patients with adult T cell leukemia/lymphoma. J Radiat Res 2019;60:98-108. [PMID: 30124892 DOI: 10.1093/jrr/rry068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
521 Subtil A. Cutaneous Gamma-Delta T-Cell Lymphoma. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_31] [Reference Citation Analysis]
522 Subtil A. Folliculotropic Mycosis Fungoides. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_23] [Reference Citation Analysis]
523 Subtil A. Blastic Plasmacytoid Dendritic Cell Neoplasm. Diagnosis of Cutaneous Lymphoid Infiltrates 2019. [DOI: 10.1007/978-3-030-11654-5_43] [Reference Citation Analysis]
524 Tsang M, Gantchev J, Netchiporouk E, Moreau L, Ghazawi FM, Glassman S, Sasseville D, Litvinov IV. A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL). Oncotarget 2018;9:37647-61. [PMID: 30701021 DOI: 10.18632/oncotarget.26479] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
525 Servitje O, Climent F, Colomo L, Ruiz N, García‐herrera A, Gallardo F, Mercadal S, Pomares H, Muniesa C, Martin‐callizo C, Marcoval J, Rovira R, Estrach T, Pujol RM. Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression. J Cutan Pathol 2018;46:182-9. [DOI: 10.1111/cup.13399] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
526 Trautinger F. Phototherapy of cutaneous T-cell lymphomas. Photochem Photobiol Sci 2018;17:1904-12. [PMID: 30325389 DOI: 10.1039/c8pp00170g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
527 Zoumberos NA, McMullen E, Wang L, Wang X, Harms KL, Tejasvi T, Chan MP, Fullen DR, Hristov AC, Harms PW. Merkel cell carcinoma arising in association with cutaneous T-cell lymphoma: A potential diagnostic pitfall. J Cutan Pathol 2019;46:199-203. [PMID: 30561044 DOI: 10.1111/cup.13404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
528 Gilson D, Whittaker S, Child F, Scarisbrick J, Illidge T, Parry E, Mohd Mustapa M, Exton L, Kanfer E, Rezvani K, Dearden C, Morris S, Mchenry P, Leslie T, Wakelin S, Hunasehally R, Cork M, Johnston G, Chiang N, Worsnop F, Salim A, Buckley D, Petrof G, Callachand N, Flavell T, Salad A. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018. Br J Dermatol 2019;180:496-526. [DOI: 10.1111/bjd.17240] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 13.6] [Reference Citation Analysis]
529 Kondo H, Kagawa Y, Shirota K, Moore PF, Nagata M. Canine non-epitheliotropic CD4-positive cutaneous T-cell lymphoma: a case report. Vet Med Sci 2019;5:206-9. [PMID: 30548472 DOI: 10.1002/vms3.137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
530 Yang D, Zhang WP, Yang JM, He MX, Cheng C, Chen J. Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report. Medicine (Baltimore) 2018;97:e13093. [PMID: 30544372 DOI: 10.1097/MD.0000000000013093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
531 Lin TA, Yang CF, Liu YC, Liu JH, Chiou TJ, Hsiao LT, Yen HJ, Liu CJ, Wang HY, Ko PS, Chien SH, Gau JP. Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian population. Int J Hematol 2019;109:187-96. [PMID: 30547418 DOI: 10.1007/s12185-018-02568-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
532 Obara K, Mii S, Amoh Y. A case of primary cutaneous peripheral T‐cell lymphoma, not otherwise specified, with cytotoxic phenotype showing multiple ulcers on the entire body. J Cutan Pathol 2018. [DOI: 10.1111/cup.13386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
533 Georgakopoulos I, Papadavid E, Platoni K, Dilvoi M, Patatoukas G, Kypraiou E, Nikolaou V, Efstathopoulos E, Kelekis N, Kouloulias V. Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy) treatment schedule. Clin Transl Radiat Oncol 2019;15:26-30. [PMID: 30582018 DOI: 10.1016/j.ctro.2018.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
534 De Luca D, Zambrano E, Galimberti R, Enz P. The Effectiveness of a Twice-weekly Narrowband Ultraviolet B Phototherapy Schedule in Early-stage Mycosis Fungoides in a Cohort of 18 Argentinian Patients. Actas Dermo-Sifiliográficas (English Edition) 2018;109:922-924. [DOI: 10.1016/j.adengl.2018.07.015] [Reference Citation Analysis]
535 Gottesman SP, Rosen JR, Geller JD, Freeman BB. Atypical Varicella-Zoster Kaposi Varicelliform Eruption in Sézary Syndrome. The American Journal of Dermatopathology 2018;40:920-3. [DOI: 10.1097/dad.0000000000001264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
536 Yuki A, Shinkuma S, Hayashi R, Fujikawa H, Kato T, Homma E, Hamade Y, Onodera O, Matsuoka M, Shimizu H, Iwata H, Abe R. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases. Journal of the American Academy of Dermatology 2018;79:1039-46. [DOI: 10.1016/j.jaad.2018.06.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
537 Rajabi-estarabadi A, Zheng C, Vazquez T, Akhtar S, Williams N, Nouri K. Cells to Surgery Quiz: December 2018. Journal of Investigative Dermatology 2018;138:e87-92. [DOI: 10.1016/j.jid.2018.10.005] [Reference Citation Analysis]
538 Luca DA, Enz PA, Galimberti RL, Rinflerch AR. No detection of c-kit gene mutations in exons 9, 11, 13 and 17 and low CD117 expression in plaque-stage mycosis fungoides. An Bras Dermatol 2018;93:913-5. [PMID: 30484546 DOI: 10.1590/abd1806-4841.20187930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
539 Dong P, Wang L, Zhu H, Li L. Relapsed subcutaneous panniculitis-like T cell lymphoma evaluated by FDG PET/CT: A clinical case report. Medicine (Baltimore) 2018;97:e12980. [PMID: 30431571 DOI: 10.1097/MD.0000000000012980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
540 Scarisbrick J, Quaglino P, Prince H, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz‐romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Child F, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram‐wolff C, Battistella M, Alberti‐violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot‐barry M, Pham‐ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel‐kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon‐pennamen M, Battistella M, Climent F, Gonzalez‐barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots A, Hauben E, Bervoets A, Woei‐a‐jin F, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, Mckay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches J, Miyashiro D, Akilov O, Mccann S, Sahi H, Damasco F, Querfeld C, Folkes A, Bur C, Klemke C, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R. The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 2019;181:350-7. [DOI: 10.1111/bjd.17258] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 15.6] [Reference Citation Analysis]
541 Rutnin S, Porntharukcharoen S, Boonsakan P. Clinicopathologic, immunophenotypic, and molecular analysis of subcutaneous panniculitis-like T-cell lymphoma: A retrospective study in a tertiary care center. J Cutan Pathol 2019;46:44-51. [PMID: 30350476 DOI: 10.1111/cup.13377] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
542 Rivers CI, Singh AK. Total Skin Electron Beam Therapy for Mycosis Fungoides Revisited With Adjuvant Systemic Therapy. Clin Lymphoma Myeloma Leuk 2019;19:83-8. [PMID: 30528417 DOI: 10.1016/j.clml.2018.11.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
543 Raychaudhuri S, Rahvar M, Jedrych J, Karunamurthy A, Kruglov O, Rakfal S, Kane K, Akilov OE. Dual-Positive CD4/CD8 Primary Cutaneous Peripheral T-Cell Lymphoma Previously Classified as Mycosis Fungoides a Tumor D'Emblée. The American Journal of Dermatopathology 2018;40:836-40. [DOI: 10.1097/dad.0000000000001188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
544 Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 2018;93:1427-30. [PMID: 30039522 DOI: 10.1002/ajh.25224] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
545 Moritz RKC. [43/m with alopecia and suberythroderma : Preparation for the specialist examination: part 9]. Hautarzt 2018;69:114-7. [PMID: 30374557 DOI: 10.1007/s00105-018-4246-y] [Reference Citation Analysis]
546 Demina OM, Akilov OE, Rumyantsev AG. Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy. Onkogematologiâ 2018;13:25-38. [DOI: 10.17650/1818-8346-2018-13-3-25-38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
547 Bastidas Torres AN, Cats D, Mei H, Szuhai K, Willemze R, Vermeer MH, Tensen CP. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides. Genes Chromosomes Cancer 2018;57:653-64. [PMID: 30144205 DOI: 10.1002/gcc.22679] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
548 Deenen N, Koens L, Jaspars E, Vermeer M, Willemze R, Rie M, Bekkenk M. Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD 8 + T‐cell lymphoma. Br J Dermatol 2018;180:411-2. [DOI: 10.1111/bjd.17252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
549 Connolly A, Grandi V, Semkova K, Morris S, Child F. Multiple ulcerated nodules on the leg. Clin Exp Dermatol 2019;44:556-8. [PMID: 30341833 DOI: 10.1111/ced.13779] [Reference Citation Analysis]
550 Ye AL, Willis MS, Link BK, Naridze RL, Syrbu SI, Liu V. Primary diffuse large B cell lymphoma of the vulva-Two new cases of a rare entity and review of the literature. JAAD Case Rep 2018;4:962-7. [PMID: 30364749 DOI: 10.1016/j.jdcr.2018.06.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
551 Horna P, Moscinski LC, Sokol L, Shao H. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification. Cytometry B Clin Cytom 2019;96:234-41. [PMID: 30328260 DOI: 10.1002/cyto.b.21738] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
552 Accetta JL, Helm MM, Wirth P Jr, Merzianu M. IgG4 expression in cutaneous marginal zone lymphoma with plasmacytic differentiation and localized amyloid deposition: A useful clue to cutaneous origin. JAAD Case Rep 2018;4:883-6. [PMID: 30306118 DOI: 10.1016/j.jdcr.2018.06.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
553 Fanoni D, Corti L, Alberti-violetti S, Tensen CP, Venegoni L, Vermeer M, Willemze R, Berti E. Array-based CGH of primary cutaneous CD8+ aggressive EPIDERMO-tropic cytotoxic T-cell lymphoma. Genes Chromosomes Cancer 2018;57:622-9. [DOI: 10.1002/gcc.22673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
554 Fountain E, Mistry H, Jain P, Duvic M, Fowler N. Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides. Leuk Lymphoma 2019;60:1079-82. [PMID: 30301395 DOI: 10.1080/10428194.2018.1516879] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
555 Abeldaño A, Enz P, Maskin M, Cervini AB, Torres N, Acosta AC, Narbaitz M, Vanzulli S, Orentrajch M, Villareal MA, Garcia Pazos ML, Arias M, Zambrano Franco EA, Fontana MI, Chuit R. Primary cutaneous lymphoma in Argentina: a report of a nationwide study of 416 patients. Int J Dermatol 2019;58:449-55. [PMID: 30294921 DOI: 10.1111/ijd.14262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
556 Lee MH, Choi ME, Won CH, Chang SE, Lee MW, Choi JH, Lee WJ. Comparative clinicopathologic analysis of cutaneous peripheral T-cell lymphoma, not otherwise specified, according to primary tumor site. J Am Acad Dermatol 2019;80:1771-4. [PMID: 30296539 DOI: 10.1016/j.jaad.2018.09.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
557 Amorim GM, Corbellini JPN, Quintella DC, Cuzzi T, Ramos-E-Silva M. Evaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoides. An Bras Dermatol 2018;93:680-5. [PMID: 30156617 DOI: 10.1590/abd1806-4841.20187134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
558 Lapczynski NL, Flaig MJ. [Polymorphic cutaneous T‑cell lymphoma]. Hautarzt 2018;69:52-5. [PMID: 30264306 DOI: 10.1007/s00105-018-4218-2] [Reference Citation Analysis]
559 Sharma P, Goyal S, Yadav AK, Singh J, Mandal AK. Hodgkin's lymphoma arising in a case of mycosis fungoides: An unusual association. Indian J Dermatol Venereol Leprol 2018;84:292-7. [PMID: 29098990 DOI: 10.4103/ijdvl.IJDVL_744_16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
560 Poggio T, Duyster J, Illert AL. Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas. Cancers (Basel) 2018;10:E339. [PMID: 30231561 DOI: 10.3390/cancers10090339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
561 Gug G, Huang Q, Chiticariu E, Solovan C, Baudis M. DNA copy number imbalances in primary cutaneous lymphomas (PCL).. [DOI: 10.1101/417766] [Reference Citation Analysis]
562 Amorim GM, Niemeyer-Corbellini JP, Quintella DC, Cuzzi T, Ramos-E-Silva M. Clinical and epidemiological profile of patients with early stage mycosis fungoides. An Bras Dermatol 2018;93:546-52. [PMID: 30066762 DOI: 10.1590/abd1806-4841.20187106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
563 Kamijo H, Miyagaki T, Shishido-Takahashi N, Nakajima R, Oka T, Suga H, Sugaya M, Sato S. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. Blood 2018;132:1922-35. [PMID: 30194255 DOI: 10.1182/blood-2018-04-845834] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
564 Hosoi H, Hatanaka K, Murata S, Mushino T, Kuriyama K, Nishikawa A, Hanaoka N, Tamura S, Nakakuma H, Sonoki T. Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome. Hematol Rep 2018;10:7497. [PMID: 30283619 DOI: 10.4081/hr.2018.7497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
565 Beylot-barry M, Mermin D, Maillard A, Bouabdallah R, Bonnet N, Duval-modeste A, Mortier L, Ingen-housz-oro S, Ram-wolff C, Barete S, Dalle S, Maubec E, Quereux G, Templier I, Bagot M, Grange F, Joly P, Vergier B, Vially P, Gros A, Pham-ledard A, Frison E, Merlio J. A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type. Journal of Investigative Dermatology 2018;138:1982-9. [DOI: 10.1016/j.jid.2018.03.1516] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
566 Peñate Y, Servitje O, Machan S, Fernández-de-misa R, Estrach M, Acebo E, Mitxelena J, Ramón M, Flórez A, Blanes M, Morillo M, Medina S, Bassas J, Zayas A, Espinosa P, Pérez A, Gónzalez-romero N, Domínguez J, Muniesa C, López Robles J, Combalia A, Yanguas I, Suh H, Polo-rodríguez I, Bielsa I, Mateu A, Ferrer B, Descalzo M, García-doval I, Ortiz-romero P. Registro de linfomas cutáneos primarios de la AEDV: primer año de funcionamiento. Actas Dermo-Sifiliográficas 2018;109:610-6. [DOI: 10.1016/j.ad.2018.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
567 Peñate Y, Servitje O, Machan S, Fernández-de-misa R, Estrach M, Acebo E, Mitxelena J, Ramón M, Flórez A, Blanes M, Morillo M, Medina S, Bassas J, Zayas A, Espinosa P, Pérez A, Gónzalez-romero N, Domínguez J, Muniesa C, López Robles J, Combalia A, Yanguas I, Suh H, Polo-rodríguez I, Bielsa I, Mateu A, Ferrer B, Descalzo M, García-doval I, Ortiz-romero P. The First Year of the AEVD Primary Cutaneous Lymphoma Registry. Actas Dermo-Sifiliográficas (English Edition) 2018;109:610-616. [DOI: 10.1016/j.adengl.2018.06.003] [Reference Citation Analysis]
568 Iyer A, Patterson J, Salopek T, Wong GK, Gniadecki R. Clonotypic Heterogeneity In Cutaneous T-Cell Lymphoma Revealed By Comprehensive Whole Exome/Transcriptome Sequencing.. [DOI: 10.1101/405415] [Reference Citation Analysis]
569 Maheswari SU, Sampath V, Ramesh A. Granulomatous slack skin syndrome: Report of a unique case. Indian J Dermatol Venereol Leprol 2018;84:169-73. [PMID: 29067930 DOI: 10.4103/ijdvl.IJDVL_727_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
570 López-Lerma I, Peñate Y, Gallardo F, Martí RM, Mitxelena J, Bielsa I, Velasco-Tamariz V, Yanguas-Bayona JI, Sánchez-Sambucety P, García-Patos V, Ortiz-Romero PL, Pujol RM, Estrach T. Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients. J Am Acad Dermatol 2018;79:892-8. [PMID: 30126736 DOI: 10.1016/j.jaad.2018.05.1243] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
571 Bombonato C, Pampena R, Lallas A, Giovanni P, Longo C. Dermoscopy of Lymphomas and Pseudolymphomas. Dermatol Clin 2018;36:377-88. [PMID: 30201147 DOI: 10.1016/j.det.2018.05.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
572 Girisha BS, Srinivas T, Noronha TM, Alva AC, Menon A. A Case of an Indolent CD8-Positive Lymphoid Proliferation of the Ear. Indian J Dermatol 2018;63:342-5. [PMID: 30078881 DOI: 10.4103/ijd.IJD_393_16] [Reference Citation Analysis]
573 Chernova NG, Badmazhapova DS, Kovrigina AM, Karamova AE, Vorontsova AA, Sinitcina MN, Sidorova YV, Grebenyuk LA, Nefedova MA, Znamenskaya LF, Zvonkov EE, Savchenko VG. Successful experience in treating primary cutaneous anaplastic large cell lymphoma occuring with common lesions of the skin and lung tissue. Vestnik dermatologii i venerologii 2018;94:30-42. [DOI: 10.25208/0042-4609-2018-94-4-30-42] [Reference Citation Analysis]
574 Scarisbrick J. Staging of Mycosis Fungoides and Sézary Syndrome: Time for an Update? EMJ Hematol 2018. [DOI: 10.33590/emjhematol/10313097] [Reference Citation Analysis]
575 Jani A, Innes M, Reddy V, Prieto-Granada CN, Graham LV, Ergen EN. Peripheral T-cell lymphoma, not otherwise specified, presenting with generalized ulcerated plaques and hypereosinophilia. JAAD Case Rep 2018;4:651-4. [PMID: 30094309 DOI: 10.1016/j.jdcr.2018.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
576 Mashima E, Sawada Y, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M. A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides. Clinical Immunology 2018;193:121-2. [DOI: 10.1016/j.clim.2018.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
577 Sun J, Yi S, Qiu L, Fu W, Wang A, Liu F, Wang L, Wang T, Chen H, Wang L, Kadin ME, Tu P, Wang Y. SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile. Journal of Investigative Dermatology 2018;138:1795-804. [DOI: 10.1016/j.jid.2018.02.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
578 De Souza A, Ferry JA, Burghart DR, Tinguely M, Goyal A, Duncan LM, Kutzner H, Kempf W. IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study. Applied Immunohistochemistry & Molecular Morphology 2018;26:462-7. [DOI: 10.1097/pai.0000000000000462] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
579 Robotis J, Tsiodras S, Rokkas T. Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma. Helicobacter 2018;23:e12499. [PMID: 29897650 DOI: 10.1111/hel.12499] [Reference Citation Analysis]
580 Kansal R, Grody WW, Zhou J, Dong L, Li X. The Value of T-Cell Receptor γ (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues. Am J Clin Pathol 2018;150:193-223. [PMID: 29982316 DOI: 10.1093/ajcp/aqy046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
581 Amitay-Laish I, Reiter O, Prag-Naveh H, Kershenovich R, Hodak E. Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work? J Dermatolog Treat 2019;30:258-63. [PMID: 29889596 DOI: 10.1080/09546634.2018.1487525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
582 Pulitzer M, Geller S, Kumar E, Frosina D, Moskowitz A, Horwitz S, Myskowski P, Kheterpal M, Chan A, Dogan A, Jungbluth A. T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. Histopathology 2018;73:653-62. [PMID: 29893430 DOI: 10.1111/his.13671] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
583 Christensen L, Cooper K, Honda K, Mansur D. Relapse rates in patients with unilesional primary cutaneous B-cell lymphoma treated with radiation therapy: a single-institution experience. Br J Dermatol 2018;179:1172-3. [PMID: 29761874 DOI: 10.1111/bjd.16783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
584 Gorenkova LG, Kravchenko SK, Kovrigina AM, Kolomeitsev OA. Successful sequential immune epigenetic therapy of erythrodermic mycosis fungoidesessful sequential immune epigenetic therapy with the resistant course of erythrodermic mycosis fungoides. Vestnik dermatologii i venerologii 2018;94:77-84. [DOI: 10.25208/0042-4609-2018-94-3-77-84] [Reference Citation Analysis]
585 Prince HM, Querfeld C. Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome. Best Pract Res Clin Haematol 2018;31:322-35. [PMID: 30213403 DOI: 10.1016/j.beha.2018.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
586 Yuson C, Maiolo C, Hissaria P. A case of deadly panniculitis. BMJ Case Rep 2018;2018:bcr-2018-225170. [PMID: 29970609 DOI: 10.1136/bcr-2018-225170] [Reference Citation Analysis]
587 Gru AA, Voorhess PJ. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation. The American Journal of Dermatopathology 2018;40:519-22. [DOI: 10.1097/dad.0000000000001061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
588 Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, Arampatzi P, Goebeler M, Rosenwald A, Geissinger E, Wobser M. Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma. Journal of Investigative Dermatology 2018;138:1573-81. [DOI: 10.1016/j.jid.2018.02.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
589 Serrano L, Martinez-escala ME, Zhou XA, Guitart J. Pruritus in Cutaneous T-Cell Lymphoma and Its Management. Dermatologic Clinics 2018;36:245-58. [DOI: 10.1016/j.det.2018.02.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
590 Marovt M, Luzar B, Marko PB. [Acrally emphasized papules-a case report]. Hautarzt 2019;70:44-6. [PMID: 29955917 DOI: 10.1007/s00105-018-4227-1] [Reference Citation Analysis]
591 Wickenden K, Graham-Brown MPM, Veitch D, Dormer J, Bamford M, Graham-Brown RAC, Warwick G, Wagner S, Burton JO. Sézary Syndrome Presenting With Renal Involvement. Am J Kidney Dis 2018;72:890-4. [PMID: 29941220 DOI: 10.1053/j.ajkd.2018.04.013] [Reference Citation Analysis]
592 Kim SR, Lewis JM, Cyrenne BM, Monico PF, Mirza FN, Carlson KR, Foss FM, Girardi M. BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition. Oncotarget 2018;9:29193-207. [PMID: 30018745 DOI: 10.18632/oncotarget.25670] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
593 Nikolaou V, Sachlas A, Papadavid E, Economidi A, Karambidou K, Marinos L, Stratigos A, Antoniou C. Phototherapy as a first-line treatment for early-stage mycosis fungoides: The results of a large retrospective analysis. Photodermatol Photoimmunol Photomed 2018;34:307-13. [DOI: 10.1111/phpp.12383] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
594 Melchers R, Willemze R, Bekkenk M, de Haas E, Horvath B, van Rossum M, Sanders C, Veraart J, Vermeer M, Quint K. Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group. Br J Dermatol 2018;179:724-31. [DOI: 10.1111/bjd.16501] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
595 Amitay-laish I, Davidovici B, Moyal L, Gurevich M, Akerman L, Hodak E. Lack of detectable effect of narrow-band ultraviolet B on peripheral blood mononuclear cell cytokine expression in early-stage mycosis fungoides. Photodermatol Photoimmunol Photomed 2018;34:350-3. [DOI: 10.1111/phpp.12397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
596 De Luca DA, Zambrano EA, Galimberti RL, Enz PA. The Effectiveness of a Twice-weekly Narrowband Ultraviolet B Phototherapy Schedule in Early-stage Mycosis Fungoides in a Cohort of 18 Argentinian Patients. Actas Dermosifiliogr (Engl Ed) 2018;109:922-4. [PMID: 29908635 DOI: 10.1016/j.ad.2017.11.018] [Reference Citation Analysis]
597 Estrach T, Servitje O, Ortiz-Romero PL. AEDV Primary Cutaneous Lymphoma Registry. Actas Dermosifiliogr 2017;108:181-3. [PMID: 28347423 DOI: 10.1016/j.ad.2017.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
598 Querfeld C, Leung S, Myskowski PL, Curran SA, Goldman DA, Heller G, Wu X, Kil SH, Sharma S, Finn KJ, Horwitz S, Moskowitz A, Mehrara B, Rosen ST, Halpern AC, Young JW. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Cancer Immunol Res 2018;6:900-9. [PMID: 29895574 DOI: 10.1158/2326-6066.CIR-17-0270] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 10.2] [Reference Citation Analysis]
599 Manso R, Martínez-Magunacelaya N, Eraña-Tomás I, Monsalvez V, Rodríguez-Peralto JL, Ortiz-Romero PL, Santonja C, Cristóbal I, Piris MA, Rodríguez-Pinilla SM. Mycosis fungoides progression could be regulated by microRNAs. PLoS One 2018;13:e0198477. [PMID: 29894486 DOI: 10.1371/journal.pone.0198477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
600 Prodinger CM, Koller J, Laimer M. Scalp tumors. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2018;16:730-53. [DOI: 10.1111/ddg.13546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
601 Fujii K. New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma. Front Oncol 2018;8:198. [PMID: 29915722 DOI: 10.3389/fonc.2018.00198] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
602 Belada D. Brentuximab vedotin in the treatment of relapsed CD30 positive cutaneous lymphoma - results of an international, open label, randomised, phase 3, multicentre trial - ALCANZA. Onkologie 2018;12:123-7. [DOI: 10.36290/xon.2018.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
603 Kamarádová K. Pitfalls in cutaneous lymphoma diagnosis - a pathologists point of view. Onkologie 2018;12:105-110. [DOI: 10.36290/xon.2018.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
604 Gángó A, Bátai B, Varga M, Kapczár D, Papp G, Marschalkó M, Kuroli E, Schneider T, Csomor J, Matolcsy A, Bödör C, Szepesi Á. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein. Virchows Arch 2018;473:453-62. [DOI: 10.1007/s00428-018-2384-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
605 Ettler J, Mužík J, Polívka J. Epidemiology of primary cutaneous lymphomas in the Czech Republic according to data of the Czech National Cancer Registry from 2005-2015. Onkologie 2018;12:100-104. [DOI: 10.36290/xon.2018.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
606 Prodinger CM, Koller J, Laimer M. Tumoren der Kopfhaut. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2018;16:730-754. [DOI: 10.1111/ddg.13546_g] [Reference Citation Analysis]
607 Yuan Z, Grass GD, Robinson TJ, Kim S. Management of primary cutaneous CD4+ small and medium pleomorphic T-cell lymphoma: A retrospective study. J Am Acad Dermatol 2018;79:772-4. [PMID: 29857014 DOI: 10.1016/j.jaad.2018.05.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
608 Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann Oncol 2017;28:2517-25. [PMID: 28961843 DOI: 10.1093/annonc/mdx352] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 12.0] [Reference Citation Analysis]
609 Iżykowska K, Przybylski GK, Gand C, Braun FC, Grabarczyk P, Kuss AW, Olek-Hrab K, Bastidas Torres AN, Vermeer MH, Zoutman WH, Tensen CP, Schmidt CA. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome. Oncotarget 2017;8:39627-39. [PMID: 28489605 DOI: 10.18632/oncotarget.17383] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
610 Grandi V, Delfino C, Pileri A, Pimpinelli N. Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic. Br J Dermatol 2017;177:406-10. [PMID: 28078669 DOI: 10.1111/bjd.15302] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
611 Fredholm S, Willerslev-Olsen A, Met Ö, Kubat L, Gluud M, Mathiasen SL, Friese C, Blümel E, Petersen DL, Hu T, Nastasi C, Lindahl LM, Buus TB, Krejsgaard T, Wasik MA, Kopp KL, Koralov SB, Persson JL, Bonefeld CM, Geisler C, Woetmann A, Iversen L, Becker JC, Ødum N. SATB1 in Malignant T Cells. J Invest Dermatol 2018;138:1805-15. [PMID: 29751003 DOI: 10.1016/j.jid.2018.03.1526] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
612 Pedretti S, Urpis M, Leali C, Borghetti P, Baushi L, Sala R, Tucci A, Greco D, Pasinetti N, Triggiani L, Rossi G, Calzavara-Pinton P, Magrini SM, Buglione M. Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines. Tumori 2018;104:394-400. [PMID: 28218382 DOI: 10.5301/tj.5000606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
613 Tsang Y, Gu T, Sharma G, Raspa S, Drake B 3rd, Tan H. Healthcare resource utilization, costs of care, and treatment of mycosis fungoides cutaneous T-cell lymphoma patterns in a large managed care population: a retrospective US claims-based analysis. J Dermatolog Treat 2018;29:747-53. [PMID: 29733229 DOI: 10.1080/09546634.2018.1466026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
614 Mitteldorf C, Stadler R, Sander CA, Kempf W. Folliculotropic mycosis fungoides. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2018;16:543-57. [DOI: 10.1111/ddg.13514] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
615 Alaibac M. Small molecule inhibitors for cutaneous T-cell lymphomas. Expert Opinion on Orphan Drugs 2018;6:345-350. [DOI: 10.1080/21678707.2018.1469004] [Reference Citation Analysis]
616 Geller S, Myskowski PL, Pulitzer M. NK/T-cell lymphoma, nasal type, γδ T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma-clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg 2018;37:30-8. [PMID: 29719018 DOI: 10.12788/j.sder.2018.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
617 Mitteldorf C, Stadler R, Sander CA, Kempf W. Die follikulotrope Mycosis fungoides. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2018;16:544-559. [DOI: 10.1111/ddg.13514_g] [Reference Citation Analysis]
618 Nicolay JP. Die follikulotrope Mycosis fungoides – vielschichtiger als gedacht. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2018;16:537-538. [DOI: 10.1111/ddg.13517] [Reference Citation Analysis]
619 Yi S, Sun J, Qiu L, Fu W, Wang A, Liu X, Yang Y, Kadin ME, Tu P, Wang Y. Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment. Journal of Investigative Dermatology 2018;138:1126-36. [DOI: 10.1016/j.jid.2017.10.036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
620 Abba Zarami B, Akawu Denue B. Mycosis fungoides mimicking neurofibromatosus and aspergillosis: reports of two unusual presentation and literature review. IJMBOA 2018;3. [DOI: 10.15406/ijmboa.2018.03.00056] [Reference Citation Analysis]
621 Seyed Jafari SM, Cazzaniga S, Hunger RE. Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis. G Ital Dermatol Venereol 2018;153:827-32. [PMID: 29683282 DOI: 10.23736/S0392-0488.18.05977-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
622 Owczarczyk-Saczonek A, Sokołowska-Wojdyło M, Olszewska B, Malek M, Znajewska-Pander A, Kowalczyk A, Biernat W, Poniatowska-Broniek G, Knopińska-Posłuszny W, Kozielec Z, Nowicki R, Placek W. Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms. Postepy Dermatol Alergol 2018;35:128-38. [PMID: 29760611 DOI: 10.5114/ada.2017.72269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
623 Su C, Nguyen KA, Bai HX, Zogg CK, Cao Y, Karakousis G, Zhang PJ, Zhang G, Xiao R. Ethnic disparity in primary cutaneous CD30+ T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer Database. Br J Haematol 2018;181:752-9. [PMID: 29676444 DOI: 10.1111/bjh.15222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
624 Dulmage BO, Kong BY, Holzem K, Guitart J. What Is New in CTCL—Pathogenesis, Diagnosis, and Treatments. Curr Derm Rep 2018;7:91-8. [DOI: 10.1007/s13671-018-0214-0] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
625 Olisova OY, Grekova EV, Gorenkova LG, Alekseeva EA, Zaletayev DV. OVEREXPRESSION OF STAT4 - A POSSIBLE DIAGNOSTIC MARKER OF EARLY STAGES OF MYCOSIS FUNGOIDES. Russ J Skin & Ven Dis 2018;21:94-100. [DOI: 10.18821/1560-9588-2018-21-2-94-100] [Reference Citation Analysis]
626 Hurabielle C, Battistella M, Ram-Wolff C, Fite C, Meignin V, Rivet J, Vignon-Pennamen MD, de Risi-Pugliese T, Raffoux E, Arnulf B, Oksenhendler E, Sicre de Fontbrune F, Peffault de Latour R, Socié G, Bouaziz JD, Lebbé C, Bensussan A, Bagot M. Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016. Ann Dermatol Venereol 2018;145:405-12. [PMID: 29661476 DOI: 10.1016/j.annder.2018.01.049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
627 Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol 2018;71:814-20. [DOI: 10.1136/jclinpath-2018-205004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
628 Oka T, Miyagaki T, Takahashi N, Nakajima R, Kamijo H, Suga H, Asano Y, Sugaya M, Sato S. Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome. J Invest Dermatol 2018;138:2286-8. [PMID: 29605670 DOI: 10.1016/j.jid.2018.03.1519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
629 Gru AA, Dehner LP. Cutaneous Hematolymphoid and Histiocytic Proliferations in Children. Pediatr Dev Pathol 2018;21:208-51. [DOI: 10.1177/1093526617750947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
630 Graham PM, Richardson AS, Schapiro BL, Saunders MD, Stewart DM. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response. JAAD Case Rep 2018;4:305-9. [PMID: 29693055 DOI: 10.1016/j.jdcr.2017.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
631 Menguy S, Frison E, Prochazkova-carlotti M, Dalle S, Dereure O, Boulinguez S, Dalac S, Machet L, Ram-wolff C, Verneuil L, Gros A, Vergier B, Beylot-barry M, Merlio J, Pham-ledard A. Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas. Mod Pathol 2018;31:1332-42. [DOI: 10.1038/s41379-018-0041-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
632 Bergallo M, Daprà V, Novelli M, Rassu M, Montanari P, Galliano I, Quaglino P, Fierro MT. Is HERV-K and HERV-W expression regulated by mir-155 in Sézary Syndrome? G Ital Dermatol Venereol 2020;155:477-82. [PMID: 29582620 DOI: 10.23736/S0392-0488.18.05897-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
633 Photiou L, van der Weyden C, McCormack C, Miles Prince H. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome. Curr Oncol Rep 2018;20:32. [PMID: 29572582 DOI: 10.1007/s11912-018-0678-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
634 Ettler J, Arenberger P, Polívka J. Current therapeutical options in primary cutaneous T-cell lymphomas. Dermatol praxi 2018;12:31-35. [DOI: 10.36290/der.2018.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
635 Shen X, Wang B, Li K, Wang L, Zhao X, Xue F, Shi R, Zheng J. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 2018;138:2024-32. [PMID: 29559342 DOI: 10.1016/j.jid.2018.03.1500] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
636 Malveira MIB, Pascoal G, Gamonal SBL, Castañon MCMN. Folliculotropic mycosis fungoides: challenging clinical, histopathological and immunohistochemical diagnosis. An Bras Dermatol 2017;92:73-5. [PMID: 29267452 DOI: 10.1590/abd1806-4841.20175634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
637 Wei T, Biskup E, Gjerdrum LM, Niazi O, Ødum N, Gniadecki R. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma. Oncotarget 2016;7:48391-400. [PMID: 27351221 DOI: 10.18632/oncotarget.10268] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
638 Ge X, Zhu N, Yao J, Zeng H, Su J, Jiang Z, Ji Y, Tan Y, Hou Y. A case report of nodal CD4-positive T-cell lymphoproliferative disorder with an indolent course. Medicine (Baltimore) 2018;97:e0099. [PMID: 29517683 DOI: 10.1097/MD.0000000000010099] [Reference Citation Analysis]
639 Stefoni V, Broccoli A, Argnani L, Sabattini E, Cavo M, Zinzani PL. Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience. Clin Lymphoma Myeloma Leuk 2018;18:297-9. [PMID: 29500149 DOI: 10.1016/j.clml.2018.02.007] [Reference Citation Analysis]
640 Abe F, Kitadate A, Ikeda S, Yamashita J, Nakanishi H, Takahashi N, Asaka C, Teshima K, Miyagaki T, Sugaya M, Tagawa H. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma. Oncotarget 2017;8:7572-85. [PMID: 27935859 DOI: 10.18632/oncotarget.13810] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
641 Pinos-león V, Granizo-rubio J, Granizo-rubio A, Ortiz-prado E. Linfoma cutáneo primario de células T agresivo epidermotrópico citotóxico CD8 positivo. Piel 2018;33:168-172. [DOI: 10.1016/j.piel.2017.05.011] [Reference Citation Analysis]
642 Wen P, Liu H. Hydroa Vacciniforme-Like Cutaneous T-Cell Lymphoma in an Adult Presenting With Facial Edema and Recurrent Oral Ulceration. The American Journal of Dermatopathology 2018;40:227-9. [DOI: 10.1097/dad.0000000000000845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
643 Vachhani P, Neppalli VT, Cancino CJ, Bogner P, Roche CL, Paragh G, Grassi MA, Hernandez-Ilizaliturri FJ. Radiological imaging and bone marrow biopsy in staging of cutaneous B-cell lymphoma. Br J Haematol 2019;184:674-6. [PMID: 29468663 DOI: 10.1111/bjh.15154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
644 Kreuter A, Pantelaki I, Michalowitz A, Wieland U, Cerroni L, Oellig F, Tigges C. CD30-positive primary cutaneous anaplastic large cell lymphoma with coexistent pseudocarcinomatous hyperplasia. Clin Exp Dermatol 2018;43:585-8. [DOI: 10.1111/ced.13416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
645 Ruiz R, Morante Z, Mantilla R, Mas L, Casanova L, Gomez HL. Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute. An Bras Dermatol 2017;92:649-54. [PMID: 29166501 DOI: 10.1590/abd1806-4841.20176825] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
646 Cudillo L, Cerretti R, Picardi A, Mariotti B, De Angelis G, Cantonetti M, Postorino M, Ceresoli E, De Santis G, Nasso D, Pisani F, Scala E, Di Piazza F, Lanti A; William Arcese for the Rome Transplant Network. Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma. Ann Hematol 2018;97:1041-8. [PMID: 29442161 DOI: 10.1007/s00277-018-3275-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
647 Petković IZ, Pejčić I, Tiodorović D, Krstić M, Stojnev S, Vrbić S. Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type. Postepy Dermatol Alergol 2017;34:625-8. [PMID: 29422831 DOI: 10.5114/pdia.2017.66625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
648 Bergallo M, Fava P, Galliano I, Novelli M, Montanari P, Daprà V, Rassu M, Quaglino P, Fierro MT. Molecular genetic analyses of human endogenous retroviral elements belonging to the HERV-P and HERV-R family in primary cutaneous T-cell lymphomas. J Eur Acad Dermatol Venereol 2018;32:e297-8. [PMID: 29405482 DOI: 10.1111/jdv.14840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
649 Wang JY, Nguyen GH, Ruan J, Magro CM. Primary Cutaneous Follicular Helper T-Cell Lymphoma: A Case Series and Review of the Literature. Am J Dermatopathol 2017;39:374-83. [PMID: 28375859 DOI: 10.1097/DAD.0000000000000695] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
650 Milovanović M, Mijušković Ž, Kandolf Sekulović L, Radić-tasić O, Tarabar O, Mijušković-janković D, Rajović M. Primary Cutaneous Diffuse Large B-Cell Lymphoma – a Case Report. Serbian Journal of Dermatology and Venereology 2017;9:57-62. [DOI: 10.1515/sjdv-2017-0009] [Reference Citation Analysis]
651 McKesey J, Vandergriff T, Wickless H. Not bitten by the bug: A CD30+ lymphoproliferative disorder masquerading as arthropod bites. Am J Hematol 2018;93:315-6. [PMID: 28699166 DOI: 10.1002/ajh.24846] [Reference Citation Analysis]
652 Jiang G, Shen X, Kang H, Li K, Zheng J, Yu Y. Serum metabolite profiling of cutaneous T-cell lymphoma based on a multiplatform approach. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1077-1078:71-6. [PMID: 29413580 DOI: 10.1016/j.jchromb.2018.01.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
653 Abed K, Stopa Z, Siewert-Gutowska M. Primary cutaneous anaplastic large-cell lymphoma: A case report. Medicine (Baltimore) 2018;97:e9645. [PMID: 29369180 DOI: 10.1097/MD.0000000000009645] [Reference Citation Analysis]
654 Gupta P, Agarwal P, Ahuja A, Durga CK. Primary cutaneous non-Hodgkin's lymphoma, clinically mimicking a soft tissue sarcoma. Cytojournal 2018;15:2. [PMID: 29497455 DOI: 10.4103/cytojournal.cytojournal_41_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
655 Jain G, Aiyer HM. Primary cutaneous CD4 positive small/medium T cell lymphoma. Indian J Dermatol Venereol Leprol 2018;84:186-8. [PMID: 29363627 DOI: 10.4103/ijdvl.IJDVL_91_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
656 Ehrentraut S, Schneider B, Nagel S, Pommerenke C, Quentmeier H, Geffers R, Feist M, Kaufmann M, Meyer C, Kadin ME, Drexler HG, MacLeod RA. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. Oncotarget 2016;7:34201-16. [PMID: 27144517 DOI: 10.18632/oncotarget.9077] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
657 Numata T, Nagatani T, Shirai K, Maeda T, Mae K, Nakasu M, Saito M, Usuda T, Tsuboi R, Okubo Y. Sézary syndrome managed with histone deacetylase inhibitor followed by anti-CCR4 monoclonal antibody. Clin Exp Dermatol 2018;43:281-5. [PMID: 29327377 DOI: 10.1111/ced.13357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
658 Malhotra KP, Neyaz A, Gupta A, Das M, Husain N. Multiple inflamed cutaneous nodules in an elderly female. Indian J Dermatol Venereol Leprol 2018;84:518-20. [PMID: 29327695 DOI: 10.4103/ijdvl.IJDVL_831_16] [Reference Citation Analysis]
659 Wang J, Liang R, Hao C, Liu X, Zhang N, Duan X, Dong H, Dong B, Gu H, Gao G, Zhang T, Bai Q, Chen X. Survival outcomes of primary cutaneous T-cell lymphoma in HIV-infected patients: a national population-based study. J Investig Med 2018;66:762-7. [PMID: 29330308 DOI: 10.1136/jim-2017-000636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
660 Ghahramani GK, Goetz KE, Liu V. Dermoscopic characterization of cutaneous lymphomas: a pilot survey. Int J Dermatol 2018;57:339-43. [DOI: 10.1111/ijd.13860] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
661 Emge DA, Lewis DJ, Aung PP, Duvic M. How to Discern Folliculotropic Mycosis Fungoides From Follicular Mucinosis Using a Pediatric Case. J Cutan Med Surg 2018;22:336-40. [DOI: 10.1177/1203475417752366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
662 Purnak S, Azar J, Mark LA. Etoposide as a single agent in the treatment of mycosis fungoides: A retrospective analysis. Dermatologic Therapy 2018;31. [DOI: 10.1111/dth.12586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
663 Lindahl LM, Fredholm S, Joseph C, Nielsen BS, Jønson L, Willerslev-Olsen A, Gluud M, Blümel E, Petersen DL, Sibbesen N, Hu T, Nastasi C, Krejsgaard T, Jæhger D, Persson JL, Mongan N, Wasik MA, Litvinov IV, Sasseville D, Koralov SB, Bonefeld CM, Geisler C, Woetmann A, Ralfkiaer E, Iversen L, Odum N. STAT5 induces miR-21 expression in cutaneous T cell lymphoma. Oncotarget 2016;7:45730-44. [PMID: 27329723 DOI: 10.18632/oncotarget.10160] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
664 Janiga J, Kentley J, Nabhan C, Abdulla F. Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome. Leuk Lymphoma 2018;59:562-77. [PMID: 29308723 DOI: 10.1080/10428194.2017.1347650] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
665 Chu C, Rudnick EW, Motaparthi K. Blastic plasmacytoid dendritic cell neoplasm with centrocyte-like morphology clinically simulating a melanocytic nevus. J Cutan Pathol 2018;45:249-53. [PMID: 29293270 DOI: 10.1111/cup.13099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
666 Tanaka Y, Usuda T, Koumura M, Tsurumi Y, Inasaka Y, Sugawara K, Ito Y, Kodera M. Primary cutaneous anaplastic large cell lymphoma showing relapse after 20 years : A case report. Skin Cancer 2018;33:55-60. [DOI: 10.5227/skincancer.33.55] [Reference Citation Analysis]
667 Kacem I, Hafsia M, Bousoffara L, Fetoui NG, Maalel OE, Boughattas W, Ghariani N, Denguezli M, Brahem A, Guedri SE, Kalboussi H, Chatti S, Mrizak N. Mycosis Fungoides in Relation to Environmental and Occupational Exposures: A Case-Control Study in the Tunisian Center. IJCM 2018;09:528-539. [DOI: 10.4236/ijcm.2018.96046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
668 Montanelli L, Benvenga S, Hegedüs L, Vitti P, Latrofa F, Duntas LH. Drugs and Other Substances Interfering with Thyroid Function. Endocrinology 2018. [DOI: 10.1007/978-3-319-45013-1_27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
669 Kungurov NV, Kuklin IA, Kokhan MM, Zilberberg NV, Topychkanova EP, Kuznetsov ID. Experience in application of the confocal laser scanning microscopy of the skin is diagnosis of primary cutaneous diffuse large B-cell lymphoma. Klin dermatol venerol 2018;17:72. [DOI: 10.17116/klinderma201817172-76] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
670 Bhat T, Zwerner JP, Musiek A. Cutaneous Lymphomas. A Practical Guide to Skin Cancer 2018. [DOI: 10.1007/978-3-319-74903-7_8] [Reference Citation Analysis]
671 Wang SA. T- and NK-Cell Lymphocytosis. Diagnosis of Blood and Bone Marrow Disorders 2018. [DOI: 10.1007/978-3-319-20279-2_11] [Reference Citation Analysis]
672 Haggerty H, Price K, Shenton J. Immunotoxicology of Biopharmaceutics. Comprehensive Toxicology 2018. [DOI: 10.1016/b978-0-08-100601-6.02008-1] [Reference Citation Analysis]
673 Sequeira C, Ozer H. Immunology of the Lymphomas. Neoplastic Diseases of the Blood 2018. [DOI: 10.1007/978-3-319-64263-5_41] [Reference Citation Analysis]
674 Zatorskaya NF, Grebenyuk VN, Grishko TN, Valitova IV, Bakuseva ZY, Pilyavskaya SO, Bobrov MA, Negasheva ES. Difficulties of the differential diagnosis of cutaneous lymphomas in children. Klin dermatol venerol 2018;17:92. [DOI: 10.17116/klinderma201817397] [Reference Citation Analysis]
675 Hurabielle C, Sbidian E, Beltraminelli H, Bouchindhomme B, Chassagne-clément C, Balme B, Bossard C, Delfau-larue M, Wolkenstein P, Chosidow O, Cordonnier C, Toma A, Pautas C, Ortonne N. Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients. Human Pathology 2018;71:100-8. [DOI: 10.1016/j.humpath.2017.10.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
676 Slack GW, Hsi ED. Diffuse Aggressive B-Cell Lymphomas. Hematopathology 2018. [DOI: 10.1016/b978-0-323-47913-4.00008-2] [Reference Citation Analysis]
677 Boos M, Samimi S. Lymphoproliferative Disorders of the Skin. Skin Tumors and Reactions to Cancer Therapy in Children 2018. [DOI: 10.1007/978-3-319-66200-8_3] [Reference Citation Analysis]
678 Assaf C, Amani AU, Yildiz E, Hwang ST. Tumors in Pigmented Skin. Pigmented Ethnic Skin and Imported Dermatoses 2018. [DOI: 10.1007/978-3-319-69422-1_36] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
679 Chernova NG, Kolomeitsev O. Current Opportunities for Treatment Optimization of Mycosis Fungoides and Sezary Syndrome. Клиническая онкогематология 2018;11:34-41. [DOI: 10.21320/2500-2139-2018-11-1-34-41] [Reference Citation Analysis]
680 Macon WR. Peripheral T-Cell Lymphomas. Hematopathology 2018. [DOI: 10.1016/b978-0-323-47913-4.00009-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
681 Kempf W, Stadler R. Maligne Lymphome der Haut. Braun-Falco’s Dermatologie, Venerologie und Allergologie 2018. [DOI: 10.1007/978-3-662-49544-5_109] [Reference Citation Analysis]
682 Singer L, Garsa A. Cutaneous Lymphomas. Handbook of Evidence-Based Radiation Oncology 2018. [DOI: 10.1007/978-3-319-62642-0_37] [Reference Citation Analysis]
683 Olisova O, Sydikov A, Chuprov I, Gorenkova L, Chernysh S, Doronin V, Grekova EV. Erythrodermic Mycosis Fungoides: The Algorithm of Diagnosis and Treatment. Клиническая онкогематология 2018;11:295-302. [DOI: 10.21320/2500-2139-2018-11-4-295-302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
684 Weber MB, Camozzato FO. Pruritus. Dermatology in Public Health Environments 2018. [DOI: 10.1007/978-3-319-33919-1_61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
685 Nudelmann L, Bonamigo RR. Cutaneous T-Cell Lymphoma and NK Cells. Dermatology in Public Health Environments 2018. [DOI: 10.1007/978-3-319-33919-1_17] [Reference Citation Analysis]
686 Montanelli L, Benvenga S, Hegedus L, Vitti P, Latrofa F, Duntas LH. Drugs and Other Substances Interfering with Thyroid Function. Endocrinology 2018. [DOI: 10.1007/978-3-319-29195-6_27-1] [Reference Citation Analysis]
687 Mishra S, Shelly D, Vinu Balraam KV, Bharadwaj R. Primary Cutaneous B-cell Lymphomas: Case Report of Two Cases. Indian J Dermatol 2017;62:675. [PMID: 29263552 DOI: 10.4103/ijd.IJD_83_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
688 Ikeda S, Kitadate A, Ito M, Abe F, Nara M, Watanabe A, Takahashi N, Miyagaki T, Sugaya M, Tagawa H. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Oncotarget 2016;7:13563-74. [PMID: 26789110 DOI: 10.18632/oncotarget.6916] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
689 Guerzoni ME, Pruccoli F, Palazzi G, Mariotti I, Cano C, Cellini M, Cesinaro AM, Mataca E, Iughetti L. Primary Pediatric Cutaneous T-Cell Lymphoproliferative Disorders: 3 New Cases. J Pediatr Hematol Oncol 2018;40:231-4. [PMID: 29240032 DOI: 10.1097/MPH.0000000000001021] [Reference Citation Analysis]
690 van Santen S, Jansen PM, Vermeer MH, Willemze R. Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long-term follow-up data in a series of 9 cases. J Cutan Pathol 2018;45:122-8. [DOI: 10.1111/cup.13077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
691 Sugeeth MT, Narayanan G, Jayasudha AV, Nair RA. Subcutaneous panniculitis-like T-cell lymphoma. Proc (Bayl Univ Med Cent) 2017;30:76-7. [PMID: 28127142 DOI: 10.1080/08998280.2017.11929537] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
692 Su C, Nguyen KA, Bai HX, Cao Y, Tao Y, Karakousis G, Zhang PJ, Zhang G, Xiao R. Disease site as a determinant of survival outcome in patients with primary cutaneous peripheral T-cell lymphoma, unspecified: an analysis of 4057 cases from the US National Cancer Database. Leuk Lymphoma 2018;59:2105-12. [PMID: 29214867 DOI: 10.1080/10428194.2017.1410886] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
693 Cyrenne BM, Gibson JF, Subtil A, Girardi M, Isufi I, Seropian S, Foss F. Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8-Positive T-Cell Lymphoma. Clin Lymphoma Myeloma Leuk 2018;18:e85-93. [PMID: 29223388 DOI: 10.1016/j.clml.2017.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
694 Adamski H, Ingen‐housz‐oro S, Machet L, Carriou A, Ram‐wolff C, Ortonne N, Le Gall F, Durlach A, Dupuis J, Dauriac C, Dupuy A, Grange F, Bagot M. Lymphomatoid papulosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: three cases. Br J Dermatol 2018;178. [DOI: 10.1111/bjd.15698] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
695 Lindahl LM, Besenbacher S, Rittig AH, Celis P, Willerslev-Olsen A, Gjerdrum LMR, Krejsgaard T, Johansen C, Litman T, Woetmann A, Odum N, Iversen L. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study. Blood 2018;131:759-70. [PMID: 29208599 DOI: 10.1182/blood-2017-06-788950] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
696 Melchers RC, Willemze R, Daniëls LA, Neelis KJ, Bekkenk MW, de Haas ER, Horvath B, van Rossum MM, Sanders CJ, Velstra B, Veraart JC, Roach RE, Vermeer MH, Quint KD. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group. International Journal of Radiation Oncology*Biology*Physics 2017;99:1279-85. [DOI: 10.1016/j.ijrobp.2017.08.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
697 Wehkamp U, Weichenthal M. Therapie seltener kutaner T‑Zell-Lymphome und der blastären plasmazytoiden dendritischen Zellneoplasie. best practice onkologie 2017;12:316-322. [DOI: 10.1007/s11654-017-0052-8] [Reference Citation Analysis]
698 Hope CB, Pincus LB. Primary Cutaneous B-cell Lymphomas. Clin Lab Med 2017;37:547-74. [PMID: 28802500 DOI: 10.1016/j.cll.2017.05.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
699 Pulitzer M. Cutaneous T-cell Lymphoma. Clin Lab Med 2017;37:527-46. [PMID: 28802499 DOI: 10.1016/j.cll.2017.06.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
700 Schwartz Z, Coleman M, Toyohara JP, Freedman PD, Magro CM. Oral Lymphomatoid papulosis type C: A diagnostic pitfall, often confused with T-cell lymphoma. Annals of Diagnostic Pathology 2017;31:50-5. [DOI: 10.1016/j.anndiagpath.2017.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
701 van Santen S, Vermeer MH, Willemze R. Classification and recommended treatment options for folliculotropic mycosis fungoides. Expert Opinion on Orphan Drugs 2017;6:35-45. [DOI: 10.1080/21678707.2018.1406796] [Reference Citation Analysis]
702 Chan WH, Lewis DJ, Hinojosa T, Curry JL, Duvic M. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation. Pediatr Dermatol 2018;35:e13-6. [PMID: 29159918 DOI: 10.1111/pde.13338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
703 Grandi V, Alberti Violetti S, La Selva R, Cicchelli S, Delfino C, Fava P, Fierro MT, Pileri A, Pimpinelli N, Quaglino P, Berti E. Primary cutaneous B-cell lymphoma: narrative review of the literature. G Ital Dermatol Venereol 2019;154:466-79. [PMID: 29144099 DOI: 10.23736/S0392-0488.17.05670-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
704 Mascolo M, Romano MF, Ilardi G, Romano S, Baldo A, Scalvenzi M, Argenziano G, Merolla F, Russo D, Varricchio S, Pagliuca F, Russo M, Ciancia G, De Rosa G, Staibano S. Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides. J Eur Acad Dermatol Venereol 2018;32:735-44. [PMID: 28977697 DOI: 10.1111/jdv.14614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
705 Ramos-Rodríguez C, García-Rojo M, Romero-Aguilera G, García-Arpa M, González-López L, Sánchez-Caminero MP, González-García J, Delgado-Portela M, Cortina-De La Calle MP, Relea-Calatayud MF, Martín-Dávila F, López-Pérez R, Ramos-Rodríguez M. Epidemiologic, clinical and demographic features of primary cutaneous lymphomas in Castilla-La Mancha, Spain: are we different? J Eur Acad Dermatol Venereol 2018;32:e168-71. [PMID: 29114937 DOI: 10.1111/jdv.14672] [Reference Citation Analysis]
706 Fanok MH, Sun A, Fogli LK, Narendran V, Eckstein M, Kannan K, Dolgalev I, Lazaris C, Heguy A, Laird ME, Sundrud MS, Liu C, Kutok J, Lacruz RS, Latkowski JA, Aifantis I, Ødum N, Hymes KB, Goel S, Koralov SB. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 2018;138:1116-25. [PMID: 29128259 DOI: 10.1016/j.jid.2017.10.028] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 8.3] [Reference Citation Analysis]
707 Nhu QM, Du EZ, Kiyani A, Frenette CT. A rare localised nasal CD30+ primary cutaneous T-cell lymphoma following liver transplantation. BMJ Case Rep 2017;2017:bcr-2017-221028. [PMID: 29103006 DOI: 10.1136/bcr-2017-221028] [Reference Citation Analysis]
708 Haverkos BM, Gru AA, Geyer SM, Bingman AK, Hemminger JA, Mishra A, Wong HK, Pancholi P, Freud AG, Caligiuri MA, Baiocchi RA, Porcu P. Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma. Clin Lymphoma Myeloma Leuk 2016;16 Suppl:S181-S190.e4. [PMID: 27521316 DOI: 10.1016/j.clml.2016.02.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
709 Scarisbrick JJ. Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management. Future Oncology 2017;13:2405-11. [DOI: 10.2217/fon-2017-0263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
710 Atilla E, Atilla P, Bozdag S, Yuksel M, Toprak S, Topcuoglu P, Akay B, Sanli H, Akan H, Demirer T, Beksac M, Arslan O, Ozcan M, Gurman G, Ilhan O. Extracorporeal photochemotherapy in mycosis fungoides. Transfusion Clinique et Biologique 2017;24:454-7. [DOI: 10.1016/j.tracli.2017.05.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
711 Chen H, Xiong J, Sheng N, Zong W, Wang Y, Li M, Sun J. Primary Cutaneous Sarcomatoid Anaplastic Lymphoma Kinase-Positive Anaplastic Large-Cell Lymphoma With Linear Distributional Lesions. The American Journal of Dermatopathology 2017;39:863-6. [DOI: 10.1097/dad.0000000000000925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
712 Laribi K, Lemaire P, Sandrini J, Baugier de Materre A. Advances in the understanding and management of T-cell prolymphocytic leukemia. Oncotarget 2017;8:104664-86. [PMID: 29262669 DOI: 10.18632/oncotarget.22272] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
713 Argnani L, Broccoli A, Zinzani PL. Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease. Cancer Treat Rev 2017;61:61-9. [PMID: 29102679 DOI: 10.1016/j.ctrv.2017.10.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
714 Huggins AB, Kim C, Rabinowitz MP. Orbital T-cell lymphoma versus lupus panniculitits: a T-cell-mediated spectrum of orbital lymphoproliferative disease. Orbit 2018;37:102-4. [PMID: 29039997 DOI: 10.1080/01676830.2017.1383460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
715 Berg S, Villasenor-Park J, Haun P, Kim EJ. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome. Curr Hematol Malig Rep 2017;12:234-43. [PMID: 28540671 DOI: 10.1007/s11899-017-0387-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
716 Cyrenne BM, Subtil A, Girardi M, Foss F. Primary cutaneous aggressive epidermotropic cytotoxic CD8+ T-cell lymphoma: long-term remission after brentuximab vedotin. Int J Dermatol 2017;56:1448-50. [PMID: 29047111 DOI: 10.1111/ijd.13792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
717 Sławińska M, Sobjanek M, Olszewska B, Nowicki R, Sokołowska-wojdyło M. Trichoscopic spectrum of folliculotropic mycosis fungoides. J Eur Acad Dermatol Venereol 2018;32:e107-8. [DOI: 10.1111/jdv.14596] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
718 Panagopoulos I, Gorunova L, Spetalen S, Bassarova A, Beiske K, Micci F, Heim S. Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma. Oncotarget 2017;8:103775-84. [PMID: 29262599 DOI: 10.18632/oncotarget.21790] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
719 Fernández-de-misa R, Hernández-machín B, Servitje O, Valentí-medina F, Maroñas-jiménez L, Ortiz-romero PL, Sánchez Schmidt J, Pujol RM, Gallardo F, Pau-charles I, García Muret MP, Pérez Gala S, Román C, Cañueto J, Blanch Rius L, Izu R, Ortiz-brugués A, Martí RM, Blanes M, Morillo M, Sánchez P, Peñate Y, Bastida J, Pérez Gil A, Lopez-lerma I, Muniesa C, Estrach T. First-line treatment in lymphomatoid papulosis: a retrospective multicentre study. Clin Exp Dermatol 2018;43:137-43. [DOI: 10.1111/ced.13256] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
720 Nguyen HV, Jakobiec FA, Zakka FR, Yoon MK. Bilateral upper and lower eyelid margin swelling and madarosis due to lymphoma. Surv Ophthalmol 2018;63:589-94. [PMID: 28986312 DOI: 10.1016/j.survophthal.2017.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
721 Netchiporouk E, Gantchev J, Tsang M, Thibault P, Watters AK, Hughes JM, Ghazawi FM, Woetmann A, Ødum N, Sasseville D, Litvinov IV. Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines. Oncotarget 2017;8:95981-98. [PMID: 29221181 DOI: 10.18632/oncotarget.21619] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
722 Su C, Nguyen KA, Bai HX, Balaji D, Cao Y, Karakousis G, Zhang PJ, Zhang G, Xiao R. Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients. Leukemia & Lymphoma 2018;59:1406-12. [DOI: 10.1080/10428194.2017.1379078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
723 Sun JR, Nong L, Liu XQ, Tu P, Wang Y. Frequent immunoglobulin G4 expression in a common variant of primary cutaneous marginal zone B-cell lymphoma. Australas J Dermatol 2018;59:141-5. [PMID: 28980311 DOI: 10.1111/ajd.12699] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
724 Mangold AR, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-laish I, Pujol RM, Pittelkow MR, Gniadecki R. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study. Journal of the American Academy of Dermatology 2017;77:719-27. [DOI: 10.1016/j.jaad.2017.05.036] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
725 Wilcox RA. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 2017;92:1085-102. [PMID: 28872191 DOI: 10.1002/ajh.24876] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 13.3] [Reference Citation Analysis]
726 Rezk Hassan GF, Marey K. Immunohistopathological Study of c-FLIP Protein in Mycosis Fungoides. Asian Pac J Cancer Prev 2017;18:2493-9. [PMID: 28952283 DOI: 10.22034/APJCP.2017.18.9.2493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
727 Phan A, Veldman R, Lechowicz MJ. T-cell Lymphoma Epidemiology: the Known and Unknown. Curr Hematol Malig Rep 2016;11:492-503. [PMID: 27995419 DOI: 10.1007/s11899-016-0353-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
728 Reiter O, Ben Amitai D, Amitay-laish I, Israeli M, Pavlovsky L, Hodak E. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients. Arch Dermatol Res 2017;309:851-6. [DOI: 10.1007/s00403-017-1783-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
729 Kheterpal M, Mehta-Shah N, Virmani P, Myskowski PL, Moskowitz A, Horwitz SM. Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides. Curr Hematol Malig Rep 2016;11:224-33. [PMID: 27101016 DOI: 10.1007/s11899-016-0322-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
730 Miyashiro D, Torrealba MP, Manfrere KC, Pereira J, Sato MN, Sanches JA. Double-positive CD4 and CD8 Sézary syndrome. JAAD Case Rep 2017;3:485-8. [PMID: 28971139 DOI: 10.1016/j.jdcr.2017.06.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
731 Lefrançois P, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Duvic M, Litvinov IV. TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform. Front Med (Lausanne) 2017;4:153. [PMID: 29018799 DOI: 10.3389/fmed.2017.00153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
732 Kalogeropoulos D, Papoudou-Bai A, Kanavaros P, Kalogeropoulos C. Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue. Clin Exp Med 2018;18:151-63. [PMID: 28939925 DOI: 10.1007/s10238-017-0474-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
733 Ott CJ, Wu CJ. HDAC Inhibitors Finally Open Up: Chromatin Accessibility Signatures of CTCL. Cancer Cell 2017;32:1-3. [PMID: 28697338 DOI: 10.1016/j.ccell.2017.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
734 Mitteldorf C, Berisha A, Pfaltz MC, Broekaert SMC, Schön MP, Kerl K, Kempf W. Tumor Microenvironment and Checkpoint Molecules in Primary Cutaneous Diffuse Large B-Cell Lymphoma-New Therapeutic Targets. Am J Surg Pathol 2017;41:998-1004. [PMID: 28504999 DOI: 10.1097/PAS.0000000000000851] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
735 Fabbrocini G, Mazzella C, Cantelli M, Baldo A, Russo D, De Rosa G, Monfrecola G. Reflectance Confocal Microscopy as New Diagnostic Tool in Folliculotropic Mycosis Fungoides. Skin Appendage Disord 2018;4:118-21. [PMID: 29765972 DOI: 10.1159/000479822] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
736 Walsh NM, Lano IM, Green P, Gallant C, Pasternak S, Ly TY, Requena L, Kutzner H, Chott A, Cerroni L. AL Amyloidoma of the Skin/Subcutis: Cutaneous Amyloidosis, Plasma Cell Dyscrasia or a Manifestation of Primary Cutaneous Marginal Zone Lymphoma? Am J Surg Pathol 2017;41:1069-76. [PMID: 28505007 DOI: 10.1097/PAS.0000000000000861] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
737 Wu CC, Takahashi E, Asano N, Miyata-Takata T, Takata K, Furukawa K, Elsayed AA, Hu LM, Satou A, Kohno K, Kosugi H, Ohashi K, Kinoshita T, Nakamura S, Kato S. Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease? Hum Pathol 2017;68:61-8. [PMID: 28873353 DOI: 10.1016/j.humpath.2017.08.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
738 Moreno-suárez F, Bautista Martínez P, Jiménez Burgos F. Nasal-Type Extranodal Natural Killer T-Cell Lymphoma. Actas Dermo-Sifiliográficas (English Edition) 2017;108:687-689. [DOI: 10.1016/j.adengl.2017.06.008] [Reference Citation Analysis]
739 Schmitt C, Marie-Cardine A, Bensussan A. Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas. Front Immunol 2017;8:1010. [PMID: 28912774 DOI: 10.3389/fimmu.2017.01010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
740 Keehn CA, Belongie IP, Shistik G, Fenske NA, Glass LF. The Diagnosis, Staging, and Treatment Options for Mycosis Fungoides. Cancer Control 2007;14:102-11. [DOI: 10.1177/107327480701400203] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
741 Keeling BH, Gavino ACP, Admirand J, Soldano AC. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature: KEELING et al . J Cutan Pathol 2017;44:944-7. [DOI: 10.1111/cup.13011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
742 Sokol L, Glass LF. T/NK-Cell Lymphomas/Leukemias: Shedding New Light on These Rare Diseases. Cancer Control 2007;14:96-7. [DOI: 10.1177/107327480701400201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
743 Rezania D, Sokol L, Cualing HD. Classification and Treatment of Rare and Aggressive Types of Peripheral T-Cell/Natural Killer-Cell Lymphomas of the Skin. Cancer Control 2007;14:112-23. [DOI: 10.1177/107327480701400204] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
744 Duvic M, Bates SE, Piekarz R, Eisch R, Kim YH, Lerner A, Robak T, Samtsov A, Becker JC, McCulloch W, Waksman J, Whittaker S. Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy. Leuk Lymphoma 2018;59:880-7. [PMID: 28853310 DOI: 10.1080/10428194.2017.1361022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
745 Alaibac M. Monoclonal antibodies against cutaneous T-cell lymphomas. Expert Opinion on Biological Therapy 2017;17:1503-10. [DOI: 10.1080/14712598.2017.1369951] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
746 de Brito M, Gazzani P, Amel-Kashipaz R, Vydianath B, Scarisbrick JJ. Image Gallery: Secondary cutaneous involvement of the ear with systemic small lymphocytic lymphoma: a rare manifestation. Br J Dermatol 2017;177:e26. [PMID: 28833023 DOI: 10.1111/bjd.15718] [Reference Citation Analysis]
747 Mitteldorf C, Grabbe S, Stadler R. WHO-Klassifikation und klinisches Spektrum der kutanen Lymphome. Hautarzt 2017;68:682-95. [DOI: 10.1007/s00105-017-4025-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
748 Lamos C, Dippel E. [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities]. Hautarzt 2017;68:727-39. [PMID: 28815289 DOI: 10.1007/s00105-017-4018-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
749 Kim HS, Kim HJ, Kim SH, Choi JY, Ko YH, Kim WS, Jung CW, Kim SJ. Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea. Korean J Intern Med 2017;32:890-9. [PMID: 28870016 DOI: 10.3904/kjim.2015.406] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
750 Wehkamp U, Weichenthal M. [Treatment of rare cutaneous T‑cell lymphoma and blastic plasmacytoid dendritic cell neoplasm]. Hautarzt 2017;68:711-5. [PMID: 28795194 DOI: 10.1007/s00105-017-4024-2] [Reference Citation Analysis]
751 Ehsani AH, Nasimi M, Azizpour A, Noormohammadpoor P, Kamyab K, Seirafi H, Noori M. Nail Changes in Early Mycosis Fungoides. Skin Appendage Disord 2018;4:55-9. [PMID: 29457018 DOI: 10.1159/000478946] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
752 Damsky WE, Choi J. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside. Curr Treat Options Oncol 2016;17:33. [PMID: 27262707 DOI: 10.1007/s11864-016-0410-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
753 Felcht M, Hillen U, Klemke CD. [Diagnostics of primary cutaneous lymphomas]. Hautarzt 2017;68:696-701. [PMID: 28779267 DOI: 10.1007/s00105-017-4020-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
754 Gabeeva NG, Koroleva DA, Belyaeva AV, Chernova NG, Kuzmina LA, Sudarikov AB, Obukhova TN, Kovrigina AM, Zvonkov EE, Savchenko VG. [Diffuse large B-cell lymphoma with concomitant c-MYC and BCL6 gene rearrangements with primary skin involvement: A case report and a review of literature]. Ter Arkh 2017;89:85-92. [PMID: 28766546 DOI: 10.17116/terarkh201789785-92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
755 Enos TH, Feigenbaum LS, Wickless HW. Brentuximab vedotin in CD30 + primary cutaneous T-cell lymphomas: a review and analysis of existing data. Int J Dermatol 2017;56:1400-5. [DOI: 10.1111/ijd.13696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
756 Roelens M, Delord M, Ram-Wolff C, Marie-Cardine A, Alberdi A, Maki G, Homyrda L, Bensussan A, Bagot M, Toubert A, Moins-Teisserenc H. Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity. Blood 2017;130:1468-71. [PMID: 28760889 DOI: 10.1182/blood-2017-03-772996] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
757 Lauenborg B, Litvinov IV, Zhou Y, Willerslev-Olsen A, Bonefeld CM, Nastasi C, Fredholm S, Lindahl LM, Sasseville D, Geisler C, Wasik MM, Krejsgaard T, Gjerdrum LMR, Iversen L, Odum N, Woetmann A. Malignant T cells activate endothelial cells via IL-17 F. Blood Cancer J 2017;7:e586. [PMID: 28731459 DOI: 10.1038/bcj.2017.64] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
758 Schiller M, Tsianakas A, Sterry W, Dummer R, Hinke A, Nashan D, Stadler R. Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol 2017;31:1841-7. [PMID: 28557110 DOI: 10.1111/jdv.14366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
759 Wollina U, Hansel G, Langner D, Koch A, Schönlebe J, Tchernev G. Rapid Evolving Unilateral Indurated Oozing Facial Plaques in a Patient with Head-and-Neck Cancer: Peripheral T-Cell Lymphoma Not Otherwise Specified (NOS). Open Access Maced J Med Sci 2017;5:476-9. [PMID: 28785337 DOI: 10.3889/oamjms.2017.085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
760 Mature T/NK-Cell Lymphoproliferations. Flow Cytometry in Neoplastic Hematology 2017. [DOI: 10.1201/9781315113715-19] [Reference Citation Analysis]
761 Lehmer LM, Amber KT, de Feraudy SM. Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic "Sigh of Relief". Am J Dermatopathol 2017;39:920-3. [PMID: 28692463 DOI: 10.1097/DAD.0000000000000926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
762 Other Tumors. Flow Cytometry in Neoplastic Hematology 2017. [DOI: 10.1201/9781315113715-29] [Reference Citation Analysis]
763 Chang TW, Weaver AL, Shanafelt TD, Habermann TM, Wriston CC, Cerhan JR, Call TG, Brewer JD. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma. Int J Dermatol 2017;56:1125-9. [PMID: 28685851 DOI: 10.1111/ijd.13653] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
764 Cervini A, Torres-huamani A, Sanchez-la-rosa C, Galluzzo L, Solernou V, Digiorge J, Rubio P. Mycosis Fungoides: Experience in a Pediatric Hospital. Actas Dermo-Sifiliográficas (English Edition) 2017;108:564-70. [DOI: 10.1016/j.adengl.2017.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
765 Virmani P, Jawed S, Myskowski PL, Horwitz S, Skripnik Lucas A, Moskowitz A, Pulitzer M, Zain J, Rosen ST, Querfeld C. Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience. Int J Dermatol 2016;55:1248-54. [PMID: 27369070 DOI: 10.1111/ijd.13340] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
766 Smolewski P, Robak T. The discovery and development of romidepsin for the treatment of T-cell lymphoma. Expert Opin Drug Discov 2017;12:859-73. [PMID: 28641053 DOI: 10.1080/17460441.2017.1341487] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
767 Notay M, Petukhova TA, Kiuru M, Kunder CA, Hwang ST. Mycosis fungoides presenting as symmetric concentric patches mimicking figurate erythema. JAAD Case Rep 2017;3:288-90. [PMID: 28702497 DOI: 10.1016/j.jdcr.2017.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
768 Kong SH, Han SH, Suh HS, Choi YS. Blastic Plasmacytoid Dendritic Cell Neoplasm Presenting as Erythematous Nodules with Gallbladder Involvement. Ann Dermatol 2017;29:501-3. [PMID: 28761306 DOI: 10.5021/ad.2017.29.4.501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
769 Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BS. Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma. Adv Radiat Oncol 2017;2:363-9. [PMID: 29114604 DOI: 10.1016/j.adro.2017.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
770 Qu K, Zaba LC, Satpathy AT, Giresi PG, Li R, Jin Y, Armstrong R, Jin C, Schmitt N, Rahbar Z, Ueno H, Greenleaf WJ, Kim YH, Chang HY. Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors. Cancer Cell 2017;32:27-41.e4. [PMID: 28625481 DOI: 10.1016/j.ccell.2017.05.008] [Cited by in Crossref: 103] [Cited by in F6Publishing: 112] [Article Influence: 17.2] [Reference Citation Analysis]
771 AbuHilal M, Walsh S, Shear N. Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study. J Cutan Med Surg 2017;21:507-12. [PMID: 28614957 DOI: 10.1177/1203475417716366] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
772 Virmani P, Busam K, Myskowski PL, Yang A, Magro C, Horwitz S. Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab. JAAD Case Rep 2017;3:269-72. [PMID: 28653027 DOI: 10.1016/j.jdcr.2017.02.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
773 Morris S, Scarisbrick J, Frew J, Irwin C, Grieve R, Humber C, Kuciejewska A, Bayne S, Weatherhead S, Child F, Wain M, Whittaker S. The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group. Int J Radiat Oncol Biol Phys 2017;99:627-33. [PMID: 28843374 DOI: 10.1016/j.ijrobp.2017.05.052] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
774 Kamijo H, Sugaya M, Takahashi N, Oka T, Miyagaki T, Asano Y, Sato S. BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines. Arch Dermatol Res 2017;309:491-7. [DOI: 10.1007/s00403-017-1749-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
775 Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin H, Liu Y, Huebner D, Little M, Whittaker S, Duvic M, Trotman J, Joske D, Prince HM, Taylor K, Lewis ID, Jonak C, Trautinger F, Bechter O, Wolter P, Bron D, de Lima VCC, Sanches JA, Klasa R, Bagot M, Beylot-barry M, Dalle S, D'incan M, Dreno B, Grange F, Nicolay J, Stadler R, Weichenthal M, Wobser M, Assaf C, Loquai C, Quaglino P, Spina M, Zinzani PL, Bosi A, Fattori PP, Grzanka A, Walewski J, Lopez-hernandez A, Ortiz-romero PL, Roca JJR, Canales SN, Dummer R, Illidge T, Johnson R, Whittaker S, Morris S, Mckay P, Scarisbrick J, Duvic M, Feldman T, Akilov O, Geskin L, Horwitz S, Kim YH, Pro B, Kuzel T, Lerner A, Eradat H, Sokol L, Fisher DC, Hughey S. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. The Lancet 2017;390:555-66. [DOI: 10.1016/s0140-6736(17)31266-7] [Cited by in Crossref: 334] [Cited by in F6Publishing: 278] [Article Influence: 55.7] [Reference Citation Analysis]
776 Al-haseni A, Sahni D. Skin Cancer. In: Vashi NA, Maibach HI, editors. Dermatoanthropology of Ethnic Skin and Hair. Cham: Springer International Publishing; 2017. pp. 257-84. [DOI: 10.1007/978-3-319-53961-4_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
777 Binamer Y. Cutaneous T-cell lymphoma in Saudi Arabia: retrospective single-center review. Ann Saudi Med 2017;37:212-5. [PMID: 28578360 DOI: 10.5144/0256-4947.2017.212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
778 Hayes C, Arkoumani E, Pandya D, Verdolini R. Discoloured saggy skin in a 57- year-old woman. Clin Exp Dermatol 2017;42:444-447. [DOI: 10.1111/ced.13048] [Reference Citation Analysis]
779 Wehkamp U, Weichenthal M, Klapper W, Schwarz T, Oschlies I. Unilesional locally recurrent lymphomatoid papulosis with variable histological presentation. Leuk Lymphoma 2018;59:262-4. [PMID: 28562138 DOI: 10.1080/10428194.2017.1323274] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
780 Heitmiller K, Barnes J, Chen ST. Cutaneous Lymphoma—Inpatient Considerations. Curr Derm Rep 2017;6:63-76. [DOI: 10.1007/s13671-017-0173-x] [Reference Citation Analysis]
781 . 5th Congress of WUWHS Abstract book Florence, Italy September 25–29 2016. J Wound Care 2017;26:1-518. [DOI: 10.12968/jowc.2017.26.sup6b.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
782 Nithya PJ, Parimkayala R, Saha D, Kushtagi P. Vulvar Mycosis Fungoides: A Rare Non-Hodgkin’s Cutaneous Lymphoma. Indian J Gynecol Oncolog 2017;15:17. [DOI: 10.1007/s40944-017-0107-3] [Reference Citation Analysis]
783 Carton de Tournai D, Deschamps L, Laly P, Zeboulon C, Bouaziz J, Ram-wolff C, Doumecq-lacoste J, Ortonne N, Rivet J, Battistella M, Bagot M. Mycosis fongoïde chalazodermique associé à un séminome testiculaire métastatique. Annales de Dermatologie et de Vénéréologie 2017;144:446-9. [DOI: 10.1016/j.annder.2017.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
784 García-herrera A, Calonje E. Cutaneous Lymphomas with Cytotoxic Phenotype. Surgical Pathology Clinics 2017;10:409-27. [DOI: 10.1016/j.path.2017.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
785 Chan S, Shah F, Chaganti S, Stevens A, Amel-kashipaz R, Vydianath B, Scarisbrick J. Primary cutaneous B-cell lymphoma: systemic spread is rare while cutaneous relapses and secondary malignancies are frequent. Br J Dermatol 2017;177:287-9. [DOI: 10.1111/bjd.15071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
786 Sauder MB, O'Malley JT, LeBoeuf NR. CD30+ Lymphoproliferative Disorders of the Skin. Hematol Oncol Clin North Am 2017;31:317-34. [PMID: 28340881 DOI: 10.1016/j.hoc.2016.11.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
787 Vural S, Akay BN, Botsalı A, Atilla E, Parlak N, Okçu Heper A, Şanlı H. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis. Turk J Haematol 2018;35:35-41. [PMID: 28533196 DOI: 10.4274/tjh.2016.0502] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
788 Wieser I, Wang C, Alberti-Violetti S, Lyons G, Tran C, Talpur R, Duvic M. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides. Arch Dermatol Res 2017;309:453-9. [PMID: 28516243 DOI: 10.1007/s00403-017-1744-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
789 Pantelaki I, Tigges C, Nußbaum T, Oellig F, Wieland U, Kreuter A. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy. Dermatol Ther 2017;30. [PMID: 28508527 DOI: 10.1111/dth.12499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
790 van Santen S, van Doorn R, Neelis KJ, Daniëls LA, Horváth B, Bruijn MS, Sanders CJG, van Rossum MM, de Haas ERM, Veraart JCJM, Bekkenk MW, Vermeer MH, Willemze R. Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group. Br J Dermatol 2017;177:223-8. [PMID: 28132406 DOI: 10.1111/bjd.15355] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
791 Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean S, Pehr K, Sasseville D, Litvinov IV. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy: CTCL Incidence and Mortality in Canada. Cancer 2017;123:3550-67. [DOI: 10.1002/cncr.30758] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
792 Mareschal S, Pham-Ledard A, Viailly PJ, Dubois S, Bertrand P, Maingonnat C, Fontanilles M, Bohers E, Ruminy P, Tournier I, Courville P, Lenormand B, Duval AB, Andrieu E, Verneuil L, Vergier B, Tilly H, Joly P, Frebourg T, Beylot-Barry M, Merlio JP, Jardin F. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. J Invest Dermatol 2017;137:1984-94. [PMID: 28479318 DOI: 10.1016/j.jid.2017.04.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 11.3] [Reference Citation Analysis]
793 Atilla E, Atilla PA, Bozdag SC, Yuksel MK, Toprak SK, Topcuoglu P, Akay BN, Sanli H, Gurman G, Ozcan M. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS). Int J Hematol 2017;106:426-30. [DOI: 10.1007/s12185-017-2245-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
794 Areán C, Córdoba A, García J, Larumbe A. Transformation of a primary cutaneous marginal zone lymphoma into a cutaneous diffuse large B-cell lymphoma. Piel 2017;32:314-316. [DOI: 10.1016/j.piel.2016.11.009] [Reference Citation Analysis]
795 Svendsen FH, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Honavar SG, Khong JJ, McKelvie PA, Mulay K, Ralfkiaer E, Sjö LD, Vemuganti GK, Thuro BA, Curtin J, Heegaard S. Lymphoma of the Eyelid - An International Multicenter Retrospective Study. Am J Ophthalmol 2017;177:58-68. [PMID: 28209503 DOI: 10.1016/j.ajo.2017.02.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
796 Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke C, Ortiz-romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017. European Journal of Cancer 2017;77:57-74. [DOI: 10.1016/j.ejca.2017.02.027] [Cited by in Crossref: 260] [Cited by in F6Publishing: 202] [Article Influence: 43.3] [Reference Citation Analysis]
797 Covington M, Cassarino D, Abdulla F. ALK Expression is a Rare Finding in Mycosis Fungoides. The American Journal of Dermatopathology 2017;39:342-3. [DOI: 10.1097/dad.0000000000000717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
798 Svendsen FH, Heegaard S. Lymphoma of the eyelid. Survey of Ophthalmology 2017;62:312-31. [DOI: 10.1016/j.survophthal.2016.11.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
799 Bilgiç Temel A, Unal B, Erdi Şanlı H, Duygulu Ş, Uzun S. A Severe Case of Lymphomatoid Papulosis Type E Successfully Treated with Interferon-Alfa 2a. Case Rep Dermatol Med 2017;2017:3194738. [PMID: 28540091 DOI: 10.1155/2017/3194738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
800 Plachouri KM, Weishaupt C, Metze D, Evers G, Berdel WE, Kempf W, Sunderkötter C, Stelljes M. Complete durable remission of a fulminant primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma after autologous and allogeneic hematopoietic stem cell transplantation. JAAD Case Rep 2017;3:196-9. [PMID: 28443307 DOI: 10.1016/j.jdcr.2017.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
801 Stephen S, Kim EJ, Introcaso CE, Richardson SK, Rook AH. Cutaneous T-Cell Lymphoma. In: Gaspari AA, Tyring SK, Kaplan DH, editors. Clinical and Basic Immunodermatology. Cham: Springer International Publishing; 2017. pp. 715-40. [DOI: 10.1007/978-3-319-29785-9_41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
802 Brown RA, Fernandez-Pol S, Kim J. Primary cutaneous anaplastic large cell lymphoma. J Cutan Pathol 2017;44:570-7. [PMID: 28342276 DOI: 10.1111/cup.12937] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
803 Him M, Meier M, Mehta V. Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion. Case Rep Oncol Med 2017;2017:4296802. [PMID: 28409043 DOI: 10.1155/2017/4296802] [Reference Citation Analysis]
804 Jagati A, Shah BJ, Tibrewal S, Gajjar T. CD3+, CD56+, CD4-, CD8-, CD20-, CD30- Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report. Indian J Dermatol 2017;62:200-2. [PMID: 28400642 DOI: 10.4103/ijd.IJD_440_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
805 Ferretti E, Corcione A, Pistoia V. The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment. J Leukoc Biol 2017;102:711-7. [PMID: 28408397 DOI: 10.1189/jlb.3MR0117-033R] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
806 Saruta H, Ohata C, Muto I, Imamura T, Oku E, Ohshima K, Nagafuji K, Nakama T. Hematopoietic stem cell transplantation in advanced cutaneous T-cell lymphoma. J Dermatol 2017;44:1038-42. [PMID: 28391645 DOI: 10.1111/1346-8138.13848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
807 Nikolaou V, Papadavid E, Patsatsi A, Siakantaris M, Economidi A, Marinos L, Koletsa T, Georgiou E, Pappa V, Stratigos A, Antoniou C. Prognostic indicators for mycosis fungoides in a Greek population. Br J Dermatol 2017;176:1321-30. [DOI: 10.1111/bjd.15000] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
808 Kempf W, Mitteldorf C, Karai LJ, Robson A. Die histologischen Typen der lymphomatoiden Papulose - Ein Vorschlag für die Vereinfachung des Buchstabenchaos: Terminologie der lymphomatoiden Papulose. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2017;15:390-4. [DOI: 10.1111/ddg.13207_g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
809 Bustos-Villalobos I, Bergstrom JW, Haigh NE, Luna JI, Mitra A, Marusina AI, Merleev AA, Wang EA, Sukhov A, Sultani H, Liu R, Bhardwaj G, Guo W, Kung HJ, Lam KS, Maverakis E. ITK inhibition for the targeted treatment of CTCL. J Dermatol Sci 2017;87:88-91. [PMID: 28434812 DOI: 10.1016/j.jdermsci.2017.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
810 Thompson AK, Killian JM, Weaver AL, Pittelkow MR, Davis MD. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic. Journal of the American Academy of Dermatology 2017;76:683-8. [DOI: 10.1016/j.jaad.2016.10.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
811 Foss FM, Girardi M. Mycosis Fungoides and Sezary Syndrome. Hematology/Oncology Clinics of North America 2017;31:297-315. [DOI: 10.1016/j.hoc.2016.11.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
812 Muñoz-gonzález H, Molina-ruiz A, Requena L. Clinicopathologic Variants of Mycosis Fungoides. Actas Dermo-Sifiliográficas (English Edition) 2017;108:192-208. [DOI: 10.1016/j.adengl.2017.02.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
813 Muñoz-gonzález H, Molina-ruiz A, Requena L. Variantes clínico-patológicas de micosis fungoide. Actas Dermo-Sifiliográficas 2017;108:192-208. [DOI: 10.1016/j.ad.2016.08.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
814 McEvenue G, Kim A, Binhammer P. Surgical Excision of Mycosis Fungoides Using Thumb-Sparing Reconstruction. Hand (N Y) 2017;12:NP22-6. [PMID: 28344538 DOI: 10.1177/1558944716669085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
815 Grijsen ML, Mtayangulwa RG, Naafs B, Jansen P, Vermeer MH, Mavura D, Masenga EJ, Willemze R. The clinical spectrum of mycosis fungoides in Tanzania, East Africa. Br J Dermatol 2017;176:1653-6. [PMID: 27529394 DOI: 10.1111/bjd.14963] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
816 Lymphoid Leukaemias of Mature B, T and Natural Killer Cells. Leukaemia Diagnosis 2017. [DOI: 10.1002/9781119210511.ch7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
817 Jia J, Li W, Zheng Y. Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature. Medicine (Baltimore) 2017;96:e6161. [PMID: 28225499 DOI: 10.1097/MD.0000000000006161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
818 Gros A, Laharanne E, Vergier M, Prochazkova-Carlotti M, Pham-Ledard A, Bandres T, Poglio S, Berhouet S, Vergier B, Vial JP, Chevret E, Beylot-Barry M, Merlio JP. TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma. PLoS One 2017;12:e0173171. [PMID: 28301507 DOI: 10.1371/journal.pone.0173171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
819 Li Z, Lu L, Zhou Z, Xue W, Wang Y, Jin M, Qiu Y, Sun W, Fu X, Zhang X, Chang Y, Nan F, Yan J, Wang G, Sun Z, Fu X, Li L, Li X, Wang X, Wu J, Zhang L, Zhang M. Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma. Br J Haematol 2018;181:406-10. [PMID: 28294301 DOI: 10.1111/bjh.14611] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
820 Kaufmann F, Kettelhack N, Hilty N, Kempf W. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature. J Eur Acad Dermatol Venereol 2017;31:1633-7. [DOI: 10.1111/jdv.14160] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
821 Moreno-Suárez F, Bautista Martínez P, Jiménez Burgos F. Nasal-Type Extranodal Natural Killer T-Cell Lymphoma. Actas Dermosifiliogr 2017;108:687-9. [PMID: 28291529 DOI: 10.1016/j.ad.2017.01.007] [Reference Citation Analysis]
822 Cervini AB, Torres-Huamani AN, Sanchez-La-Rosa C, Galluzzo L, Solernou V, Digiorge J, Rubio P. Mycosis Fungoides: Experience in a Pediatric Hospital. Actas Dermosifiliogr 2017;108:564-70. [PMID: 28279399 DOI: 10.1016/j.ad.2017.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
823 Pappo AS, Rodriguez-galindo C. Malignant Tumors of the Skin and Subcutaneous Tissue in Children. Textbook of Uncommon Cancer 2017. [DOI: 10.1002/9781119196235.ch80] [Reference Citation Analysis]
824 Liao C, Yang M, Liu P, Zhang W. A 92-year-old man with primary cutaneous diffuse large B-cell non-Hodgkin's lymphoma manifesting as a giant scalp mass: A case report. Medicine (Baltimore) 2017;96:e6270. [PMID: 28272240 DOI: 10.1097/MD.0000000000006270] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
825 Baykal C, Atci T, Ozturk Sari S, Polat Ekinci A, Buyukbabani N. Vernachlässigte klinische Merkmale der follikulotropen Mycosis fungoides: eine große klinische Fallserie. J Dtsch Dermatol Ges 2017;15:289-301. [PMID: 28252867 DOI: 10.1111/ddg.12976_g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
826 Pearson DR, Fujita M, High WA. Fulminant Mycosis Fungoides with Tissue Eosinophilia: A Unique Presentation of Two Cases with Acro-Periorbital Ulceration and An Aggressive Clinical Course. J Mol Biomark Diagn 2017;8:337. [PMID: 28758048 DOI: